
<html lang="en"     class="pb-page"  data-request-id="b22e21bc-80c3-4896-b04f-c46002b843d4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00811"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of the Privileged Position in the Imidazo[1,2-a]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors" /></meta><meta name="dc.Creator" content="Aleksandra  Kaźmierczak" /></meta><meta name="dc.Creator" content="Damian  Kusy" /></meta><meta name="dc.Creator" content="Sanna P.  Niinivehmas" /></meta><meta name="dc.Creator" content="Joanna  Gmach" /></meta><meta name="dc.Creator" content="Łukasz  Joachimiak" /></meta><meta name="dc.Creator" content="Olli T.  Pentikäinen" /></meta><meta name="dc.Creator" content="Edyta  Gendaszewska-Darmach" /></meta><meta name="dc.Creator" content="Katarzyna M.  Błażewska" /></meta><meta name="dc.Description" content="Members of the Rab GTPase family are master regulators of vesicle trafficking. When disregulated, they are associated with a number of pathological states. The inhibition of RGGT, an enzyme respons..." /></meta><meta name="Description" content="Members of the Rab GTPase family are master regulators of vesicle trafficking. When disregulated, they are associated with a number of pathological states. The inhibition of RGGT, an enzyme respons..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 17, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00811" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00811" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00811" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00811" /></link>
        
    
    

<title>Identification of the Privileged Position in the Imidazo[1,2-a]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00811" /></meta><meta property="og:title" content="Identification of the Privileged Position in the Imidazo[1,2-a]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0010.jpeg" /></meta><meta property="og:description" content="Members of the Rab GTPase family are master regulators of vesicle trafficking. When disregulated, they are associated with a number of pathological states. The inhibition of RGGT, an enzyme responsible for post-translational geranylgeranylation of Rab GTPases represents one way to control the activity of these proteins. Because the number of molecules modulating RGGT is limited, we combined molecular modeling with biological assays to ascertain how modifications of phosphonocarboxylates, the first reported RGGT inhibitors, rationally improve understanding of their structure–activity relationship. We have identified the privileged position in the core scaffold of the imidazo[1,2-a]pyridine ring, which can be modified without compromising compounds’ potency. Thus modified compounds are micromolar inhibitors of Rab11A prenylation, simultaneously being inactive against Rap1A/Rap1B modification, with the ability to inhibit proliferation of the HeLa cancer cell line. These findings were rationalized by molecular docking, which recognized interaction of phosphonic and carboxylic groups as decisive in phosphonocarboxylate localization in the RGGT binding site." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00811"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00811">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00811&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00811&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00811&amp;href=/doi/10.1021/acs.jmedchem.7b00811" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8781-8800</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00788" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00841" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of the Privileged Position in the Imidazo[1,2-<i>a</i>]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aleksandra++Ka%C5%BAmierczak">Aleksandra Kaźmierczak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damian++Kusy">Damian Kusy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanna+P.++Niinivehmas">Sanna P. Niinivehmas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanna++Gmach">Joanna Gmach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=%C5%81ukasz++Joachimiak">Łukasz Joachimiak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9962-2333" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olli+T.++Pentik%C3%A4inen">Olli T. Pentikäinen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edyta++Gendaszewska-Darmach">Edyta Gendaszewska-Darmach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katarzyna+M.++B%C5%82a%C5%BCewska">Katarzyna M. Błażewska</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1218-7111" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego Street 116, 90-924 Łódź, Poland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego Street 4/10, 90-924 Łódź, Poland</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Biological and Environmental Science & Nanoscience Center, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institute of Biomedicine, University of Turku, FI-20520 Turku, Finland</span></div><div class="corresp-info"><strong>*</strong>Phone: 0048 426313143. E-mail: <a href="/cdn-cgi/l/email-protection#b9d2d8cdd8cbc3c0d7d897dbd5d8c3dccecad2d8f9c997d5d6ddc397c9d5"><span class="__cf_email__" data-cfemail="d2b9b3a6b3a0a8abbcb3fcb0beb3a8b7a5a1b9b392a2fcbebdb6a8fca2be">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00811&amp;href=/doi/10.1021%2Facs.jmedchem.7b00811" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8781–8800</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 June 2017</li><li><span class="item_label"><b>Published</b> online</span>17 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00811" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00811</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8781%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAleksandra%2BKa%25C5%25BAmierczak%252C%2BDamian%2BKusy%252C%2BSanna%2BP.%2BNiinivehmas%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D21%26contentID%3Dacs.jmedchem.7b00811%26title%3DIdentification%2Bof%2Bthe%2BPrivileged%2BPosition%2Bin%2Bthe%2BImidazo%255B1%252C2-a%255Dpyridine%2BRing%2Bof%2BPhosphonocarboxylates%2Bfor%2BDevelopment%2Bof%2BRab%2BGeranylgeranyl%2BTransferase%2B%2528RGGT%2529%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8800%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00811"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1636</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00811" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of the Privileged Position in the Imidazo[1,2-a]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aleksandra&quot;,&quot;last_name&quot;:&quot;Kaźmierczak&quot;},{&quot;first_name&quot;:&quot;Damian&quot;,&quot;last_name&quot;:&quot;Kusy&quot;},{&quot;first_name&quot;:&quot;Sanna&quot;,&quot;last_name&quot;:&quot;P. Niinivehmas&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;Gmach&quot;},{&quot;first_name&quot;:&quot;Łukasz&quot;,&quot;last_name&quot;:&quot;Joachimiak&quot;},{&quot;first_name&quot;:&quot;Olli&quot;,&quot;last_name&quot;:&quot;T. Pentikäinen&quot;},{&quot;first_name&quot;:&quot;Edyta&quot;,&quot;last_name&quot;:&quot;Gendaszewska-Darmach&quot;},{&quot;first_name&quot;:&quot;Katarzyna&quot;,&quot;last_name&quot;:&quot;M. Błażewska&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8781-8800&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00811&quot;},&quot;abstract&quot;:&quot;Members of the Rab GTPase family are master regulators of vesicle trafficking. When disregulated, they are associated with a number of pathological states. The inhibition of RGGT, an enzyme responsible for post-translational geranylgeranylation of Rab GTPases represents one way to control the activity of these proteins. Because the number of molecules modulating RGGT is limited, we combined molecular modeling with biological assays to ascertain how modifications of phosphonocarboxylates, the first reported RGGT inhibitors, rationally improve understanding of their structure–activity relationship. We have identified the privileged position in the core scaffold of the imidazo[1,2-a]pyridine ring, which can be modified without compromising compounds’ potency. Thus modified compounds are micromolar inhibitors of Rab11A prenylation, simultaneously being inactive against Rap1A/Rap1B modification, with the ability to inhibit proliferation of the HeLa cancer cell line. These findings were rationalized by molecular do&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00811&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00811" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00811&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00811" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00811&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00811" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00811&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00811&amp;href=/doi/10.1021/acs.jmedchem.7b00811" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00811" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00811" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00811%26sid%3Dliteratum%253Aachs%26pmid%3D28953373%26genre%3Darticle%26aulast%3DKa%25C5%25BAmierczak%26date%3D2017%26atitle%3DIdentification%2Bof%2Bthe%2BPrivileged%2BPosition%2Bin%2Bthe%2BImidazo%255B1%252C2-a%255Dpyridine%2BRing%2Bof%2BPhosphonocarboxylates%2Bfor%2BDevelopment%2Bof%2BRab%2BGeranylgeranyl%2BTransferase%2B%2528RGGT%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D21%26spage%3D8781%26epage%3D8800%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291945" title="Ketones">Ketones</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290642" title="pH">pH</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/jmcmar.2017.60.issue-21/20171109/jmcmar.2017.60.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Members of the Rab GTPase family are master regulators of vesicle trafficking. When disregulated, they are associated with a number of pathological states. The inhibition of RGGT, an enzyme responsible for post-translational geranylgeranylation of Rab GTPases represents one way to control the activity of these proteins. Because the number of molecules modulating RGGT is limited, we combined molecular modeling with biological assays to ascertain how modifications of phosphonocarboxylates, the first reported RGGT inhibitors, rationally improve understanding of their structure–activity relationship. We have identified the privileged position in the core scaffold of the imidazo[1,2-<i>a</i>]pyridine ring, which can be modified without compromising compounds’ potency. Thus modified compounds are micromolar inhibitors of Rab11A prenylation, simultaneously being inactive against Rap1A/Rap1B modification, with the ability to inhibit proliferation of the HeLa cancer cell line. These findings were rationalized by molecular docking, which recognized interaction of phosphonic and carboxylic groups as decisive in phosphonocarboxylate localization in the RGGT binding site.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rab GTPases constitute the most abundant class among the Ras superfamily of small GTP-binding proteins. They are considered master regulators of vesicle trafficking and their secretion to the extracellular matrix. Rab geranylgeranyl transferase (RGGT, Rab GGTase, GGT-II) is responsible for post-translational geranylgeranylation of Rab GTPases (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Attachment of lipophilic prenyl group(s) is crucial for their correct subcellular membrane localization and functioning. Most Rab GTPases undergo double prenylation catalyzed by RGGT, with the formation of a thioether bond between two C-terminal cysteines and 20-carbon isoprenoid chains, derived from geranylgeranyl pyrophosphate (GGPP).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Isoprenoid biosynthesis pathway. NBP, nitrogen-containing bisphosphonates; FPPS, farnesyl pyrophosphate synthase; GGPPS, geranylgeranyl pyrophosphate synthase; FT, farnesyl transferase; GGT-1, geranylgeranyl transferase 1; FPP, farnesyl pyrophosphate; GPP, geranyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; RGGT, Rab geranylgeranyl transferase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The abnormal activities of RGGT and some Rab proteins have been identified in a number of diseases, including neurodegenerative and infectious disorders<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> as well as in several cancer types, in some cases being connected with increased tumor aggression.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Specifically, members of the Rab11 family (Rab11A, Rab11B, Rab25/Rab11C) along with their effectors exert an important role in development of cancers of multiple lineages, including pancreas, skin, breast, colon, endometrial, lung, ovarian, renal, prostate, and bladder.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1, 7)</a></div><div class="NLM_p">It has been also reported that disruption of prenylation by inhibition of more upstream enzymes of isoprenoid pathway, e.g., farnesyl pyrophosphate synthase, FPPS (by nitrogen-containing bisphosphonates (NBPs)), can reduce proliferation of malignant cells. Even though the molecular target of NBPs is farnesyl pyrophosphate synthase, their molecular mechanism of action might be related to downstream depletion of geranylgeranyl pyrophosphate, a substrate for geranylgeranyl transferases (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a></div><div class="NLM_p">Additionally, the unexpectedly low cytotoxicity of farnesyl transferase (FT) inhibitors, which should disrupt prenylation of the oncogenic K-Ras GTPase, is associated with alternative prenylation of this protein by geranylgeranyl transferases.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> The combined therapy using both farnesyl transferase and geranylgeranyl transferase inhibitors, may overcome this surrogate prenylation.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">Therefore, identification of specific inhibitors of RGGT and their application as tools to study RGGT and Rab-connected processes may open new avenues for therapeutic intervention and advances in understanding of Rab proteins prenylation.</div><div class="NLM_p">The α-phosphonocarboxylate (PC), 3-PEHPC<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> derived from risedronate, a bisphosphonate antiosteoporotic drug, was the first identified inhibitor of RGGT, which showed moderate but selective activity. Up to now, several other classes of RGGT inhibitors have been reported,<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> with the most active analogues being developed from a tetrahydrobenzodiazepine core.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> None of them were studied with respect to inhibition of first or second geranylgeranylation process, except for phosphonocarboxylates, which were reported to prohibit the introduction of the second geranylgeranyl group to Rabs, therefore selectively affecting Rabs, which require double prenylation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Further studies led to the identification of the more potent RGGT phosphonocarboxylate inhibitors. We found that other analogues of heterocyclic bisphosphonates show greater activity against RGGT than originally reported 3-PEHPC,<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> while those derived from aminoalkyl BP are inactive.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Oxidation of nitrogen in the pyridine ring of 3-PEHPC to <i>N</i>-oxide did not improve activity against RGGT.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We demonstrated that the most active derivatives of currently known phosphonocarboxylates contain imidazo[1,2-<i>a</i>]pyridine (3-IPEHPC and its analogues)<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> or the imidazole ring<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in their structure.</div><div class="NLM_p">Thus, here we describe the synthesis of an extended set of phosphonocarboxylate inhibitors (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), varying in lipophilicity, size, and geometry of substituent in order to probe their affinity toward RGGT. We investigated analogues of 3-IPEHPC with the diversely substituted imidazo[1,2-<i>a</i>]pyridine ring (<b>1a</b>–<b>1c</b>, <b>1e</b>–<b>1r</b>, <b>2a</b>, <b>2b</b>, <b>2d</b>, <b>2h</b>) as well as analogues with a modified phosphonic acid moiety in the form of hydroxy(phenyl)phosphoryl or ethyl(hydroxy)phosphoryl residues (<b>1s</b>,<b>t</b>, <b>2s</b>,<b>t</b>). We have also synthesized compounds potentially resembling GGPP, one of the RGGT substrates (<b>1u</b>, <b>1w</b>, <b>1y</b>, <b>2z</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> where a prenyl chain was mimicked with a polyphenyl moiety. Because it is suggested that PCs interact with the enzyme cavity storing the geranylgeranyl residue after first prenylation,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> we hypothesized that such prenyl-mimicking moiety could inhibit RGGT by interacting with this lipophilic pocket.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of studied compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We examined the potency of thus synthesized compounds by investigating their effect on RGGT-driven geranylgeranylation of Rab11A, one of the most characterized molecule among all Rab proteins, along with nonselective prenylation of Rap1A/Rap1B, a strict substrate of GGTase-1.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Novel Phosphonocarboxylate Analogues</h3><div class="NLM_p">We applied synthetically robust approach, in which the functionalized phosphonocarboxylate scaffold was built through condensation of an aldehyde <b>3</b> and triethyl phosphonoacetate <b>5</b> or diethyl phosphinoacetate <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route 1).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> That way we obviated the formation of the doubly substituted analogue and necessity of preparing the alkylating entity, as was needed for the previously used low-yielding strategy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> While this new approach worked well for most studied analogues, it turned out to be troublesome for derivatives of 2-substituted imidazo[1,2-<i>a</i>]pyridines (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, compounds <b>1a</b>–<b>c</b>, <b>2a</b>−<b>b</b>) because preparation of corresponding starting aldehydes required low-yielding and tedious formylation, e.g., through Vilsmeier–Haack reaction.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, instead of using aldehydes <b>3</b> as the starting materials, we synthesized 2-substituted imidazo[1,2-<i>a</i>]pyridine analogues <b>4</b> and subjected them to Friedel–Crafts alkylation with ethyl 2-(diethoxyphosphoryl)acrylate <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route 2), according to the procedure applied for 2-phenylindolizine.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unfortunately, none of these strategies worked for imidazo[1,2-<i>a</i>]pyridine analogues substituted with a halogen atom in the position 5, therefore only representatives with alkyl and aryl substituent in this location were obtained.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Two Strategies Used for the Synthesis of Phosphonocarboxylates, Presented on the Example of 3-IPEHPC Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triethyl phosphonoacetate, TiCl<sub>4</sub>, TEA, DCM, −20 °C to rt; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, −40 °C; (c) <b>7</b>, 1,4-dioxane, AlCl<sub>3</sub> (cat), reflux; (d) NFSI, BuLi, THF, −70 °C/20 min, −20 °C/1 h; (e) 12 M HCl, reflux.</p></p></figure><div class="NLM_p">Route 1 required synthesis of imidazo[1,2-<i>a</i>]pyridine-3-carbaldehydes <b>3</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). For their synthesis, appropriate 2-aminopyridine analogues were used in the reaction with bromomalonaldehyde.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Apart from commercially available halogen and methyl substituted 2-aminopyridine, phenyl substituted analogues had to be first synthesized either from halogen-containing 2-aminopyridines or from the corresponding halogen-substituted aldehydes <b>3</b>, in the Suzuki–Miyaura coupling with phenylboronic acid.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Polyphenyl aldehydes <b>3u</b>, <b>3w</b>, <b>3y</b>, <b>3z</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) were synthesized according to literature procedures (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Starting materials for the synthesis of target compounds representing: (a) heterocycle and aromatic part; (b) phosphonoacetate and phosphinoacetate derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus obtained aldehydes <b>3</b> were subjected to TiCl<sub>4</sub>-mediated condensation with phosphonoacetate <b>5</b> or phosphinoacetate <b>6</b> in the presence of TEA (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), following the procedure applied previously by Tanabe for condensation of triethyl phosphonoacetate and benzaldehyde.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The products <b>8</b> in the form of a <i>E/Z</i> mixture were obtained with yields in the range 40–84%.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">Compounds <b>8</b> were subjected to hydrogenation catalyzed by Pd-C. However, that reaction was accompanied by partial reduction of the pyridine ring, as was observed previously for 2-(imidazo[1,2-<i>a</i>]pyridin-2-yl)acetates.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Therefore, the reduction was carried out with NaBH<sub>4</sub> and NiCl<sub>2</sub> hydrate instead to obtain products <b>9</b> with yields 59–98%.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> While nonhalogen containing analogues <b>8</b> could be reduced using conditions of 15 min at −20 °C, reduction of halogen-containing derivatives required a shorter time (8 min) and lower temperature (−40 °C) due to their propensity toward halogen-carbon bond cleavage (up to 30% of dehalogenated product was detected if such precaution was not undertaken). As we proved for selected examples, condensation and reduction steps can be run subsequently without purification of an intermediate vinyl analogue <b>8</b>, giving comparable yields to procedure involving its purification.</div><div class="NLM_p">Thus, obtained analogues <b>9</b> were subjected to fluorination using <i>N</i>-fluorobenzenesulfonimide (NFSI) and butyl lithium, according to the procedure previously applied for fluorination of bisphosphonates.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Fluorinated products <b>10</b> were obtained with 41–98% yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The last step involved hydrolysis of desoxy <b>9</b> and fluoro <b>10</b> esters under acidic conditions. Final products were obtained with 55–99% yields<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> upon precipitation. The same procedure was applied in the synthesis of phosphinoacetate analogues <b>1s</b>,<b>t</b> and <b>2s</b>,<b>t</b>.</div><div class="NLM_p">For the synthesis of analogues with the imidazo[1,2-<i>a</i>]pyridine ring substituted in the position 2, compounds <b>4</b> (obtained by condensation of suitable 2-aminopyridine and chloroacetone or bromoacetophenone) were subject to Friedel–Crafts alkylation, leading to esters <b>9</b> with 55–63% yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route 2). This approach seem advantageous compared with route 1, the advantages being: (a) starting materials <b>4</b> are obtained in yields >70%, while synthesis of appropriate aldehydes <b>3</b> requires low yielding formylation; (b) substrates can be directly transformed to product <b>9</b>, thereby eliminating one reaction step; (c) avoidance of dehalogenation upon reduction, see (b). However, we found it applicable only to analogues of imidazo[1,2-<i>a</i>]pyridines, in which the position 2 is occupied by substituent. In such cases, selective alkylation takes place only on carbon 3, the position of imidazo[1,2-<i>a</i>]pyridine most activated.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Thus, obtained products of alkylation <b>9</b> were subjected to fluorination (72–95% yield) and hydrolysis (53–89% yield) according to the same protocol as the one described above.</div><div class="NLM_p">To study the role of chirality in interaction between RGGT and α-fluorinated phosphonocarboxylate analogues, we carried out the resolution of enantiomers on the example of compound <b>1i</b>. We used previously developed HPLC method,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> utilizing weak anion exchange chiral column introduced by Lindner et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p last">All synthesized fluorine-containing compounds <b>1</b> were screened for their biological activity using cell-based assays. On the basis of previous studies,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we predicted that desoxy analogues <b>2</b> should be less potent, therefore representatives of such were screened only in selected cases. In the case of <b>2d</b>, a fluoro analogue was not obtained, leaving the 5-methyl substituted compound <b>1e</b> as the sole fluorinated representative of this position.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> The Cytotoxic Efficacy of Phosphonocarboxylates against the HeLa Cancer Cell Line</h3><div class="NLM_p">Inhibition of prenyltransferases or enzymes in the mevalonate pathway may be associated with decreased cell viability.<a onclick="showRef(event, 'ref13 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref13 ref40 ref41">(13, 40, 41)</a> Therefore, the newly synthesized phosphonocarboxylate analogues were initially evaluated for their antiproliferative activity against the human epithelial adenocarcinoma cell line (HeLa), using previously described 3-IPEHPC<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a> as a reference. Taking into account that activities of tested compounds could be attenuated or modulated by serum proteins,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> the influence of FBS-containing and FBS-free media was also investigated (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Synthesized PC Analogues on HeLa Cell Viability in Serum-Supplemented and Serum-Free Medium<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>, and Rab11A Prenylation Tested at a Concentration of 100 μM<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">HeLa cells were treated with the compounds for 72 h and then viable cell number was assayed. Represented data were calculated from the means of eight tested concentrations from at least three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">HeLa cells were treated for 48 h with 100 μM concentration of the compounds, then lysed and separated into cytosolic and membrane-rich fractions and Western blotted for Rab11A and β-actin in cytosolic fractions. Data shown in the table, from at least three independent experiments, indicates for which compounds higher bands intensity compared to control (untreated cells) was observed.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">For analogues modified in the imidazo[1,2-<i>a</i>]pyridine ring, the position of modification is given according to the numbering of heterocycle.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">“NE” stands for lack of response in cells treated with up to 2 mM concentration of inhibitor.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Compounds in bold were evaluated to inhibit Rab11A and Rap1A/Rap1B prenylation in wide concentration range.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">The enantiomers of <b>1i</b> are distinguished as E1 and E2, based on their retention times during chiral HPLC separation. The enantiomer with the shorter retention time is labeled as E1, and the one with the longer retention time, as E2.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Compounds demonstrated insignificant activity to inhibit Rab11A prenylation (based on densitometry analysis), which was the reason why they have not been tested in wide concentration range.</p></div></div><div></div></div><div class="NLM_p">All analogues of 3-IPEHPC, in which a hydroxyl group on the branching carbon atom between the phosphonic and carboxylic groups (C-α) was exchanged for a hydrogen atom (<b>2a</b>, <b>2b</b>, <b>2d</b>, <b>2h</b>), had no effect on the number of viable HeLa cells up to maximum concentration tested (2 mM) in both serum-containing or serum-free medium. The same effect was observed also for 2-(alkyl/aryl(hydroxy)phosphoryl)-propanoic acid analogues (<b>1s</b>–<b>t</b>, <b>2s</b>–<b>t</b>).</div><div class="NLM_p">Introduction of a phenyl (<b>1a</b>, <b>1n</b>), a methyl (<b>1b</b>, <b>1o</b>), or a bromine (<b>1p</b>) substituent into positions 2 or 8 of the imidazo[1,2-<i>a</i>]pyridine ring of fluoro analogues did not show any effect on HeLa cell proliferation either. Substitution at the 7 (<b>1j</b>–<b>m</b>) or 5 (<b>1e</b>) positions in turn had negligible or no effect when cells were cultured in complete medium but in most cases significantly increased cytotoxic effect when applied under serum-free condition.</div><div class="NLM_p">Remaining fluoro analogues modified at the 6 position of the imidazo[1,2-<i>a</i>]pyridine ring (<b>1f</b>–<b>i</b>) demonstrated cytotoxic effect under both medium conditions, being the most potent molecules, with IC<sub>50</sub> values ranging from 68 to 323 μM in fasting medium and from 267 to 521 μM in FBS-containing medium. They showed similar or even stronger effect when compared to the reference compound, 3-IPEHPC. It is noteworthy that introduction of an additional methyl substituent in the 2 position of compound <b>1i</b> (<b>1c</b>) led to significant limitation of antiproliferative activity against HeLa cells (IC<sub>50</sub> = 1952 μM in complete medium).</div><div class="NLM_p last">Exchanging a heterocycle with biphenyl or benzylphenyl moieties resulted in no or weak cytotoxic effect in DMEM supplemented with FBS (<b>1u</b>, <b>1w</b>, <b>1y</b>), while the desoxy analogue containing a triphenyl residue (<b>2z</b>) turned out to be very potent. The IC<sub>50</sub> values in fasting medium were in the range of 318–930 μM for compounds <b>1u</b>, <b>1w</b>, and <b>1y</b>, and the most active appeared to be <b>2z</b> with IC<sub>50</sub> below 25 μM.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Functionalization of the Imidazo[1,2-<i>a</i>]pyridine Ring in the Position 6 Increases Potency of 3-IPEHPC Analogues against Rab Prenylation</h3><div class="NLM_p">All synthesized fluorine-containing compounds <b>1</b> and selected representatives of desoxy analogues <b>2</b> were screened for their ability to inhibit RGGT and GGT-1 in intact cells, which also allowed assessing their cellular availability. As previously,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the assays were based on determination of the unprenylated forms of Rab11A and Rap1A/Rap1B, which are modified with geranylgeranyl groups by RGGT and GGT-1, respectively. We reasoned that the independent effect observed either for Rab11A or Rap1A/Rap1B would indicate selective inhibition of RGGT or GGT-1, while a comparable effect for both proteins would indicate that mevalonate pathway enzymes, e.g., GGPPS or FPPS, might be affected, because they are providing prenyl pyrophosphate substrate for both transferases (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p">Our choice of the method for activity assessment was dictated by the fact that most assays on isolated RGGT utilize diversely labeled, noncommercially available GGPP analogues, often requiring multistep synthesis, and being labile due to the presence of pyrophosphate moiety. The differences in IC<sub>50</sub> values obtained in different in vitro assays<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> suggest that they may measure different modes of inhibition, none of them being adjusted to inhibitors of second geranylgeranylation such as phosphonocarboxylates. For such inhibitors, using labeled GGPP may lead to ambiguous readout because both the properly doubly geranylgeranylated as well as the mono geranylgeranylated intermediate will be functionalized with a visualizing handle. Therefore, we studied the activity of compounds through fractionation of cellular lysates and immunochemical detection of mis-prenylated Rab11A present in cytosol.</div><div class="NLM_p">The inhibitory activity of the set of investigated compounds <b>1</b>–<b>2</b> was initially tested at 100 μM concentration under serum-free conditions, and the Rab11A enrichment in the cytosol fraction was examined with Western Blot analysis (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Treatment with the series of GGPP mimetics (<b>1u</b>, <b>1w</b>, <b>1y</b>, <b>2z</b>) and with desoxy analogues of 3-IPEHPC (<b>2a</b>, <b>2b</b>, <b>2d</b>, <b>2h</b>) did not deplete Rab11A from membrane fractions of HeLa cells. Among five analogues modified at the 2 or 8 position of the imidazo[1,2-<i>a</i>]pyridine ring, only two, compounds <b>1a</b> and <b>1o</b>, have shown an effect on Rab11A prenylation. 7-Substituted fluoro analogues (<b>1j</b>–<b>m</b>) did not inhibit prenylation of Rab11A, but they did show the ability to reduce HeLa cells viability in serum-free medium. The 5-substituted fluoro analogue, compound <b>1e</b>, has shown inhibition of Rab11A prenylation at 100 μM and significant reduction of HeLa cell viability but only in serum-free medium.</div><div class="NLM_p">The set of phosphinic acid derivatives (<b>1s</b>,<b>t</b>, <b>2s</b>,<b>t</b>) also weakly inhibited Rab11A prenylation at 100 μM despite their noncytotoxic character.</div><div class="NLM_p">Interestingly, all the fluoro analogues containing substituent at the position 6 of the imidazo[1,2-<i>a</i>]pyridine ring (<b>1f</b>–<b>i</b>) enriched Rab11A protein levels in cytosolic fractions, which correlates well with their ability to reduce HeLa cell viability. As an example of a desoxy analogue, compound <b>2h</b> was also tested and it had no effect on both HeLa cells viability and Rab11A potency. It supports the previously observed trend<a onclick="showRef(event, 'ref21 ref43'); return false;" href="javascript:void(0);" class="ref ref21 ref43">(21, 43)</a> that fluorinated analogues are more active than their desoxy counterparts.</div><div class="NLM_p">Thirteen compounds (3-IPEHPC, <b>1a</b>, <b>1c</b>, <b>1e</b>–<b>j</b>, <b>1o</b>, <b>1r</b>, <b>2s</b>–<b>t</b>) were selected for full panel six-dose assay to determine the lowest effective dose inhibition of Rab11A prenylation based on their antiproliferative activity (IC<sub>50</sub> values) and the initial Western Blot screening at a single concentration of 100 μM (see last column in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Selected compounds were assessed for their ability to inhibit Rab11A and Rap1A/Rap1B prenylation by RGGT and GGTase 1, respectively (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of 6-substituted analogues of 3-IPEHPC (<b>1f</b>–<b>i</b>) on Rab11A and Rap1A/Rap1B prenylation in HeLa cells. Cells were treated for 48 h with the indicated concentrations of PCs (μM) and 10 μM lovastatin (Lov) acting as a positive control in serum-free medium. Subsequently, cells were lysed and fractionated into cytosolic and membrane-rich fractions. Cytosolic fractions containing unprenylated proteins were Western blotted for Rab11A, Rap1A/Rap1B, and β-actin (A), and the immunoblot bands were quantified by densitometry analysis, normalized to β-actin, and displayed as a percentage of controls (B). Data represented mean ± SEM from at least three independent experiments, *<i>p</i> ≤ 0.05, **<i>p</i> ≤ 0.01, ***<i>p</i> ≤ 0.001, and ****<i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because compounds <b>1j</b> and <b>1r</b> did not show any effect on Rab11A prenylation inhibition, their significant potency to reduce HeLa cell viability (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) should be associated with a different mechanism of action.</div><div class="NLM_p">Compounds that showed no influence on HeLa cell viability (<b>1a</b>, <b>1o</b>, <b>2s</b>–<b>t</b>) were proven to be weak inhibitors of Rab11A prenylation. They demonstrated a similar effect in the case of Rap1A/Rap1B prenylation, except for <b>1a</b>, which turned out to be inactive even at 100 μM concentration. <b>1e</b> was another weak inhibitor, with equal LEDs obtained for both Rab11A and Rap1A/Rap1B prenylation. Such results suggest that those PCs may inhibit an enzyme of the mevalonate pathway such as GGPPS or FPPS (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), responsible for synthesis of geranylgeranyl pyrophosphate, a substrate necessary for prenylation mediated by RGGT or GGTase 1. It cannot be excluded though that these compounds inhibit both RGGT and GGT-1 at similar concentrations.</div><div class="NLM_p">The α-fluorine analogues of 3-IPEHPC with the imidazo[1,2-<i>a</i>]pyridine ring substituted in the position 6 were the most potent inhibitors of Rab11A prenylation as measured by LED (10 μM for <b>1g</b>, <b>1h</b>; 25 μM for <b>1f</b>, <b>1i</b>; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). At the same time, Rap1A/Rap1B prenylation was not affected (LED > 100 μM), except for <b>1h</b> (LED = 100 μM). Our data suggest that they are even stronger selective RGGT inhibitors than a reference (±)-3-IPEHPC (LED for inhibition of Rab11A = 25<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> or 50 μM in our research model). Densitometry analysis confirmed their efficacy, showing at least 2.5-fold enrichment of unprenylated Rab11A in the cytosol fraction of treated cells compared to untreated control (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compound <b>1c</b> combining structural features characteristics for <b>1i</b> (bromine in the position 6) and <b>1b</b> (methyl in the position 2) did not inhibit Rab11A and Rap1A/Rap1B prenylation up to 100 μM. It confirmed that C6 substitution of the imidazo[1,2-<i>a</i>]pyridine ring is the key and privileged position among all analogues tested within this study, and simultaneous modification at other positions reduces the compounds’ activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Selected PC Analogues on Rab11A and Rap1A/Rap1B Prenylation<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> in HeLa Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">inhibition of Rab11A prenylation (LED/μM)</th><th class="colsep0 rowsep0" align="center">densitometry analyses of the quantity of Rab11A in cytosolic fractions after treatment with 100 μM concentrations of compounds (% of control ± SD)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">inhibition of Rap1A/Rap1B prenylation (LED/μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.</td><td class="colsep0 rowsep0" align="left">3-IPEHPC<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">258 ± 109</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.</td><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">2-Ph</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">181 ± 81</td><td class="colsep0 rowsep0" align="center">no effect</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.</td><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">2-Me-6-Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">no effect</td><td class="colsep0 rowsep0" align="center">129 ± 38</td><td class="colsep0 rowsep0" align="center">no effect</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4.</td><td class="colsep0 rowsep0" align="left"><b>1e</b></td><td class="colsep0 rowsep0" align="left">5-Me</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">155 ± 56</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5.</td><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left"><b>6-Ph</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>25</b></td><td class="colsep0 rowsep0" align="center"><b>262 ± 102</b></td><td class="colsep0 rowsep0" align="center"><b>no effect</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6.</td><td class="colsep0 rowsep0" align="left"><b>1g</b></td><td class="colsep0 rowsep0" align="left"><b>6-Me</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center"><b>335 ± 69</b></td><td class="colsep0 rowsep0" align="center"><b>no effect</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7.</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left"><b>6-Cl</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center"><b>312 ± 87</b></td><td class="colsep0 rowsep0" align="center"><b>100</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8.</td><td class="colsep0 rowsep0" align="left"><b>1i</b></td><td class="colsep0 rowsep0" align="left"><b>6-Br</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>25</b></td><td class="colsep0 rowsep0" align="center"><b>357 ± 121</b></td><td class="colsep0 rowsep0" align="center"><b>no effect</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9.</td><td class="colsep0 rowsep0" align="left"><b>1i</b>-<b>E2</b></td><td class="colsep0 rowsep0" align="left"><b>6-Br</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center"><b>1539 ± 1143</b></td><td class="colsep0 rowsep0" align="center"><b>no effect</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10.</td><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="left">7-Me</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">no effect</td><td class="colsep0 rowsep0" align="center">118 ± 20</td><td class="colsep0 rowsep0" align="center">not determined</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11.</td><td class="colsep0 rowsep0" align="left"><b>1o</b></td><td class="colsep0 rowsep0" align="left">8-Me</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">180 ± 70</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12.</td><td class="colsep0 rowsep0" align="left"><b>2s</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">133 ± 36</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13.</td><td class="colsep0 rowsep0" align="left"><b>2t</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">143 ± 42</td><td class="colsep0 rowsep0" align="center">50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">LED = lowest effective dose. No effect = LED is not included in concentration up to 100 μM.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Densitometry analysis was performed with ImageLab Software (Bio-Rad) and relative unprenylated protein band intensity was normalized to β-actin and quantified with respect to controls (untreated cells).</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Inhibition of Rab11A prenylation (LED) by (<i>S</i>)-3-IPEHPC was determined to be 25 μM.</p></div></div></div><div class="NLM_p last">Similarly to the trend observed in viability assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <b>1i</b>-<b>E2</b>: IC<sub>50</sub> is 267 μM in full medium and 130 μM in serum-free medium; no effect for <b>1i</b>-<b>E1</b>), out of two enantiomers of <b>1i</b>, only one had the desired biological activity as measured by LED, confirming previous findings that chirality plays a pivotal role in interaction between phosponocarboxylates and RGGT.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Fractionation of Prenylated and Nonprenylated Proteins Prior to Western Blot</h3><div class="NLM_p">Triton X-114 is the nonionic mild detergent, commonly used to extract membrane proteins from biological samples. It rarely denatures membrane proteins and allows phase separation above its clouding point (about 22 °C). It was previously used for cell lysis and separation of hydrophobic prenylated proteins from their more polar counterparts.<a onclick="showRef(event, 'ref22 ref44'); return false;" href="javascript:void(0);" class="ref ref22 ref44">(22, 44)</a> However, separation into hydrophilic and hydrophobic phases by Triton X-114 extraction is not highly effective and may be substantially improved. Our experience shows that the procedure based on the use of Triton X-114 is very tedious, partly due to inefficient lysis of cells and temperature dependent partitioning, both factors lowering protein yields and leading to contamination of cytosolic fraction with membrane proteins. While this method should leave no doubt when applied to proteins which are monoprenylated, e.g., by GGT-1 or FT,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> in the case of RGGT, which is an enzyme capable of mono- as well as double geranylgeranylation, the partition between detergent-rich and aqueous phase may raise the question about localization of not completely prenylated Rab GTPases. A similar problem may arise when using activity assays based on attachment to Rabs an isoprenoid analogues functionalized either with a bioorthogonal, affinity, or fluorescent handle. While this method is efficient for protein identification, it can give an ambiguous read-out for inhibitors of second prenylation, because both the proper product of double geranylgeranylation as well as the mono geranylgeranylated intermediate will be tagged and therefore provide a positive signal.</div><div class="NLM_p last">Therefore, knowing that previously studied phosphonocarboxylates are inhibitors of second geranylgeranylation<a onclick="showRef(event, 'ref19 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref22">(19, 22)</a> and based on our previous studies,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> where we have shown that disruption of prenylation by phosphonocarboxylates leads to mislocalization of Rab proteins into cytosol instead of Triton X-114, we applied commercial kit, dedicated to the enrichment of integral membrane proteins and membrane-associated proteins from cultured mammalian cells and eliminates the hassle of phase separation based on hydrophobicity. Here it was used for the first time for fractionation of prenylated proteins and it turned out highly reproducible and efficient for this type of studies.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Docking</h3><div class="NLM_p">Because the crystal structure of the phosphonocarboxylate–RGGT complex is not available, we elaborated the model of their interactions using molecular docking and new biological data. We determined that interactions of the acidic residues, phosphonic and carboxylic groups, guide the location of the novel inhibitors in the RGGT binding area. The suggested binding mode differs slightly from our previous study<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> but depends now more on interactions that ensure that compounds are well stabilized into the binding site. As these novel compounds are smaller and chemically distinct from inhibitors of other classes that have been cocrystallized with RGGT,<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> the binding mode likely differs. In our induced-fit docking simulations, the phosphonic group of the novel RGGT inhibitors coordinates to zinc ion (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). In addition, docking suggests that the phosphonic group could form a hydrogen bond with D238B. Furthermore, several amino acids, K235B, D238B, Y241B, and K105A, are in hydrogen bonding distance of the carboxylic acid group of the novel inhibitors (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Example of the binding interactions of the novel RGGT inhibitors suggested by docking simulations. The phosphonic and the carboxylic acid groups guide the novel RGGT inhibitors to the close proximity of the catalytic zinc ion and several amino acids with hydrogen bonding ability (K235B, D238B, Y241B, and K105A). In the binding of compound <b>1c</b> (purple) and compound <b>1g</b> (turquoise), K105A has a crucial role. When a methyl group is added to position 2 (compound <b>1c</b>), this substitution prevents K105A from forming a hydrogen bond to the carboxylic acid, weakening the binding (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The black dashed lines indicate interactions between the inhibitor and the protein. Used atom colors: C in compounds <b>1c</b> and <b>1g</b> are in purple and in turquoise, respectively. O = red, N = blue, P = orange, S = yellow, F = bright green, Zn = dark green, Br = burgundy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All the active compounds (<b>1f</b>, <b>1g</b>, <b>1h</b>, and <b>1i</b>) are suggested to have similar binding modes (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Their substituents in the position 6 (Ph, Me, Cl, and Br, respectively) face the W244B indole side chain, yielding to favorable packing. H190B and Y107A are in hydrogen bonding distance of N in the position 1 of the imidazo[1,2-<i>a</i>]pyridine ring. However, when Me is added to position 2 (compound <b>1c</b>), this substitution prevents K105A from forming a hydrogen bond to the carboxylic acid, affecting disruptively the binding efficiency (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p">As far as chirality is concerned, we observed that one of the enantiomers of the active compound (<b>1i</b>) is mainly responsible for racemate activity toward RGGT. On the basis of previous studies when higher potency toward RGGT was detected for the (<i>S</i>)-3-IPEHPC isomer,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> we tentatively extended this stereochemical preference to fluorine analogues. Such preference for the (<i>S</i>)-isomer might come from fluorine interaction with C240B and/or W244B, while in the (<i>R</i>)-isomer there is no interaction with fluorine (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf" class="ext-link">Figure S294</a>). Having two acceptors around, the donor adjusts itself to both, which might be responsible for stronger interaction than either one alone.</div><div class="NLM_p">The methyl group present in other positions of the imidazo[1,2-<i>a</i>]pyridine ring, 5, 7, or 8 (compounds <b>1e</b>, <b>1k</b>, and <b>1o</b>, respectively) cause a slight shift in the binding mode compared to, e.g., the pose of compound <b>1g</b> when they pursue hydrophobic interactions with W52B, R144B, G192B, Y195B, W244B, and F289B. Because of that shift, Y107A cannot form hydrogen bond with N in the position 1 of the imidazo[1,2-<i>a</i>]pyridine ring and thus some binding potential is lost.</div><div class="NLM_p">The presence of a phenyl group in the position 2 of compound <b>1a</b> strongly influences the binding mode, making it very different from other analogues. It changes the interactions formed with the carboxylic acid and the phosphonic group of the inhibitor. Still, the same amino acids, H190B, K235B, D238B, and Y241B, remain in hydrogen bonding distance. W244B and F289B form a flat hydrophobic layer for hydrophobic packing of both the imidazo[1,2-<i>a</i>]pyridine ring and the phenyl group. However, hydrogen bonding with N in the position 1 in the imidazo[1,2-<i>a</i>]pyridine ring is lost and with that also binding potential.</div><div class="NLM_p last">On the basis of docking simulations, inhibitor <b>2s</b> binds in principle similarly as, e.g., compound <b>1c</b> or <b>1g</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), but the phenyl group in the phosphinate shifts the binding pose so that aromatic carbocycle forms π–π stacking interaction with F289B. With this interaction, some binding potential is gained. However, simultaneously, H190B or Y107A have difficulties to reach the hydrogen bonding distance of N in the position 1 of the imidazo[1,2-<i>a</i>]pyridine ring and thus some potential is likely lost. Basically, compound <b>2t</b> binds similarly as compound <b>2s</b>, but because <b>2t</b> has smaller, hydrophobic substitution in the phosphinate part, the shift in the binding mode toward F289B is larger and then H190B and Y107A have even bigger difficulties to reach N in position 1 in the imidazo[1,2-<i>a</i>]pyridine ring to form the hydrogen bond.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have elaborated convenient protocols for the synthesis of novel α-fluoro and α-desoxy phosphonocarboxylates functionalized with heterocycle or polyphenyl moieties. We have identified four phosphonocarboxylates (<b>1f</b>, <b>1g</b>, <b>1h</b>, <b>1i</b>) among them, which inhibit prenylation of Rab11A and show reduction of human HeLa cancer cell line viability. Three compounds have shown selectivity toward RGGT and no inhibition of geranylgeranylation of Rap1A/Rap1B protein up to 100 μM concentration. All active compounds bear a substituent in the same location of the core scaffold, carbon C-6 of the imidazo[1,2-<i>a</i>]pyridine ring. Therefore, it was designated as the leading position for future modifications. Such a choice is supported by molecular docking studies, which identified the coordination of phosphonic group to zinc cation, stabilized by several amino acid residues being in the hydrogen bonding distance to phosphonic and carboxylic groups as well as nitrogen atom in position 1 of imidazo[1,2-<i>a</i>]pyridine ring as the guiding interaction in the complex.</div><div class="NLM_p">We evaluated compounds’ potency by immunochemical detection of not completely prenylated Rab11A proteins by taking into consideration the possible ambiguity of their separation from fully digeranylgeranylated proteins. For the first time, here we applied the commercially available kit for fractionation of membrane from cytosolic proteins, which in our hands exceeded previously used for this application Triton X-114 in terms of efficiency of lysis and reproducibility.</div><div class="NLM_p">Phosphonocarboxylates as inhibitors of second prenylation mediated by RGGT mostly affect digeranylgeranylated and not monogeranylgeranylated Rab proteins. Because it is still difficult to determine how specific prenylated proteins mediate different pathological processes, e.g., cancer cell growth and survival, such selectivity should be advantageous. Considering that inhibition of RGGT affects over 60 proteins, such broadness of targets pose a threat of high toxicity. It remains to be determined if inhibition only of the second prenylation can lead to some salvage effect on cell well-being and not be so deleterious to healthy cells.</div><div class="NLM_p last">The works on development of new analogues as more potent inhibitors of RGGT and tools for studying Rab GTPase-associated processes combined with the studies on elaboration of the efficient asymmetric synthesis of phosphonocarboxylates and confirmation of the preferred stereochemistry for interaction with RGGT are in progress now.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Synthesis</h4><div class="NLM_p">All reagents were purchased from commercial sources and used as obtained unless specified otherwise. Thin-layer chromatography was performed using silica gel 60 with F254 indicator on alumina plates. Compounds were purified using Flash chromatograhy and 40–63 μm silica gel. Solvent ratios for the purification of compounds by flash chromatography are reported as volume ratios (v/v). Preparative HPLC for purification of compounds <b>1s</b> and <b>1t</b> was performed using Gilson Prep equipped with a UV–vis-156 detector and semipreparative column Kromasil 100–5-C18 (5 μm, 10 mm × 250 mm). Enantiomers of <b>1i</b> were separated using Chiralpak QN-AX column (Chiral Technologies Europe; 0.46 cm × 15 cm), according to the method previously described for 3-IPEHPC.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Each enantiomer was repurified using the same chiral column. Column was eluted isocratically (1 mL/min) with 0.7 M TEAAc containing 75% MeOH at pH 5.8. The optical purity of enantiomers was evaluated based on HPLC analysis using Chiralpak QN-AX column. The enantiomer with the shorter retention time, 4.9 min, has been labeled as E1, while the one with the longer retention time, 5.7 min, is E2.</div><div class="NLM_p last">NMR spectra were measured at 250.13 or 700 MHz for <sup>1</sup>H NMR, 62.90 or 170 MHz for <sup>13</sup>C NMR, 283 or 101.30 MHz for <sup>31</sup>P NMR on Bruker Avance DPX 250 and Bruker Avance II Plus 700 spectrometrs, respectively. Chemical shifts (δ) are reported in parts per million (ppm) relative to internal residual CHCl<sub>3</sub> in CDCl<sub>3</sub> (δ 7.26 <sup>1</sup>H NMR) or CDCl<sub>3</sub> signal in <sup>13</sup>C NMR (δ 77.16); internal residual HDO in D<sub>2</sub>O (δ 4.79 <sup>1</sup>H NMR) or external 85% H<sub>3</sub>PO<sub>4</sub> (δ 0 ppm <sup>31</sup>P NMR). <sup>31</sup>P NMR and <sup>13</sup>C NMR spectra were proton-decoupled. Coupling constants (<i>J</i>) are quoted in Hz. The assignment of the signals in <sup>1</sup>H NMR and <sup>13</sup>C NMR was supported by two-dimensional experiments (COSY, HMQC, HMBC, DEPT135). In the case of compounds obtained as diastereomeric mixtures, the ratio of diastereomers was determined based on <sup>31</sup>P NMR and (if possible) sufficiently separated signals in <sup>1</sup>H NMR. For compounds <b>8</b>, the description of <sup>1</sup>H and <sup>13</sup>C NMR shows only major (at least 80%) isomer, (<i>E</i>)-<b>8</b>, unless stated otherwise. For compounds <b>9s</b>,<b>t</b> and <b>10s</b>,<b>t</b>, chemical shifts in <sup>1</sup>H and <sup>13</sup>C NMR are enlisted for both diastereoisomers, if sufficiently separated, without distinguishing isomers. The purity of biologically tested compounds was evaluated by elemental analysis. All target compounds are >95% pure.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Biological Studies</h4><div class="NLM_p last">PrestoBlue cell viability reagent, Mem-PER Plus membrane protein extraction kit, and all reagents for cell culture were purchased from Life Technologies (Carlsbad, CA, USA). Mem-PER Plus membrane protein extraction kit was used for cell lysis and separation of cytosolic and membrane-rich fractions. Bradford Protein Assay and Clarity Western ECL Substrate were obtained from Bio-Rad (Hercules, CA, USA). Protease inhibitor cocktail and lovastatin were purchased from Sigma (Saint Louis, MO, USA). Primary antibodies against Rab11A and Rap1A/Rap1B were obtained from Abcam (Cambridge, UK), and primary antibodies against β-actin along with secondary HRP-linked antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> HeLa Cell Culture</h4><div class="NLM_p">The cervical epithelial carcinoma HeLa cell line was purchased from the American Type Cell Collection (ATCC). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) containing 100 IU/mL penicillin and 100 μg/mL streptomycin. Cells were incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO<sub>2</sub>.</div><div class="NLM_p last">For biological studies, PCs were dissolved in PBS at stock concentrations of 10 mM and the pH adjusted to about 7. Compounds were stored at 4 °C or −20 °C (for longer storage) prior to use.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Molecular Docking</h4><div class="NLM_p last">Compounds were drawn with Maestro 2016.2 (Schrödinger release 2016-2: Maestro, Schrödinger, LLC, New York, NY, 2016). Both (/all) stereoisomers were drawn for 11 compounds selected for molecular docking (compounds in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>: <b>1a</b>, <b>1c</b>, <b>1e</b>, <b>1f</b>, <b>1g</b>, <b>1h</b>, <b>1i</b>, <b>1k</b>, <b>1o</b>, <b>2s</b>, and <b>2t</b>). First traditional molecular docking with Glide was tested. Protein structure for docking, (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GTS">4GTS</a>) was downloaded from the Protein Data Bank<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and prepared with Protein Preparation Wizard. In docking, the protein was held rigid, except hydroxyl and thiol groups were allowed to rotate. In ligand binding, larger conformational changes in the protein structure, according to the induced fit concept, are possible. In addition, the binding area of RGGT is spacious and the sensitivity of traditional molecular docking is not high enough. To better model the binding interactions of novel RGGT inhibitors, induced-fit docking (IFD) in Maestro 2016.2 was performed. In IFD side chains of amino acids in the defined distance from the ligand are allowed to move freely and thus subtleties of the interactions between the ligand and the protein can be considered more accurately than with traditional molecular docking. In IFD procedure center of the docking box was set to catalytic zinc ion coordinate because zinc ion is considered important in binding. After the Glide molecular docking part of the IFD procedure, 20 poses were accepted for Prime refinement. Protein amino acid residues were refined in 5 Å radius of the docking poses. OPLS3 force field<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was used in the IFD procedure. In the end, 10 complexes were saved for the visual examination.</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for Hydrolysis</h3><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Synthesis of Compounds <b>1</b> and <b>2</b></h4><div class="NLM_p">Compounds <b>9</b> and <b>10</b> (0.50 mmol) were dissolved in 12 M HCl (5.5 mL). After 4–5 h of reflux, the mixture was evaporated to dryness. The products were obtained as solids with 56–99% yields upon precipitation (using water or petroleum/diethyl ether) or by sole removal of solvents.</div><div id="sec4_1_5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 2-Fluoro-3-(2-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1a</b>)</h5><div class="NLM_p last">Yield, 53%; scale, 0.093 g. Elemental analysis C<sub>16</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.35</sub>, (C<sub>2</sub>H<sub>5</sub>OH)<sub>0.55</sub> Calculated: C, 49.62; H, 4.87; N, 6.77. Found: C, 49.66; H, 4.88; N, 6.82. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 3.88 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 8.7, <sup>3</sup><i>J</i><sub>FH</sub> = 4.4, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 4.17 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 37.3, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 1.3, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.02 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, CH<sub>Ar(6)</sub>, 1H), 7.41 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, CH<sub>Ar(7)</sub>, 1H), 7.50 (tt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, CH<sub>Ar</sub>, 1H), 7.58 (m, C<u class="uu">H</u><sub><u class="uu">Ar</u>(8)</sub>, C<u class="uu">H</u><sub>Ph</sub>, 3H), 7.85 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, CH<sub>Ph</sub>, 2H), 8.63 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.39 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 71.9). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.7 (bd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.0, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 99.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 192.1, <sup>1</sup><i>J</i><sub>PC</sub> = 140.0, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 112.4 (s, CH<sub>Ar(6)</sub>, 1C), 115.1 (s, CH<sub>Ar(8)</sub>, 1C), 117.9 (dd, <sup>3</sup><i>J</i><sub>PC</sub> = 12.7, <sup>3</sup><i>J</i><sub>FC</sub> = 3.2, C<sub>Ar(3)</sub>, 1C), 126.3 (s, CH<sub>Ar(7)</sub>, 1C), 126.5 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 5.8, CH<sub>Ar(5)</sub>, 1C), 128.0 (s, CH<sub>Ph</sub>, 1C), 128.6 (s, CH<sub>Ph</sub>, 2C), 128.9 (s, CH<sub>Ph</sub>, 2C), 134.2 (s, CH<sub>Ph</sub>, 1C), 142.8 (s, C<sub>Ar(2)</sub>, 1C), 145.1 (s, C<sub>Ar(9)</sub>, 1C), 176.3 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 21.5, <sup>2</sup><i>J</i><sub>FC</sub> = 3.3, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-Fluoro-3-(2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1b</b>)</h5><div class="NLM_p last">Yield, 78%; scale, 0.093 g. Elemental analysis C<sub>11</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>2</sub> Calculated: C, 39.06; H, 4.77; N, 8.28. Found: C, 38.70; H, 4.75, N, 8.11. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 2.44 (s, CH<sub>3</sub>, 3H), 3.65 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 7.8, <sup>3</sup><i>J</i><sub>FH</sub> = 5.3, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.96 (dd, <sup>3</sup><i>J</i><sub>FH</sub> = 39.9, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>FH</sub> = 1.4, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.12 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.3, CH<sub>Ar(6)</sub>, 1H), 7.50–7.56 (m, CH<sub>Ar (8,7)</sub>, 2H), 8.54 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.51 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 71.6). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 11.3 (s, <u class="uu">C</u>H<sub>3</sub>, 1C), 28.7 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.1, <sup>2</sup><i>J</i><sub>PC</sub> = 2.8, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.0 (dd, <sup>1</sup><i>J</i><sub><i>FC</i></sub> = 190.9, <sup>1</sup><i>J</i><sub>PC</sub> = 140.4, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 113.0 (s, CH<sub>Ar(8)</sub>, 1C), 113.6 (s, CH<sub>Ar(6)</sub>, 1C), 118.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.4, <sup>3</sup><i>J</i><sub>FC</sub> = 2.4, C<sub>Ar(3)</sub>, 1C), 126.2 (s, CH<sub>Ar(5)</sub>, <sup>5</sup><i>J</i><sub>PC</sub> = 6.0, 1C), 128.2 (s, CH<sub>Ar(7)</sub>, 1C), 136.9 (s, C<sub>Ar(2)</sub>, 1C), 142.3 (s, C<sub>Ar(9)</sub>, 1C), 176.3 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 21.1, <sup>2</sup><i>J</i><sub>FC</sub> = 3.3, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 3-(6-Bromo-2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1c</b>)</h5><div class="NLM_p last">Yield, 73%; scale, 0.156 g. Elemental analysis C<sub>11</sub>H<sub>11</sub>BrFN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.75</sub>, Calculated: C, 32.02; H, 3.54; N, 6.79. Found: C, 32.17; H, 3.7; N, 6.72. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 2.40 (s, CH<sub>3</sub>, 3H), 3.59 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>PH</sub> = 7.5, <sup>3</sup><i>J</i><sub>FH</sub> = 5.3, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.93 (dd, <sup>3</sup><i>J</i><sub>FH</sub> = 40.7, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.39 (s, CH<sub>Ar(8,7)</sub>, 1H), 8.70 (bs, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.65 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 72.1). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 12.5 (s, 1C), 28.7 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.1, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.4 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 190.7, <sup>1</sup><i>J</i><sub>PC</sub> = 139.2, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 106.2 (s, CH<sub>Ar(6)</sub>, 1C), 115.2 (s, CH<sub>Ar(8)</sub>, 1C), 118.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.1, C<sub>Ar(3)</sub>, 1C), 125.8 (s, CH<sub>Ar(5)</sub>, 1C), 128.3 (s, CH<sub>Ar(7)</sub>, 1C), 141.5 (s, C<sub>Ar(2)</sub>, 1C), 143.1 (s, C<sub>Ar(9)</sub>, 1C), 176.5 (bd, <sup>2</sup><i>J</i><sub>PC</sub> = 19.6, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 2-Fluoro-3-(5-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1e</b>)</h5><div class="NLM_p last">Yield, 56%; scale, 0.1 g; crystallized from H<sub>2</sub>O. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 3.04 (s, C<sub>Ar(5)</sub>, C<u class="uu">H</u><sub>3</sub>, 3H), 4.24–4.09 (m, C<u class="uu">H</u><sub>2</sub>CFP, 2H), 6.98 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 7.49 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.8, 6.9, C<u class="uu">H</u><sub>Ar(7)</sub>, 1H), 7.55 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.8, C<u class="uu">H</u><sub>Ar(8)</sub>, 1H), 7.63 (s, C<u class="uu">H</u><sub>Ar(2)</sub>, 1H). <sup>13</sup>C NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 20.9 (s, <u class="uu">C</u>H<sub>3</sub>, 1C), 31.6 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 18.5, <u class="uu">C</u>H<sub>2</sub>CFP, 1C), 99.9 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 192.5, <sup>1</sup><i>J</i><sub>PC</sub> = 140.1, <u class="uu">C</u>FP, 1C), 112.1 (s, <u class="uu">C</u>H<sub>Ar(8)</sub>, 1C), 116.4 (s, <u class="uu">C</u>H<sub>Ar(6)</sub>, 1C), 124.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.9, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 126.6 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1C), 129.7 (s, <u class="uu">C</u>H<sub>Ar(7)</sub>, 1C), 139.8 (s, <u class="uu">C</u><sub>Ar(5)</sub>, 1C), 144.6 (s, <u class="uu">C</u>H<sub>Ar(9)</sub>, 1C), 176.2 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.1, <u class="uu">C</u>O<sub>2</sub>, 1C). <sup>13</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.81 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 72.2)</div></div><div id="sec4_1_5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 2-Fluoro-3-(6-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1f</b>)</h5><div class="NLM_p last">Yield, 88%; scale, 0.06 g. Elemental analysis C<sub>16</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>2</sub> Calculated: C, 48.01; H, 4.53; N, 7.00. Found: C, 47.86; H, 4.60; N, 6.99. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 8) δ: 3.55–3.73 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.98 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 42.1, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>PH</sub> = 1.4, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.48–7.52 (m, CH<sub>Ar(2)</sub>, CH<sub>Ph</sub>, 2H), 7.57–7.61 (m, CH<sub>Ph</sub>, 2H), 7.64 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.3, <sup>5</sup><i>J</i><sub>HH</sub> = 0.6, CH<sub>Ar(8)</sub>, 1H), 7.68 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, CH<sub>Ar(7)</sub>, 1H), 7.81 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2, <sup>4</sup><i>J</i><sub>HH</sub> = 1.0, CH<sub>Ph</sub>, 2H), 8.73 (bs, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.26 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.4). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 29.2 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 23.3, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.9 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 190.5, <sup>1</sup><i>J</i><sub>PC</sub> = 137.8, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 115.7 (s, CH<sub>Ar(8)</sub>, 1C), 122.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.3, C<sub>Ar(3)</sub>, 1C), 122.7 (bs, CH<sub>Ar(5)</sub>, 1C), 125.8 (s, CH<sub>Ar(6)</sub>, 1C), 126.2 (s, CH<sub>Ar(7)</sub>, 1C), 127.1 (s, CH<sub>Ph</sub>, 2C), 127.9 (s, CH<sub>Ph</sub>, 1C), 129.2 (s, CH<sub>Ph</sub>, 2C), 131.5 (s, C<sub>Ar(2)</sub>, 1C), 137.2 (s, C<sub>Ph</sub>, 1C), 144.9 (s, C<sub>Ar(9)</sub>, 1C), 176.7 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.0, <sup>2</sup><i>J</i><sub>FC</sub> = 3.3, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-Fluoro-3-(6-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1g</b>)</h5><div class="NLM_p last">Yield, 64%; crystallized H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>5</sub>P Calculated: C, 43.72; H, 4.00; N, 9.27. Found: C, 43.46; H, 4.08; N, 9.05. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 2.46 (s, C<u class="uu">H</u><sub>3</sub>, 3H), 3.68 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>FH</sub> = 6.9, C<u class="uu">H</u>HCFP, 1H), 3.95 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 40.0, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>PH</sub> = 2.1, C<u class="uu">H</u>HCFP, 1 H), 7.60 (s, C<u class="uu">H</u><sub>Ar(2)</sub>, 1H), 7.63–7.66 (m, C<u class="uu">H</u><sub>Ar(7)</sub>, C<u class="uu">H</u><sub>Ar(8)</sub>, 2H), 8.50 (s, C<u class="uu">H</u><sub>Ar(5)</sub>, 1H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 7) δ: 17.4 (s, <u class="uu">C</u>H<sub>3</sub>, 1C), 29.0 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.6, <u class="uu">C</u>H<sub>2</sub>CFP, 1C), 99.9 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.4, <sup>1</sup><i>J</i><sub>PC</sub> = 141.0, CH<sub>2</sub><u class="uu">C</u>FP, 1C), 112.1 (s, <u class="uu">C</u>H<sub>Ar(8)</sub>, 1C), 122.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.8, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 123.0 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1C), 124.3 (s, <u class="uu">C</u>H<sub>Ar(5)</sub>, 1C), 126.4 (s, <u class="uu">C</u><sub>Ar(6)</sub>, 1C), 134.2 (s, <u class="uu">C</u>H<sub>Ar(7)</sub>, 1C), 140.2 (s, <u class="uu">C</u><sub>Ar(9)</sub>, 1C), 175.8 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 19.9, <u class="uu">C</u>O<sub>2</sub>H, 1C). <sup>13</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.04 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 71.7). HRMS <i>m</i>/<i>z</i> calculated 303.0475 (M + H)<sup>+</sup>, found 303.0547 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_5_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 3-(6-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic acid (<b>1h</b>)</h5><div class="NLM_p last">Yield: 55%, scale: 0.09 g. Elemental analysis C<sub>10</sub>H<sub>9</sub>ClFN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>0.3</sub> Calculated: C, 36.62; H, 2.95; N, 8.54. Found: C, 36.88; H, 2.96; N, 8.27. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.60 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>PH</sub> = 15.9, <sup>3</sup><i>J</i><sub>FH</sub> = 6.6, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.90 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 41.9, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>PH</sub> = 1.5, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.35 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>4</sup><i>J</i><sub>HH</sub> = 2.0, CH<sub>Ar(7)</sub>, 1H), 7.48 (s, CH<sub>Ar(2)</sub>, 1H), 7.53 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>4</sup><i>J</i><sub>HH</sub> = 0.6, CH<sub>Ar(8)</sub>, 1H), 8.64 (bs, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.15 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.1). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 29.00–29.3 (m, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.9 (dd, <sup>1</sup><i>J</i><sub><i>FC</i></sub> = 190.1, <i>J</i><sub>PC</sub> = 137.9, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 116.3 (s, CH<sub>Ar(8)</sub>, 1C), 120.3 (s, CH<sub>Ar(6)</sub>, 1C), 122.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.2, C<sub>Ar(3)</sub>, 1C), 123.5 (d, <sup>5</sup><i>J</i><sub><i>PC</i></sub> = 6.6, CH<sub>Ar(5)</sub>, 1C), 126.5 (s, CH<sub>Ar(7)</sub>, 1C), 131.9 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 5.2, C<sub>Ar(2)</sub>, 1C), 144.0 (s, C<sub>Ar(9)</sub>, 1C), 176.5 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.8, <sup>2</sup><i>J</i><sub>FC</sub> = 3.5, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 3-(6-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1i</b>)</h5><div class="NLM_p last">Yield, 60%; scale, 0.056 g. Elemental analysis C<sub>10</sub>H<sub>9</sub>BrFN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.15</sub> Calculated: C, 30.97; H, 2.94; N, 7.22. Found: C, 31.25; H, 3.2; N, 7.05. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 3.70 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.78 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 38.9, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 3.20, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.73 (s, CH<sub>Ar(2)</sub>, 1H), 7.74 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, CH<sub>Ar(7)</sub>, 1H), 7.90 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, CH<sub>Ar(8)</sub>, 1H), 8.96 (bs, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.14 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 71.8). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.3 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.9, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 98.3 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 192.8, <sup>1</sup><i>J</i><sub>PC</sub> = 147.7, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 110.4 (s, CH<sub>Ar(6)</sub>, 1C), 113.5 (s, CH<sub>Ar(8)</sub>, 1C), 122.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.4, C<sub>Ar(3)</sub>, 1C), 123.6 (s, CH<sub>Ar(5)</sub>, 1C), 126.9 (s, CH<sub>Ar(7)</sub>, 1C), 134.7 (s, C<sub>Ar(2)</sub>, 1C), 139.7 (s, C<sub>Ar(9)</sub>, 1C), 173.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.1, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 2-Fluoro-3-(7-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1j</b>)</h5><div class="NLM_p last">Yield: 64%, scale: 0.07 g. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 8) δ: 3.55–3.73 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.97 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 40.6, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 1.8, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.46 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, <sup>5</sup><i>J</i><sub>HH</sub> = 1.7, CH<sub>Ar (6)</sub>, 1H), 7.48–7.56 (m, CH<sub>Ph</sub>, 3H), 7.57 (s, CH<sub>Ar(2)</sub>, 1H), 7.75 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, CH<sub>Ph</sub>, 1H), 7.80 (s, CH<sub>Ar(8)</sub>, 1H), 8.56 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, C<u class="uu">H</u><sub>Ar(5)</sub>, 2H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.66 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 71.4). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.9 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.2, <sup>2</sup><i>J</i><sub>PC</sub> = 2.2, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.3, <sup>1</sup><i>J</i><sub>PC</sub> = 140.2, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 110.1 (s, CH<sub>Ar(8)</sub>, 1C), 113.7 (s, CH<sub>Ar(6)</sub>, 1C), 122.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.2, <sup>3</sup><i>J</i><sub>FC</sub> = 1.8, C<sub>Ar(3)</sub>, 1C), 126.06 (s, <sup>5</sup><i>J</i><sub>PC</sub> = 3.8, CH<sub>Ar(5)</sub>, 1C), 126.10 (s, CH<sub>Ar(2)</sub>, 1C), 126.8 (s, CH<sub>Ph</sub>, 2C), 128.9 (s, CH<sub>Ph</sub>, 1C), 129.2 (s, CH<sub>Ph</sub>, 2C), 136.8 (s, CH<sub>Ph</sub>, 1C), 140.9 (s, CH<sub>Ar(7)</sub>, 1C), 143.1 (s, C<sub>Ar(9)</sub>, 1C), 175.8 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.8, <sup>2</sup><i>J</i><sub>FC</sub> = 3.2, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2-Fluoro-3-(7-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1k</b>)</h5><div class="NLM_p last">Yield, 82%; crystallized from H<sub>2</sub>O. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 8) δ: 2.43 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 0.8, C<u class="uu">H</u><sub>3</sub>, 3H), 3.60 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>FH/PH</sub> = 6.6, C<u class="uu">H</u>HCFP, 1H), 3.89 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 41.9, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 1.4, C<u class="uu">H</u>HCFP, 1 H), 6.89 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HH</sub> = 1.6 C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 7.34–7.31 (m, C<u class="uu">H</u><sub>Ar(8)</sub>, 1H), 7.36 (s, C<u class="uu">H</u><sub>Ar(7)</sub>, 1H), 8.34 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, C<u class="uu">H</u><sub>Ar(5)</sub>, 1H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 8) δ: 20.5 (s, <u class="uu">C</u>H<sub>3</sub>, 1C), 29.3 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.4, <u class="uu">C</u>H<sub>2</sub>CFP, 1C), 101.1 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 190.2, <sup>1</sup><i>J</i><sub>PC</sub> = 138.2, CH<sub>2</sub><u class="uu">C</u>FP, 1C), 114.1 (s, <u class="uu">C</u>H<sub>Ar(8)</sub>, 1C), 115.3 (s, <u class="uu">C</u>H<sub>Ar(6)</sub>, 1C), 121.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.1, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 124.8 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 4.5, <u class="uu">C</u>H<sub>Ar(5)</sub>, 1C), 130.5 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1C), 137.5 (s, <u class="uu">C</u><sub>Ar(7)</sub>, 1C), 146.3 (s, <u class="uu">C</u><sub>Ar(9)</sub>, 1C), 176.9 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 20.7, <sup>2</sup><i>J</i><sub>PC</sub> = 3.3, <u class="uu">C</u>O<sub>2</sub>, 1C). <sup>13</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.31 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.6)</div></div><div id="sec4_1_5_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 3-(7-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1l</b>)</h5><div class="NLM_p last">Yield, 59%; scale, 0.073 g. Elemental analysis C<sub>10</sub>H<sub>9</sub>ClFN<sub>2</sub>O<sub>5</sub>P Calculated: C, 37.23; H, 2.81; N, 8.68. Found: C, 37.05; H, 3.05; N, 8.50. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.38–3.62 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.62–3.99 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 6.97 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, CH<sub>Ar(6)</sub>, 1H), 7.38 (s, CH<sub>Ar(2)</sub>, 1H), 7.56 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, CH<sub>Ar(8)</sub>, 1H), 8.37 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 10.85 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.3).</div></div><div id="sec4_1_5_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 3-(7-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1m</b>)</h5><div class="NLM_p last">Yield, 61%; scale, 0.08 g. Elemental analysis C<sub>10</sub>H<sub>9</sub>BrFN<sub>2</sub>O<sub>5</sub>P Calculated: C, 32.72; H, 2.47; N, 7.63. Found: C,32.54; H, 2.67; N, 7.59. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.61 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 16.0, <sup>3</sup><i>J</i><sub>FH</sub> = 6.6, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.90 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 41.8, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 1.4, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.14 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, CH<sub>Ar(6)</sub>, 1H), 7.44 (s, CH<sub>Ar(2)</sub>, 1H), 7.81 (bs, CH<sub>Ar(8)</sub>, 1H), 8.38 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, CH<sub>Ar(5)</sub>, 1H), <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.14 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.5). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 29.1 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.6, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.8 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 190.4, <sup>1</sup><i>J</i><sub>PC</sub> = 138.1, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 116.0 (s, CH<sub>Ar(6)</sub>, 1C), 118.0 (s, CH<sub>Ar(8)</sub>, 1C), 119.0 (s, CH<sub>Ar(7)</sub>, 1C), 122.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.0, C<sub>Ar(3)</sub>, 1C), 126.0 (s, CH<sub>Ar(5)</sub>, 1C), 131.5 (s, C<sub>Ar(2)</sub>, 1C), 145.6 (s, C<sub>Ar(9)</sub>, 1C), 176.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.8, <sup>2</sup><i>J</i><sub>FC</sub> = 3.3, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 2-Fluoro-3-(8-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1n</b>)</h5><div class="NLM_p last">Yield, 52%; scale, 0.08 g. Elemental analysis C<sub>16</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.65</sub> Calculated: C, 48.78; H, 4.43; N, 7.11. Found: C, 48.58; H, 4.18; N, 7.05. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 8) δ: 3.75 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 4.01 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 39.8, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 1.6, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 7.59 (m, C<u class="uu">H</u><sub>Ar</sub>, 3H), 7.64 (s, CH<sub>Ar(2)</sub>, 1H), 7.68 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, <u class="uu">C</u>H<sub>Ar (7)</sub>, 1H), 7.71 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, CH<sub>Ph</sub>, 2H), 8.61 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 10.11 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 74.4). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.8 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.7, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 99.1 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 192.5, <sup>1</sup><i>J</i><sub>PC</sub> = 143.6, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 115.4 (s, CH<sub>Ar(6)</sub>, 1C), 122.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.3, C<sub>Ar(3)</sub>, 1C), 125.0 (s, C<sub>Ar(2)</sub>, 1C), 125.2 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 4.4, CH<sub>Ar(5)</sub>, 1C), 127.5 (s, CH<sub>Ar(8)</sub>, 1C), 128.6 (s, CH<sub>Ph</sub>, 2C), 129.1 (s, CH<sub>Ar(7)</sub>, 1C), 129.1 (s, CH<sub>Ph</sub>, 2C), 129.3 (s, CH<sub>Ph</sub>, 1C), 134.4 (s, CH<sub>Ph</sub>, 1C), 141.0 (s, C<sub>Ar(9)</sub>, 1C), 174.9 (bd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.0, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-Fluoro-3-(8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>1o</b>)</h5><div class="NLM_p last">Yield, 82%; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>5</sub>P Calculated: C, 43.72; H, 4.00; N, 9.27, Found: C, 43.45; H, 4.06; N, 9.15. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 8) δ: 2.56 (s, C<u class="uu">H</u><sub>3</sub>, 3H), 3.67 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>FH/PH</sub> = 6.8, C<u class="uu">H</u>HCFP, 1H), 3.84 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 40.7, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 1.9, C<u class="uu">H</u>HCFP, 1 H), 7.16 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 7.44 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, C<u class="uu">H</u><sub>Ar(7)</sub>, 1H), 7.59 (s, C<u class="uu">H</u><sub>Ar(2)</sub>, 1H), 8.45 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, C<u class="uu">H</u><sub>Ar(5)</sub>, 1H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 8) δ: 15.8 (s, <u class="uu">C</u>H<sub>3</sub>, 1C), 29.2 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 18.3, <u class="uu">C</u>H<sub>2</sub>CFP, 1C), 100.1 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.4, <sup>1</sup><i>J</i><sub>CP</sub> = 140.3, CH<sub>2</sub><u class="uu">C</u>FP, 1C), 114.9 (s, <u class="uu">C</u>H<sub>Ar(6)</sub>, 1C), 123.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.0, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 124.0 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 4.3, <u class="uu">C</u>H<sub>Ar(5)</sub>, 1C), 124.3 (s, <u class="uu">C</u><sub>Ar(8)</sub>, 1C), 125.3 (s, <u class="uu">C</u>H<sub>Ar(7)</sub>, 1C), 128.5 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1C), 143.1 (s, <u class="uu">C</u><sub>Ar(9)</sub>, 1C), 176.0 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 20.6, <sup>2</sup><i>J</i><sub>PC</sub> = 3.1, <u class="uu">C</u>O<sub>2</sub>, 1C). <sup>13</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 11.00 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.5).</div></div><div id="sec4_1_5_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 3-(8-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-fluoro-2-phosphonopropanoic acid (<b>1p</b>)</h5><div class="NLM_p last">Yield, 79%; scale. 0.1 g. Elemental analysis C<sub>10</sub>H<sub>9</sub>BrFN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>2</sub>, Calculated: C, 29.80; H, 3.25; N, 6.95. Found: C, 29.71; H, 3.26; N, 6.94. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 7) δ: 3.62–3.73 (m, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.93 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 40.1, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>PH</sub> = 2.70, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 6.98 (m, CH<sub>Ar(6)</sub>, 1H), 7.57 (s, CH<sub>Ar(2)</sub>, 1H), 7.72 (m, CH<sub>Ar(7)</sub>, 1H), 8.46 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 0.9, CH<sub>Ar(5)</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 10.50 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 77.5). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.8 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 21.4, <sup>2</sup><i>J</i><sub>PC</sub> = 3.2, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 98.8 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 192.1, <sup>1</sup><i>J</i><sub>PC</sub> = 146.8, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 108.6 (s, CH<sub>Ar(8)</sub>, 1C), 113.5 (s, CH<sub>Ar(6)</sub>, 1C), 123.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.8, C<sub>Ar(3)</sub>, 1C), 125.0 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 2.6, CH<sub>Ar(5)</sub>, 1C), 129.3 (s, CH<sub>Ar(7)</sub>, 1C), 130.2 (s, C<sub>Ar(2)</sub>, 1C), 142.7 (s, C<sub>Ar(9)</sub>, 1C), 174.4 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.6, <sup>2</sup><i>J</i><sub>FC</sub> = 3.4, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 2-Fluoro-3-(imidazo[2,1-<i>a</i>]isoquinolin-3-yl)-2-phosphonopropanoic Acid (<b>1r</b>)</h5><div class="NLM_p last">Yield, 35%; scale, 0.093 g. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 9) δ: 3.66 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 16.0, <sup>3</sup><i>J</i><sub>FH</sub> = 6.6, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 3.95 (dd, <sup>3</sup><i>J</i><sub>FH</sub> = 41.3, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 0.9, C<u class="uu">H</u><sub>2</sub>CPF, 1H), 7.29 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, CH<sub>Ar</sub>, 1H), 7.42 (s, CH<sub>Ar</sub>, 1H), 7.67–7.77 (m, CH<sub>Ar</sub>, 2H), 7.89 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, CH<sub>Ar</sub>, 1H), 8.26 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, CH<sub>Ar</sub>, 1H), 8.42 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.9, CH<sub>Ar</sub>, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 9) δ: 10.33 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 70.5). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 29.1 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.0, <u class="uu">C</u>H<sub>2</sub>CPF, 1C), 100.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 190.5, <sup>1</sup><i>J</i><sub>PC</sub> = 138.2, CH<sub>2</sub><u class="uu">C</u>PF, 1C), 112.8 (s, CH<sub>Ar</sub>, 1C), 122.1 (s, CH<sub>Ar</sub>, 1C), 122.4 (s, CH<sub>Ar</sub>, 1C), 122.6 (s, CH<sub>Ar</sub>, 1C), 124.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.5, C<sub>Ar</sub>, 1C), 127.3 (s, CH<sub>Ar</sub>, 1C), 128.2 (s, CH<sub>Ar</sub>, 1C), 128.6 (s, CH<sub>Ar</sub>, 1C), 128.8 (s, CH<sub>Ar</sub>, 1C), 129.5 (s, CH<sub>Ar</sub>, 1C), 142.9 (s, CH<sub>Ar</sub>, 1C), 176.6 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 20.7, <sup>2</sup><i>J</i><sub>FC</sub> = 3.2, <u class="uu">C</u>O<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 2-Fluoro-2-(hydroxy(phenyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoic Acid (<b>1s</b>)</h5><div class="NLM_p last">Yield, 68%; scale, 0.070 g. Purification by HPLC: the column was eluted at 5 mL/min using gradient of eluents A (H<sub>2</sub>O) and B (acetonitrile) under the following conditions: isocratic elution from 0 to 5 min with A 100%, gradient from 5 to 15 min; 20% of B. Elemental analysis C<sub>16</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>4</sub>P (H<sub>2</sub>O)<sub>1.75</sub> (CH<sub>3</sub>CN)<sub>0.05</sub> Calculated: C, 50.64; H, 4.66; N, 7.52. Found: C, 50.33; H, 4.50; N, 7.89. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 7) δ: 23.11 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 74.5). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 8.32 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HH</sub> = 1.4, C<u class="uu">H</u><sub>Ar(5)</sub>, 1H), 7.87–7.78 (m, C<u class="uu">H</u><sub>Ph</sub>, 1H), 7.59 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, <sup>4</sup><i>J</i><sub>HH</sub> = 1.4, C<u class="uu">H</u><sub>Ph</sub>,1H), 7.54 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, C<u class="uu">H</u><sub>Ar(8)</sub>, 1H), 7.52 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, <sup>3</sup><i>J</i><sub>HH</sub> = 3.2, C<u class="uu">H</u><sub>Ph</sub>, 2H), 7.42 (s, C<u class="uu">H</u><sub>Ar(2)</sub>, 1H), 7.37 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, <sup>3</sup><i>J</i><sub>HH</sub> = 6.7, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, C<u class="uu">H</u><sub>Ar(7)</sub>, 1H), 7.88 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 3.91 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 39.8, <sup>3</sup><i>J</i><sub>FH</sub> = 2.7, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, PCC<u class="uu">H</u>H, 1H), 3.70 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 15.5, <sup>3</sup><i>J</i><sub>FH</sub> = 7.5, PCC<u class="uu">H</u>H, 1H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 1) δ: 171.9 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 23.4, <sup>2</sup><i>J</i><sub>PC</sub> = 4.1, <u class="uu">C</u>O<sub>2</sub>, 1C), 140.2 (s, <u class="uu">C</u><sub>Ar(9)</sub>, 1C), 133.8 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1C), 132.7 (d, <i>J</i><sub>PC</sub> = 9.8, <u class="uu">C</u>H<sub>Ph</sub>, 2C), 131.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 136.2, P<u class="uu">C</u><sub>Ph</sub>, 1C), 128.5 (d, <i>J</i><sub>PC</sub> = 12.6, <u class="uu">C</u>H<sub>Ph</sub>, 2C), 126.8 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 4.5, C<u class="uu">H</u><sub>Ph</sub>, 1C), 132.5 (s, <u class="uu">C</u>H<sub>Ar</sub>, 1C), 121.5 (s, <u class="uu">C</u>H<sub>Ar</sub>, 1C), 121.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 11.4, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 117.2 (s, <u class="uu">C</u>H<sub>Ar</sub>, 1C), 112.2 (s, <u class="uu">C</u>H<sub>Ar</sub>, 1C), 99.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 197.3, <sup>1</sup><i>J</i><sub>PC</sub> = 95.6, PCH, 1C), 26.7 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 19.6, PCF<u class="uu">C</u>H<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 2-(Ethyl(hydroxy)phosphoryl)-2-fluoro-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoic Acid (<b>1t</b>)</h5><div class="NLM_p last">Yield: 70%. Purification by HPLC: the column was eluted at 5 mL/min using gradient of eluents A (H<sub>2</sub>O), B (acetonitrile): isocratic elution from 0 to 5 min with A 100%, gradient from 5 to 10 min; 100% of B. Elemental analysis C<sub>12</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>4</sub>P (H<sub>2</sub>O)<sub>1.4</sub>, (CH<sub>3</sub>CN)<sub>0.02</sub> Calculated: C, 44.32; H, 5.21; N, 8.67. Found: C, 44.25; H, 5.20; N, 8.80. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 1) δ: 36.14 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 62.2). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 1) δ: 8.73 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 0.8, C<u class="uu">H</u><sub>Ar(5)</sub>, 1H), 7.97 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, 7.0, <sup>4</sup><i>J</i><sub>HH</sub> = 0.9, C<u class="uu">H</u><sub>Ar(7)</sub>, 1H), 7.91 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, C<u class="uu">H</u><sub>Ar(8)</sub>, 1H), 7.86 (s, C<u class="uu">H</u><sub>Ar(2)</sub>, 1H), 7.52 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 4.05 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 39.3, <sup>3</sup><i>J</i><sub>HH</sub> = 15.7, <sup>3</sup><i>J</i><sub>PH</sub> = 2.5, PCC<u class="uu">H</u>CH, 1H), 3.91–3.85 (m, PCC<u class="uu">H</u>CH, 1H), 1.88–1.72 (m, PC<u class="uu">H</u><sub>2</sub>, 2H), 1.16 (dt, <sup>3</sup><i>J</i><sub>PH</sub> = 17.8, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, PCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>, 3H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 1) δ: 172.4 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 25.7, <sup>2</sup><i>J</i><sub>PC</sub> = 2.8, CO<sub>2</sub>, 1C), 140.1 (s, <u class="uu">C</u><sub>Ar(9)</sub>, 1C), 133.6 (s, <u class="uu">C</u>H<sub>Ar(7)</sub>, 1C), 126.7 (d, <i>J</i> = 3.9, <u class="uu">C</u>H<sub>Ar(5)</sub>, 1C), 121.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.0, <u class="uu">C</u><sub>Ar(3)</sub>, 1C), 121.1 (s, <u class="uu">C</u>H<sub>Ar(2)</sub>, 1H), 117.0 (s, <u class="uu">C</u>H<sub>Ar(6)</sub>, 1C), 112.0 (s, <u class="uu">C</u>H<sub>Ar(8)</sub>, 1C), 98 (P<u class="uu">C</u>F, 1C), 26.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.5, PC<u class="uu">C</u>H<sub>2</sub>, 1C), 19.8 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 98.1, PCH<u class="uu">C</u>H<sub>2</sub>, 1C), 5.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.1, <u class="uu">C</u>H<sub>3</sub>CH<sub>2</sub>P, 1C).</div></div><div id="sec4_1_5_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 3-([1,1′-Biphenyl]-3-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1u</b>)</h5><div class="NLM_p last">Yield, 77%; scale, 0.5 mmol; crystallized from petroleum ether. Elemental analysis C<sub>15</sub>H<sub>14</sub>FO<sub>5</sub>P (H<sub>2</sub>O)<sub>0.3</sub>, Calculated: C, 54.65; H, 4.46. Found: C, 54.58; H, 4.37. <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 2) δ: 9.20 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 73.3). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 2) δ: 3.52–3.66 (m, C<u class="uu">H</u><sub>2</sub>CF, 2H), 7.36 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, C<u class="uu">H</u><sub>Ar</sub>, 1H), 7.47 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, C<u class="uu">H</u><sub>Ar</sub>, 1H), 7.50 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, C<u class="uu">H</u><sub>Ar</sub>, 1H), 7.56 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, C<u class="uu">H</u><sub>Ar</sub>, 2H), 7.61–7.65 (m, C<u class="uu">H</u><sub>Ar</sub>, 2H), 7.72 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, C<u class="uu">H</u><sub>Ar</sub>, 2H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 2) δ: 172.2 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 24.9, <u class="uu">C</u>O<sub>2</sub>, 1C), 140.7 and 140.4 (2s, <u class="uu">C</u><sub>Ar</sub>, 2C), 135.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.3, <u class="uu">C</u>CH<sub>2</sub>CP, 1C), 129.3 and 128.5 and 127.8 and 125.9 (4s, <u class="uu">C</u>H<sub>Ar</sub>, 4C), 129.1 (s, <u class="uu">C</u>H<sub>Ar</sub>, 3C), 127.0 (s, <u class="uu">C</u>H<sub>Ar</sub>, 2C), 97.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.3, <sup>1</sup><i>J</i><sub>PC</sub> = 147.0, P<u class="uu">C</u>F, 1C), 39.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 19.5, PC<u class="uu">C</u>H<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 3-([1,1′-Biphenyl]-4-yl)-2-fluoro-2-phosphonopropanoic Acid (<b>1w</b>)</h5><div class="NLM_p last">Yield, 66%; scale, 0.5 mmol; crystallized from petroleum ether. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 2) δ: 8.44 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 74.7). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 2) δ: 7.73 (s, C<u class="uu">H</u><sub>Ar</sub>, 2H), 7.68 (s, C<u class="uu">H</u><sub>Ar</sub>, 2H), 7.55 (bs, C<u class="uu">H</u><sub>Ar</sub>, 2H), 7.46 (s, C<u class="uu">H</u><sub>Ar</sub>, 3H), 3.48–3.67 (m, C<u class="uu">H</u><sub>2</sub>CF, 2H). <sup>19</sup>F NMR (235 MHz, D<sub>2</sub>O, PhCF<sub>3</sub> in CDCl<sub>3</sub> used as reference δ −63.02) δ: −176.11 (ddd, <sup>2</sup><i>J</i><sub>PF</sub> = 74.5, <sup>4</sup><i>J</i><sub>FH</sub> = 39.3, <sup>4</sup><i>J</i><sub>FH</sub> = 12.7). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 2) δ: 172.4 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 24.4, <u class="uu">C</u>O<sub>2</sub>, 1C), 140.2 and 139.5 (2s, <u class="uu">C</u><sub>Ar</sub>, 2C), 133.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.1, <u class="uu">C</u>CH<sub>2</sub>CP, 1C), 130.7 and 129.1 (2s, <u class="uu">C</u>H<sub>Ar</sub>, 4C), 127.7 (s, <u class="uu">C</u>H<sub>Ar</sub>, 1C), 126.9 (s, <u class="uu">C</u>H<sub>Ar</sub>, 4C), 97.1 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.5, <sup>1</sup><i>J</i><sub>PC</sub> = 147.5, P<u class="uu">C</u>F, 1C), 38.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 19.9, PC<u class="uu">C</u>H<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 3-(3-Benzylphenyl)-2-fluoro-2-phosphonopropanoic Acid (<b>1y</b>)</h5><div class="NLM_p last">Yield, 99%; scale, 0.5 mmol; no crystallization, only removal of solvents. Elemental analysis C<sub>16</sub>H<sub>16</sub>FO<sub>5</sub>P (H<sub>2</sub>O)<sub>0.4</sub> Calculated: C, 55.63; H, 4.9. Found: C, 55.68; H, 4.88. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 1) δ: 9.40 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 75.4). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 1) δ: 3.31–3.56 (m, C<u class="uu">H</u><sub>2</sub>CF, 2H), 4.01 (s, C<u class="uu">H</u><sub>2</sub>C<sub>Ar</sub>, 2H), 7.09–7.40 (m, C<u class="uu">H</u><sub>Ar</sub>, 9H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 1) δ: 172.2 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 24.2, <u class="uu">C</u>O<sub>2</sub>, 1C), 141.9 and 141.8 (2s, <u class="uu">C</u><sub>Ar</sub>, 2C), 134.83(d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.6, <u class="uu">C</u>CH<sub>2</sub>CP, 1C), 130.4 and 127.9 and 127.7 and 126.3 (4s, <u class="uu">C</u>H<sub>Ar</sub>, 4C), 128.80 and 128.76 (2s, <u class="uu">C</u>H<sub>Ar</sub>, 5C), 97.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 191.7, <sup>1</sup><i>J</i><sub>PC</sub> = 147.4, P<u class="uu">C</u>F, 1C), 41.0 (s, C<sub>Ar</sub><u class="uu">C</u>H<sub>2</sub>C<sub>Ar</sub>, 1C), 38.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.0, PC<u class="uu">C</u>H<sub>2</sub>, 1C).</div></div><div id="sec4_1_5_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 3-(2-Phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2a</b>)</h5><div class="NLM_p last">Yield, 75%; scale, 0.075 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 2.83–3.03 (m, 1H), 3.31–3.47 (m, 1H), 3.67–3.89 (m, 1H), 7.01 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub>= 1.2, 1H), 7.32–7.42 (m, 1H), 7.43–7.49 (m, 1H), 7.49–7.60 (m, 3H), 7.92–7.78 (m, 2H), 8.50 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub>= 1.1, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 15.98.</div></div><div id="sec4_1_5_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3-(2-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2b</b>)</h5><div class="NLM_p last">Yield, 43%; scale; 0.1 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 2.34 (s, 1H), 2.84 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 19.2, <sup>3</sup><i>J</i><sub>HH</sub> = 12.5, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.15 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.4, <sup>3</sup><i>J</i><sub>PH</sub> = 7.8, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.51 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.5, <sup>3</sup><i>J</i><sub>PH</sub> = 4.7, 1H), 6.93 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.0, 1H), 7.20–7.34 (m, 1H), 7.37–7.46 (m, 1H), 8.27 (bdd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 0.8, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 16.00.</div></div><div id="sec4_1_5_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 3-(6-Bromo-2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2c</b>)</h5><div class="NLM_p last">Yield, 89%; scale, 0.23 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 7) δ: 2.36 (s, 1H), 2.87 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 19.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.6, <sup>3</sup><i>J</i><sub>HH</sub> = 2.6, 1H), 3.14 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.4, <sup>3</sup><i>J</i><sub>PH</sub> = 7.1, <sup>3</sup><i>J</i><sub>HH</sub> = 2.6, 1H), 3.52 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.6, <sup>3</sup><i>J</i><sub>PH</sub> = 5.3, 1H), 7.26–7.40 (m, 2H), 8.48–8.62 (m, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 7) δ: 15.73 (s).</div></div><div id="sec4_1_5_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 3-(5-Phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2d</b>)</h5><div class="NLM_p last">Yield, 76%; scale, 0.040 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 2.55–2.60 (m, 1H), 2.64–2.71 (m, 1H), 2.99 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 22.2, <sup>3</sup><i>J</i><sub>HH</sub> = 12.30, <sup>3</sup><i>J</i><sub>PH</sub> = 2.60, 1H), 6.80 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub>= 1.2, 1H), 7.38 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.29, 1H), 7.47 (s, 1H), 7.54–7.57 (m, 1H), 7.58 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H) 7.59–7.64 (m, 3H), 7.48–7.68 (m, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 14.87.</div></div><div id="sec4_1_5_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 3-(5-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2e</b>)</h5><div class="NLM_p last">Yield, 66%; scale, 0.23 g; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.45</sub> Calculated: C, 42.57; H, 5.16; N, 9.03. Found: C, 42.60; H, 5.08; N, 9.11. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O) δ: 3.01 (s, 3H), 3.15–4.01 (m, 3H), 7.12 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 7.58–7.75 (m, 3H). <sup>31</sup>P NMR (250 MHz, D<sub>2</sub>O) δ: 13.65.</div></div><div id="sec4_1_5_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 3-(6-Phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2f</b>)</h5><div class="NLM_p last">Yield, 97%; scale, 0.1 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.05 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 15.7, <sup>3</sup><i>J</i><sub>HH</sub> = 12.6, <sup>3</sup><i>J</i><sub>HH</sub> = 2.6, 1H), 3.17–3.30 (m, 1H), 3.38–3.59 (m, 1H), 7.38 (s, 1H), 7.44–7.49 (m, 1H), 7.51–7.59 (m, 2H), 7.61–7.65 (m, 2H), 7.73–7.81 (m, 2H), 8.56 (bs, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 15.97.</div></div><div id="sec4_1_5_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 3-(6-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2g</b>)</h5><div class="NLM_p last">Yield, 56%; scale, 0.24 g; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.45</sub> Calculated: C, 42.57; H, 5.16; N, 9.03. Found: C, 42.43; H, 4.95; N, 8.96. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O) δ: 2.43 (s, 3H), 3.27–3.65 (m, 3H); 7.64 (s, 1H), 7.70 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.3, 1H), 7.76 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.8, 1H), 8.40 (s, 1H). <sup>31</sup>P NMR (250 MHz, D<sub>2</sub>O) δ: 14.67.</div></div><div id="sec4_1_5_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 3-(6-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2h</b>)</h5><div class="NLM_p last">Yield, 77%; scale, 0.1 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.02 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.5, <sup>3</sup><i>J</i><sub>HH</sub> = 12.9, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.18 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>PH</sub> = 7.5, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.44 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.9, <sup>3</sup><i>J</i><sub>HH</sub> = 12.9, <sup>3</sup><i>J</i><sub>PH</sub> = 5.0, 1H), 7.36 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.42 (s, 1H), 7.54 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H), 8.54 (dd, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H). <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O pH 8) δ: 15.18 (s). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 28.8 (bs, 1C), 49.8 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 113.3, 1C), 116.4, 120.5, 122.7, 126.3 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 4.6, 1C), 126.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 19.6, 1C), 129.9 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 143.7, 180.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C).</div></div><div id="sec4_1_5_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 3-(6-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2i</b>)</h5><div class="NLM_p last">Yield, 32%; scale, 0.1 g. Elemental analysis C<sub>10</sub>H<sub>10</sub>BrN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>0.95</sub>, Calculated: C, 32.80; H, 2.28; N, 7.65, Found: C, 32.78; H, 3.30; N, 7.64. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 7) δ: 2.99 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.7, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.14 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 7.1, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.41 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>HH</sub> = 12.7, <sup>3</sup><i>J</i><sub>PH</sub> = 4.8, 1H), 7.36 (s, 1H), 7.40–7.50 (m, 2H), 8.61 (bs, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 7) δ: 15.81.</div></div><div id="sec4_1_5_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 3-(7-Phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2j</b>)</h5><div class="NLM_p last">Yield, 96%; scale, 0.053 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.01 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.8, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.13–3.28 (m, 1H), 3.35–3.56 (m, 1H), 7.34 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.43–7.61 (m, 3H), 7.73–7.84 (m, 3H), 8.36 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 16.05.</div></div><div id="sec4_1_5_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 3-(7-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2k</b>)</h5><div class="NLM_p last">Yield, 45%; scale, 0.27 g; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.4</sub> Calculated: C, 42.7; H, 5.15; N, 9.05. Found: C, 42.58; H, 4.96; N, 8.94. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O) δ: 2.41 (s, 3H); 2.85–3.67 (m, 3H), 6.89 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HH</sub> = 1.5, 1H) 7.27 (s, 1H); 7.31 (bs, 1H), 8.21 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H). <sup>31</sup>P NMR (250 MHz, D<sub>2</sub>O) δ: 15.86.</div></div><div id="sec4_1_5_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 3-(7-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2l</b>)</h5><div class="NLM_p last">Yield, 77%; scale, 0.1 g. Elemental analysis C<sub>10</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>5</sub>Px(H<sub>2</sub>O)<sub>0.35</sub> Calculated: C, 38.63; H, 3.47; N, 9.01, Found: C, 38.78; H, 3.62; N, 8.84. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 2.97 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.7, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.15 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 7.8, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.41 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup>J<sub>HH</sub> = 12.7, <sup>3</sup><i>J</i><sub>PH</sub> = 5.0, 1H), 7.02 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 2.0, 1H), 7.34 (s, 1H), 7.59 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 2.0, 1H), 8.28 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 8) δ: 15.77.</div></div><div id="sec4_1_5_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 3-(8-Phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2n</b>)</h5><div class="NLM_p last">Yield, 75%; scale, 0.1 g. Elemental analysis C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.25</sub>, (HCl)<sub>1.15</sub> Calculated: C, 46.79, H, 4.58; N, 6.82. Found: C, 46.79; H, 4.62; N, 6.76. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 3.02 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.7, <sup>3</sup><i>J</i><sub>HH</sub> = 2.5, 1H), 3.12–3.27 (m, 1H), 3.36–3.54 (m, 1H), 7.09 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.33–7.40 (m, 2H), 7.44–7.58 (m, 3H), 7.70–7.79 (m, 2H), 8.31 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (63 MHz, D<sub>2</sub>O pH 8) δ: 15.95.</div></div><div id="sec4_1_5_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 3-(8-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2o</b>)</h5><div class="NLM_p last">Yield, 67%; scale, 0.22 g; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>0.2</sub> Calculated: C, 45.91; H, 4.69; N, 9.73. Found: C, 45.97; H, 4.72; N, 9.81. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O, pH 8) δ: 2.57 (s, 3H), 3.28–3.70 (m, 3H), 7.39 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.70 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 7.73 (s, 1H), 8.45 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (250 MHz, D<sub>2</sub>O pH 8) δ: 14.40.</div></div><div id="sec4_1_5_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 3-(8-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-phosphonopropanoic Acid (<b>2p</b>)</h5><div class="NLM_p last">Yield, 80%; scale, 0.14 g. Elemental analysis C<sub>10</sub>H<sub>10</sub>BrN<sub>2</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.85</sub> Calculated: C, 31.41; H, 3.61; N, 7.33. Found: C, 31.31; H, 3.44; N, 7.28. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 7) δ: 3.01 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.7, <sup>3</sup><i>J</i><sub>HH</sub> = 12.9, <sup>3</sup><i>J</i><sub>HH</sub> = 2.6, 1H), 3.12–3.29 (m, 1H), 3.36–3.53 (m, 1H), 6.94 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 7.42 (s, 1H), 7.65 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 8.36 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 7) δ: 15.76.</div></div><div id="sec4_1_5_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 3-(Imidazo[2,1-<i>a</i>]isoquinolin-3-yl)-2-phosphonopropanoic Acid (<b>2r</b>)</h5><div class="NLM_p last">Yield, 84%; scale, 0.065 g. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 9) δ: 3.01 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.6, <sup>3</sup><i>J</i><sub>HH</sub> = 12.80, <sup>3</sup><i>J</i><sub>HH</sub> = 2.70, 1H), 3.14–3.29 (m, 1H), 3.37–3.56 (m, 1H), 7.23–7.35 (m, 2H), 7.62–7.73 (m, 2H), 7.82–7.91 (m, 1H), 8.13 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 1H), 8.32–8.45 (m, 1H). <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 9) δ: 16.04.</div></div><div id="sec4_1_5_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 2-(Hydroxy(phenyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoic Acid (<b>2s</b>)</h5><div class="NLM_p last">Yield, 68%; scale, 0.065 g; crystallized from Et<sub>2</sub>O. Elemental analysis C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub>P (H<sub>2</sub>O)<sub>1.3</sub> (HCl)<sub>0.9</sub> Calculated: C, 49.72, H, 4.82, N, 7.25. Found: C, 49.75, H, 4.91, N, 7.16. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O, pH 2) δ: 25.28. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 2) δ: 8.47–8.42 (m, 1H), 7.96–7.91 (m, 1H), 7.85–7.81 (m, 1H), 7.77–7.72 (m, 2H), 7.67 (s, 1H), 7.58 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 1H), 7.52–7.47 (m, 3H), 3.58–3.40 (m, 3H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O pH 2) δ: 173.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C), 139.7 (s, 1C), 133.3 (s, 1C), 133.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 133.6, 1C), 131.8 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 2.1, 1C), 131.4 (d, <i>J</i><sub>PC</sub> = 9.8, 2C), 128.4 (d, <i>J</i><sub>PC</sub> = 12.5, 2C), 125.9 (s, 1C), 124.7 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.6, 1C), 119.5 (s, 1C), 117.1 (s, 1C), 112.1 (s, 1C), 47.9 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 76.6, 1C), 20.7.</div></div><div id="sec4_1_5_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 2-(Ethyl(hydroxy)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoic Acid (<b>2t</b>)</h5><div class="NLM_p last">Yield, 87%; scale, 0.10 g; crystallized from Et<sub>2</sub>O. <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O, pH 2) δ: 42.07. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 2) δ: 8.62 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.97–7.81 (m, 2H), 7.73 (s, 1H), 7.49 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.6, 1H), 3.66–3.31 (m, 3H), 1.90–1.73 (m, 2H), 1.16 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.8, <sup>3</sup><i>J</i><sub>PH</sub> = 3.0, 3H). <sup>13</sup>C NMR (63 MHz, D<sub>2</sub>O) δ: 171.8 (s, 1C), 138.0 (s, 1C), 131.5, 124.2, 117.4, 115.2, 110.3, 123.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.4, 1C), 44.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 69.7, 1C), 19.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 97.7, 1C), 18.0 (s, 1C), 3.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.8, 1C).</div></div><div id="sec4_1_5_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 3-([1,1′-Biphenyl]-3-yl)-2-phosphonopropanoic Acid (<b>2u</b>)</h5><div class="NLM_p last">Yield, 90%; scale, 0.5 mmol; pure compound isolated by removal of solvents. Elemental analysis C<sub>15</sub>H<sub>15</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>0.55</sub> Calculated: C, 56.95; H, 5.13. Found: C, 56.93; H, 5.09. <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 2) δ: 18.76. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 2) δ: 2.88–3.23 (m, 3H), 6.75–7.26 (m, 9H).</div></div><div id="sec4_1_5_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 3-([1,1′-Biphenyl]-4-yl)-2-phosphonopropanoic Acid (<b>2w</b>)</h5><div class="NLM_p last">Yield, 70%; scale, 0.5 mmol; crystallized from water. <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 2) δ: 15.74. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 2) δ: 3.08–3.31 (m, 3H), 7.34–7.47 (m, 3H), 7.47–7.58 (m, 2H), 7.60–7.75 (m, 4H),</div></div><div id="sec4_1_5_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 3-(3-Benzylphenyl)-2-phosphonopropanoic Acid (<b>2y</b>)</h5><div class="NLM_p last">Yield, 98%; scale, 0.5 mmol; crystallized from petroleum ether. Elemental analysis C<sub>16</sub>H<sub>17</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>0.05</sub> Calculated: C, 59.90; H, 5.56. Found: C, 59.83; H, 5.37. <sup>31</sup>P NMR (101 MHz, D<sub>2</sub>O pH 2) δ: 18.47. <sup>1</sup>H NMR (250 MHz, D<sub>2</sub>O pH 2) δ: 2.93–3.29 (m, 3H), 3.69 (s, 2H), 6.79–6.91 (m, 1H), 6.96–7.18 (m, 8H).</div></div><div id="sec4_1_5_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 3-([1,1′:4′,1″-Terphenyl]-3-yl)-2-phosphonopropanoic Acid (<b>2z</b>)</h5><div class="NLM_p last">Yield, 95%; crystallized from H<sub>2</sub>O. Elemental analysis C<sub>21</sub>H<sub>19</sub>O<sub>5</sub>P (H<sub>2</sub>O)<sub>1.2</sub> Calculated: C, 62.44; H, 5.34; Found: C, 62.28; H, 5.13. <sup>31</sup>P NMR (283 MHz, D<sub>2</sub>O, pH 7) δ: 16.85. <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O pH 7) δ: 7.87–7.81 (m, 4H), 7.79 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 2H), 7.72 (s, 1H), 7.57 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.5, 3H), 7.48 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.6, 2H), 7.40 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.6, 1H), 3.28–3.13 (m, 2H), 2.99 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 20.4, <sup>3</sup><i>J</i><sub>HH</sub> = 12.4, 2.9, 1H). <sup>13</sup>C NMR (176 MHz, D<sub>2</sub>O) δ: 181.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.0, 1C), 143.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.6, 1C), 140.3, 140.1, 140.0, 139.7, 129.40, 129.30, 128.13, 127.99, 127.77, 127.64, 127.15, 127.06, 124.37 (13s, CH<sub>Ar</sub>, 17C), 54.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 112.8, 1C), 35.5 (s, 1C).</div></div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> General Procedure for the Synthesis of Compounds (<b>8d</b>–<b>z</b>)</h4><div class="NLM_p">Reaction was carried out under argon atmosphere using oven-dried glassware. A 100 mL two-neck round-bottom flask was charged with <b>5</b> (1.79 g, 8.0 mmol, 1.2 equiv) dissolved in DCM (20 mL). The solution was cooled down below −30 °C (internal temperature control), and TiCl<sub>4</sub> (0.877 mL, 8 mmol, 1.2 equiv) was slowly added via syringe, followed by Et<sub>3</sub>N (2.63 mL, 0.0187 mol, 2.8 equiv). The reaction mixture was stirred for 15 min at −30 °C. Then, a solution of aldehyde <b>3</b> (6.67 mmol, 1 equiv) in DCM (20 mL) was dropwisely added for 15 min at the temperature below −30 °C. The resulting mixture was stirred at room temperature for 16 h and then quenched with 25 mL of water and was made basic with saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution to pH > 9. The water layer was extracted with diethyl ether (5 × 25 mL). The organic layer was dried over anhydrous Mg<sub>2</sub>SO<sub>4</sub>, the solvent was evaporated, and the residue was subjected to column chromatography using as eluent DCM:acetone (85:15) to give product as <i>Z</i>/<i>E</i> mixture in the form of orange oil. The same procedure was applied for the synthesis of compounds <b>8s</b>–<b>z</b>. In the case of <b>8u</b>–<b>z</b> analogues, the elimination reaction was not complete and up to 50% of hydroxy analogues remained, which were easily separated from the desired product. <i>Note: The crude product of condensation can be subjected to reduction without prior purification.</i></div><div id="sec4_1_5_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Ethyl 2-(Diethoxyphosphoryl)-3-(5-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8d</b>)</h5><div class="NLM_p last">Yield, 53%; scale, 0.24 g; <i>E</i>/<i>Z</i> = 0.3:1 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>Z</i>)-<b>8d</b><sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.04 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.14 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 6H), 3.96–4.09 (m, 4H), 4.17 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 6.71 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.27 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.32 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>E</i>) = 41.6, 1H), 7.34–7.41 (m, 5H), 7.56 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 8.34 (s, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 14.14. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.10, and 16.14 (2s, 2C), 60.8, 62.25, 62.29, 114.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 192.3, 1C), 116.2, 117.2, 127.0, 128.1 (s, 2C), 129.1 (s, 2C), 129.7, 134.5, 141.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 3.5, 1C), 142.6 (s, 1C), 149.1 (s, 1C), 165.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 15.9, 1C).</div></div><div id="sec4_1_5_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Ethyl 2-(Diethoxyphosphoryl)-3-(5-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8e</b>)</h5><div class="NLM_p last">Yield, 60%; scale, 9.4 mmol, 1.5 g. Ratio of isomers <i>E</i>/<i>Z</i> 1:0.1 (CHCl<sub>3</sub>:MeOH 50:1 <i>R</i><sub>f</sub> 0.28). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 15.98 (<i>E</i>) and 13.77 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.15 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H), 1.22 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 2.76 (s, 3H), 4.11–3.92 (m, 4H), 4.16 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 6.58 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.08 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 8.8, 7.0, 1H), 7.40 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, 1H), 8.01 (s, 1H), 8.18 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 23.5, 1H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.1 (s, <sup>3</sup><i>J</i><sub>PC</sub> = 6.6, 2C), 22.1, 61.4, 62.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.3, 2C), 115.8, 116.3, 116.9 (s, <sup>1</sup><i>J</i><sub>PC</sub> = 184.3, 1C), 121.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.9, 1C), 127.0 (s, 1C), 137.3 (s, 1C), 137.3 (t, <sup>2</sup><i>J</i><sub>PC</sub> = 4.9, 1C), 140.2, 149.2, 165.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.5, 1C).</div></div><div id="sec4_1_5_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Ethyl 2-(Diethoxyphosphoryl)-3-(6-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8f</b>)</h5><div class="NLM_p last">Yield, 80%; scale, 0.5 g; <i>E</i>/<i>Z</i> 1:0.14 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8f</b><sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.00, 9H), 4.10–4.28 (m, 4H), 4.39 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 7.42–7.55 (m, 3H), 7.56–7.68 (m, 3H), 7.78 (m, 1H), 8.06 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.8, 1H), 8.48 (s, 1H), 8.53 (s, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 17.17 (<i>E</i>) and 13.95 (<i>Z</i>).</div></div><div id="sec4_1_5_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Ethyl 2-(Diethoxyphosphoryl)-3-(6-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8g</b>)</h5><div class="NLM_p last">Yield, 60%; scale, 0.5 g; <i>E</i>/<i>Z</i> 1:0.03 (DCM:acetone 9:1 <i>R</i><sub>f</sub> 0.19). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 17.67 (<i>E</i>) and 14.17 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.28 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.28 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>PH</sub> = 0.7, 6H), 2.31 (s, 3H), 4.02–4.17 (m, 2H); 4.28 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 7.16 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H), 7.51 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, <sup>4</sup><i>J</i><sub>HH</sub> = 0.9, 1H), 7.92 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 23.9, 1H), 8.08 (s, 1H), 8.43 (s, 1H).</div></div><div id="sec4_1_5_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Ethyl 3-(6-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8h</b>)</h5><div class="NLM_p last">Yield, 57% yield; scale, 0.5 g; <i>E</i>/<i>Z</i> = 50/1, (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 15.71 (<i>E</i>) and 12.41 (<i>Z</i>). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 4.10–4.28 (m, 4H), 4.37 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 7.35 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.66 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>5</sup><i>J</i><sub>HH</sub> = 0.7, 1H), 7.90 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.7, 1H), 8.38 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 8.49 (s, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.32, 16.36, 61.7, 62.77, 62.80, 117.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.3, 1C), 118.8, 120.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.5, 1C), 122.1, 122.8, 128.5, 133.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 9.9, 1C), 141.6 (s, 1C), 146.1 (s, 1C), 165.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 11.6, 1C).</div></div><div id="sec4_1_5_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> Ethyl 3-(6-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8i</b>)</h5><div class="NLM_p last">Yield, 52%; scale, 0.34 g; <i>E</i>/<i>Z</i> 50/1, <i>R</i><sub>f(<i>E</i>)</sub> 0.36 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8i</b><sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 16.52 (<i>E</i>) and 13.27 (<i>Z</i>). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 4.12–4.25 (m, 4H), 4.36 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 7.43 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H), 7.59 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, 1H), 7.90 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.8, 1H), 8.45 (s, 1H), 8.52 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.2, 16.42, 16.44, 61.8, 62.87, 62.90, 109.4, 117.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.3, 1C), 119.1, 120.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.2, 1C), 124.3, 130.8, 133.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 10.1, 1C), 141.5, 146.3, 165.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 11.7, 1C).</div></div><div id="sec4_1_5_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Ethyl 2-(Diethoxyphosphoryl)-3-(7-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8j</b>)</h5><div class="NLM_p last">Yield, 52%; scale, 0.5 g; <i>E</i>/Z 100/0 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8h</b><sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 16.61. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.00, 9H), 4.10–4.26 (m, 4H), 4.39 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.00, 2H), 7.32 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H), 7.45 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 7.51 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 2H), 7.69 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 2H), 7.92 (s, 1H), 8.03 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.8, 1H), 8.40 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 8.61 (s, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.28, 16.32, 61.4, 62.5, 62.6, 113.9, 115.0, 115.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 185.5, 1C), 120.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.0), 123.7, 126.8 (s, 2C), 128.9, 129.2 (s, CH<sub>Ph</sub>, 2C), 133.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 10.2, 1C), 137.6, 140.5, 142.6, 148.4, 165.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.0, 1C).</div></div><div id="sec4_1_5_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Ethyl 2-(Diethoxyphosphoryl)-3-(7-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8k</b>)</h5><div class="NLM_p last">Yield, 47%; scale, 0.64 g; <i>E</i>/<i>Z</i> 1:0.02 (DCM:acetone 9:1 <i>R</i><sub>f</sub> 0.21). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 17.39 (<i>E</i>) and 13.84 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 8.51 (s, 1H), 8.22 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 7.95 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 23.8, 1H), 7.42 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 0.7, 1H), 6.82 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, <sup>4</sup><i>J</i><sub>HH</sub> = 1.6, 1H), 4.32 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 4.22–4.03 (m, 6H), 2.41 (s, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 165.5 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 12.6, 1C), 148.2 (s, 1C), 141.9 and 140.0 (2s, 2C), 134.2 (d, <sup>2</sup><i>J</i><sub>PC</sub>= 10.3, 1C), 119.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 23.7, 1C), 116.7 and 116.7 (2s, 2C), 113.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 186.2, 1C), 62.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.3, 2C), 61.1, 21.0, 16.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.7, 2C), 13.9.</div></div><div id="sec4_1_5_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> Ethyl 3-(7-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8l</b>)</h5><div class="NLM_p last">Yield, 67%; scale, 1 g; <i>E</i>/<i>Z</i> 5/1, <i>R</i><sub>f</sub>(<i>E</i>) 0.36, <i>R</i><sub>f</sub>(<i>Z</i>) 0.21, (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15); (<i>E</i>)-<b>8l</b><sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 4.10–4.25 (m, 4H), 4.37 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 7.01 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 2.1, 1H), 7.71 (bd, <sup>4</sup><i>J</i><sub>HH</sub> = 2.1, 1H), 7.92 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.7, 1H), 1H), 8.28 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 8.51 (s, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 16.70 (<i>E</i>) and 13.43 (<i>Z</i>). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.2, 16.3, 61.6, 62.6, 62.7, 115.7, 116.8 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.6, 1C), 117.4, 120.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.2, 1C), 124.1, 133.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 10.1, 1C), 134.1, 141.9, 147.6, 165.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.3, 1C).</div></div><div id="sec4_1_5_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> Ethyl 3-(7-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8m</b>)</h5><div class="NLM_p last">Yield, 68%; scale, 0.2 g; <i>E</i>/<i>Z</i> = 10/1, <i>R</i><sub>f</sub>(<i>E</i>) 0.33, <i>R</i><sub>f</sub>(<i>Z</i>) 0.27, (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8l</b><sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 16.68 (<i>E</i>) and 13.43 (<i>Z</i>). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 4.09–4.23 (m, 4H), 4.35 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 7.11 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.88 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.91 (d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>Z</i>) = 23.8, 1H), 1H), 8.25 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 8.47 (s, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.2, 16.39, 16.43, 61.8, 62.87, 62.88, 116.9 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.7, 1C), 118.2, 120.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.1), 120.9, 121.8, 124.3, 133.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 10.1, 1C), 141.9, 148.0, 165.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.3, 1C).</div></div><div id="sec4_1_5_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Ethyl 2-(Diethoxyphosphoryl)-3-(8-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8n</b>)</h5><div class="NLM_p last">Yield, 78% ; scale, 0.3 g; <i>E</i>/<i>Z</i> 25/1 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8h</b><sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 17.01 (<i>E</i>) and 13.86 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 4.09–4.27 (m, 4H), 4.36 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 7.11 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.40–7.56 (m, 4H), 7.87–7.94 (m, 2H), 8.00 (d, <sup>3</sup><i>J</i><sub>PH</sub> (Z) = 24.1, 1H), 8.35 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 8.50 (s, 1H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.2, 16.3, 61.5, 62.6, 62.7, 114.4, 116.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 185.2, 1C), 120.7 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.2, 1C), 122.6, 125.9, 128.56, 128.57, 129.0 (s, 2C), 131.4, 133.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 9.9, 1C), 135.6, 140.9, 146.5, 165.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.0, 1C).</div></div><div id="sec4_1_5_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Ethyl 2-(Diethoxyphosphoryl)-3-(8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8o</b>)</h5><div class="NLM_p last">Yield, 70%; scale, 1 g; <i>E</i>/<i>Z</i> 1:0.03 (DCM:acetone 9:1 <i>R</i><sub>f</sub> 0.09). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 16.84 (<i>E</i>) and 13.63 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.32 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 9H), 2.59 (s, 3H), 3.93–4.23 (m, 4H), 4.32 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.12, 2H), 6.89 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.14 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.92 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 23.8, 1H), 8.18 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 8.44 (s, 1H).</div></div><div id="sec4_1_5_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Ethyl 3-(8-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8p</b>)</h5><div class="NLM_p last">Yield, 48%; scale, 0.7 g; <i>E</i>/<i>Z</i> 5/1, <i>R</i><sub>f</sub>(<i>E</i>) 0.37, <i>R</i><sub>f</sub>(<i>Z</i>) 0.23 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8p</b><sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 15.98 (<i>E</i>) and 12.92 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 4.11–4.27 (m, 4H), 4.37 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 6.91 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 1H), 7.64 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, <sup>4</sup><i>J</i><sub>HH</sub> = 0.9, 1H), 7.89 (d, <sup>3</sup><i>J</i><sub>PH</sub> (Z) = 23.7, 1H), 8.33 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.6, 1H), 8.46 (s, 1C). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.2, 16.3, 61.7, 62.7, 62.8, 112.5, 114.2, 118.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.1, 1C), 121.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.3, 1C), 123.1, 129.5, 133.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 9.9, 1C), 140.5, 145.4, 165.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 11.8, 1C).</div></div><div id="sec4_1_5_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Ethyl 2-(Diethoxyphosphoryl)-3-(imidazo[2,1-<i>a</i>]isoquinolin-3-yl)acrylate (<b>8r</b>)</h5><div class="NLM_p last">Yield, 43%; scale, 0.4 g; <i>E</i>/<i>Z</i> 1:0.15 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). (<i>E</i>)-<b>8r</b><sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.37 (m, 9H), 4.13–4.24 (m, 4H), 4.38 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 7.23 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 7.64 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 8.0, 1H), 7.67 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 1H), 7.76 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 1H), 7.96 (d, <sup>3</sup><i>J</i><sub>PH</sub>(Z) = 23.8, 1H), 8.10 (d,, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 8.40, 8.66 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.00, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 16.72 (<i>E</i>) and 13.61 (<i>Z</i>). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.2, 16.4, 16.5, 61.8, 62.79, 62.82, 114.7, 117.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 184.5, 1C), 120.4, 122.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 24.2, C) 123.6, 124.1, 127.1, 128.9, 129.6, 130.3, 133.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 9.8, 1C), 139.0, 145.8, 165.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.0, 1C).</div></div><div id="sec4_1_5_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> Ethyl 2-(Ethoxy(phenyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8s</b>)</h5><div class="NLM_p last">Yield, 71%; scale, 1 g; <i>E</i>/<i>Z</i> 1:0.06 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 8:2, <i>R</i><sub>f</sub> 0.25). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 29.45 (<i>E</i>) and 29.90 (<i>Z</i>). (<i>E</i>)-<b>8s</b><sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 8.57 (s, 1H), 8.41 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 8.19 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 20.6, 1H), 7.85–7.78 (m, 2H), 7.65 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, 1H), 7.46 (m, 1H), 7.41–7.37 (m, 2H), 7.34 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H), 6.98 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H), 4.22–4.02 (m, 4H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.10 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 165.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.8, 1C), 148.0, 142.1, 134.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 9.1, 1C), 132.1 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 3.3, 1C), 131.7 (d, <i>J</i><sub>PC</sub> = 10.2, 2C), 131.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 148.8, 1C), 128.2 (d, <i>J</i><sub>PC</sub> = 13.9, 2C), 127.6 124.0, 120.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 19.3, 1C), 118.4, 117.9 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 127.7, 1C), 114.3, 61.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 61.2, 16. Five (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 13.9.</div></div><div id="sec4_1_5_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> Ethyl 2-(Ethoxy(ethyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)acrylate (<b>8t</b>)</h5><div class="NLM_p last">Yield, 77%; scale, 0.6 g; solvent used in reaction THF; <i>E</i>/<i>Z</i> 1:0.11 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15 <i>R</i><sub>f</sub> 0.23). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 45.96 (<i>E</i>) and 44.70 (<i>Z</i>). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 8.54 (s, 1H), 8.45 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.5, <sup>4</sup><i>J</i><sub>HH</sub> = 3.1, 1H), 8.01 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 19.4, 1H), 7.66 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.0, 1H), 7.38–7.33 (m, 1H), 6.98 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.0, 1H), 4.36–4.28 (m, 2H), 4.09–3.88 (m, 2H), 2.08–1.92 (m, 2H), 1.32 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H), 1.26 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.15 (dt, <sup>3</sup><i>J</i><sub>PH</sub> = 20.2, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, 3H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 166.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 13.4, 1C), 148.0, 141.6, 134.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 8.4, 1C), 127.6, 124.2, 120.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.1, 1C), 118.4, 116.9 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 115.2, 1C), 114.3, 61.4, 60.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.9, 1C), 21.9 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 107.3, 1C), 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 14.2, 5.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.2, 1C).</div></div><div id="sec4_1_5_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> Ethyl 3-([1,1′-Biphenyl]-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8u</b>)</h5><div class="NLM_p last">Yield, 67% (98% purity, 2% mol aldehyde from <sup>1</sup>H NMR); scale, 0.5 g; <i>E</i>/<i>Z</i> 1:0.04, <i>R</i><sub>f</sub>(<i>E</i>) = 0.66, <i>R</i><sub>f</sub>(<i>Z</i>) = 0.57 (CHCl<sub>3</sub>:acetone 10:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 14.97 (<i>E</i>) and 14.25 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.22 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HP</sub> = 0.6, 6H), 4.12–4.24 (m, 4H), 4.28 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 7.32–7.50 (m, 5H), 7.50–7.66 (m, 4H), 7.72 [(<i>E</i>) d, <sup>3</sup><i>J</i><sub>PH</sub> (<i>E</i>) = 24.2, 1H], 8.24 [(<i>Z</i>) d, <sup>3</sup><i>J</i><sub>PH (Z)</sub> = 43.3, 1H]. <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.7, 16.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.7, 2C), 61.6, 62.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.0, 2C), 124.8 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 178.7, 1C), 126.8 (s, 2C), 128.7 (s, 2C), 127.6, 127.7, 127.8, 128.89, 128.92, 134.1 (d, <sup>3</sup><i>J</i><sub>CP</sub> = 20.2, 1C), 140.0, 141.5, 147.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 166.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.5, 1C).</div></div><div id="sec4_1_5_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> Ethyl 3-([1,1′-Biphenyl]-4-yl)-2-(diethoxyphosphoryl)acrylate (<b>8w</b>)</h5><div class="NLM_p last">Yield, 44%; scale, 1.27 g; purity 95% (5% mol aldehyde based on <sup>1</sup>H NMR). <i>E</i>/<i>Z</i> 1:0.1 [<i>R</i><sub>f</sub>(<i>E</i>) = 0.55, <i>R</i><sub>f</sub>(<i>Z</i>) = 0.46 (CHCl<sub>3</sub>:acetone 10:1)]. <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 14.84 (<i>E</i>), 12.43 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.28 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>PH</sub> = 0.6, 6H), 4.14–4.27 (m, 4H), 4.31 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 7.33–7.54 (m, 5H), 7.55–7.65 (m, 4H), 7.67 [(<i>E</i>): d, <sup>3</sup><i>J</i><sub>PH (E)</sub> = 24.1, 1H], 8.21 [(<i>Z</i>): d, <sup>3</sup><i>J</i><sub>PH (Z)</sub> = 43.5, PCC<u class="uu">H</u>, 1H)]. <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.8, 16.2 (d, <sup>3</sup><i>J</i><sub>CP</sub> = 6.6, 2C), 61.6, 62.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 2C), 124.1 (d, <sup>1</sup><i>J</i><sub>CP</sub> = 178.8, 1C), 127.9, 126.9, 127.1, 128.8, 129.76, 132.40 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 20.3, 1C), 139.80, 143.08, 147.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 166.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.6, 1C).</div></div><div id="sec4_1_5_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> Ethyl 3-(3-Benzylphenyl)-2-(diethoxyphosphoryl)acrylate (<b>8y</b>)</h5><div class="NLM_p last">Yield, 84%; scale, 0.82 g; <i>E</i>/<i>Z</i> 1:0.04 (<i>R</i><sub>f</sub>(<i>E</i>) 0.65, <i>R</i><sub>f</sub>(<i>Z</i>) 0.53 (CHCl<sub>3</sub>:acetone 10:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ 14.48 (<i>E</i>) and 12.00 (<i>Z</i>). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.17 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.34 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>PH</sub> = 0.6, 6H), 3.94 (s, 2H), 4.06–4.23 (m, 6H), 7.10–7.32 (m, 9H), 7.58 [(E) d, <sup>3</sup><i>J</i><sub>PH (E)</sub> = 24.2, 1H], 8.13 [(Z) d, <sup>3</sup><i>J</i><sub>PH (Z)</sub> = 43.9, 1H]. <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.8, 16.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.7, 2C), 41.7, 61.6, 62.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 2C), 124.4 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 178.6, 1C), 126.3, 127.1, 128.8, 128.6, 128. 9, 129.6, 131.1 (7s, 9C), 133.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 20.1, 1C), 140.3, 141.7, (2s, 2C), 148.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 166.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.6, 1C).</div></div><div id="sec4_1_5_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> Ethyl 3-([1,1′:4′,1″-Terphenyl]-3-yl)-2-(diethoxyphosphoryl)acrylate (<b>8z</b>)</h5><div class="NLM_p last">Yield, 71%; scale, 0.86 g; <i>E</i>/<i>Z</i> 1:0.01 (<i>R</i><sub>f</sub>(<i>E</i>) = 0.24 (CHCl<sub>3</sub>:acetone 10:1). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 14.39 (<i>E</i>) and 12.23 (<i>Z</i>). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 7.75 (d, <sup>3</sup><i>J</i><sub>PH</sub> = 24.1, 1H), 7.72 (s, 1H), 7.68–7.61 (m, 7H), 7.47–7.41 (m, 4H), 7.35 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1.0, 1H), 4.30 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 4.27–4.17 (m, 4H), 1.39 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 1.23 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 166.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 12.4 Hz, 1C), 148.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 141.1, 140.5, 140.4, 139.0, 134.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 20.0, 1C), 129.2, 128.9, 128.8, 127.9, 127.8, 127.6, 127.5, 127.3, 127.0 (9s, 13C), 125.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 178.3, 1C), 62.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 2C), 61.7, 16.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.5, 2C), 13.9.</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> General Procedure for the Synthesis of Compounds <b>9</b></h4><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> Route 1 (<b>9d</b>–<b>z</b>)</h5><div class="NLM_p last">A 50 mL two-neck round-bottom flask was charged with <b>8</b> (1.83 mmol, 1 equiv) and NiCl<sub>2</sub>·6H<sub>2</sub>O (0.52 g, 2.2 mmol, 1.2 equiv) and dissolved in methanol (10 mL). Flask was submerged in a dry ice/acetone cooling bath (−40 °C), and then NaBH<sub>4</sub> (0.083 g, 2.2 mmol, 1.2 equiv) was added. The mixture was stirred at (−40 °C, internal control) for 8 min then quenched with 4 mL of NH<sub>4</sub>Cl. Solution was made basic with saturated Na<sub>2</sub>CO<sub>3</sub> solution to pH > 9. The water layer was extracted with dichloromethane (4 × 10 mL). Organic layer was dried over anhydrous MgSO<sub>4</sub>, the solvent was evaporated, and the residue was subjected to column chromatography using DCM:acetone (100:20) system as eluent to give product as orange oil. <i>Note: For compounds not containing aromatic ring substituted with halogen atom less stringent conditions (−20 °C, 15 min) could be applied.</i></div></div><div id="sec4_1_6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Ethyl 2-(Diethoxyphosphoryl)-3-(5-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9d</b>)</h5><div class="NLM_p last">Yield, 63%; scale, 0.1 g, <i>R</i><sub>f</sub> 0.1 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.14 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.17 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.23 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 2.71 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>PH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 3.8, 1H), 2.85 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>HH</sub> = 11.7, <sup>3</sup><i>J</i><sub>PH</sub> = 9.2, 1H), 3.08 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 22.8, <sup>3</sup><i>J</i><sub>HH</sub> = 11.7, <sup>3</sup><i>J</i><sub>HH</sub> = 3.8, 1H), 3.79–3.93 (m, 2H), 3.95–4.08 (m, 4H), 6.62 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.16 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.37 (s, 1H), 7.43–7.45 (m, 1H), 7.47–7.53 (m, 4H), 7.59 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 20.88. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.39 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C), 16.41 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.5, 1C), 25.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 1.7, 1C), 44.7 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 131.0, 1C), 61.7, 62.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 63.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 115.2, 117.4, 123.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 20.3, 1C), 123.7, 128.35, 128.29, 129.5, 129.6, 129.8, 133.0, 135.1, 138.8, 147.5, 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.0, 1C).</div></div><div id="sec4_1_6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> Ethyl 2-(Diethoxyphosphoryl)-3-(5-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9e</b>)</h5><div class="NLM_p last">Yield, 64%; scale, 1.1 g (CHCl<sub>3</sub>:MeOH 40:1 <i>R</i><sub>f</sub> 0.22). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.21 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.17, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 2.88 (s, 3H), 3.38 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 22.6, <sup>3</sup><i>J</i><sub>HH</sub> = 11.6, 3.1, 1H), 3.64–3.99 (m, 2H), 4.09–4.24 (m, 6H), 6.49 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.01 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.75, 1H), 7.34 (s, 1H), 7.43 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 21.08. HRMS <i>m</i>/<i>z</i>: found 369.1583, calculated (M + H)<sup>+</sup> 369.1508.</div></div><div id="sec4_1_6_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> Ethyl 2-(Diethoxyphosphoryl)-3-(6-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9f</b>)</h5><div class="NLM_p last">Yield, 73%; scale, 0.2 g; <i>R</i><sub>f</sub> 0.1 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.20 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.20, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.31–3.51 (m, 2H), 3.58–3.77 (m, 1H), 4.10–4.29 (m, 6H), 7.38–7.54 (m, 5H), 7.57–7.64 (m, 2H), 7.67 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>4</sup><i>J</i><sub>HH</sub> = 0.7, 1H), 8.18–8.21 (m, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.73. HRMS <i>m</i>/<i>z</i>: calculated 431.1730 (M + H)<sup>+</sup>, found 431.1739 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> Ethyl 2-(Diethoxyphosphoryl)-3-(6-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9g</b>)</h5><div class="NLM_p last">Yield, 77%; scale, 3.3 mmol (CHCl<sub>3</sub>:MeOH 40:1 <i>R</i><sub>f</sub> 0.12). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.17 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (m, 6H), 2.32 (s, 3H), 3.73–3.22 (m, 3H), 4.01–4.30 (m, 6H), 6.99 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.2, <sup>3</sup><i>J</i><sub>HH</sub> = 1.6, 1H), 7.35 (s, 1H), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, 1H), 7.75 (s, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 21.82. HRMS <i>m</i>/<i>z</i>: found 369.1583, calculated (M + H)<sup>+</sup> 369.1508.</div></div><div id="sec4_1_6_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> Ethyl 3-(6-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9h</b>)</h5><div class="NLM_p last">Yield, 87%; scale, 0.4 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.15 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 3.22–3.34 (m, 2H), 3.48–3.58 (m, 1H), 4.02–4.21 (m, 6H), 7.08 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.39 (s, 1H), 7.48 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, 1H), 8.05 (s, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, <sup>5</sup><i>J</i><sub>HH</sub> = 0.7, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 20.91. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.37 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 16.40 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.9, 1C), 21.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.7, 1C), 44.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.9, 1C), 62.0, 63.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.9, 1C), 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 118.3, 120.8, 121.2, 121.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.3, 1C), 125.3, 132.6, 144.0, 168.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 1C). HRMS <i>m</i>/<i>z</i>: calculated 389.1028 (M + H)<sup>+</sup>, found 389.1039 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> Ethyl 3-(6-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9i</b>)</h5><div class="NLM_p last">Yield, 75%; scale (0.32 g), <i>R</i><sub>f</sub> 0.08 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.18 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 3.21–3.41 (m, 2H), 3.45–3.64 (m, 1H), 4.03–4.28 (m, 6H), 7.20 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.40 (s, 1H), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H), 8.16 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.40.</div></div><div id="sec4_1_6_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Ethyl 2-(Diethoxyphosphoryl)-3-(7-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9j</b>)</h5><div class="NLM_p last">Yield, 82%; scale, 0.2 g; <i>R</i><sub>f</sub> 0.09 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.20 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.24–3.50 (m, 2H), 3.64 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.4, <sup>3</sup><i>J</i><sub>HH</sub> = 11.7, <sup>3</sup><i>J</i><sub>PH</sub> = 6.9, 1H), 4.06–4.35 (m, 6H), 7.15 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.34–7.42 (m, 1H), 7.42–7.52 (m, 3H), 7.61–7.70 (m, 2H), 7.80 (dd, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H), 8.09 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.22. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.49 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 7.7, 1C), 16.52 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 7.7, 1C), 21.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.5, 1C), 44.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.3, 1C), 62.0, 63.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 112.5, 114.8, 121.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.3, 1C), 123.1, 126.9 (s, 2C), 128.3, 129.2 (s, 2C), 132.5, 137.1, 138.8, 146.2, 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.0, 1C).</div></div><div id="sec4_1_6_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Ethyl 2-(Diethoxyphosphoryl)-3-(7-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9k</b>)</h5><div class="NLM_p last">Yield, 92%; scale, 0.27 mmol (no purification by column chromatography needed). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.18 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.40–1.30 (m, 6H), 2.39 (s, 3H), 3.19–3.69 (m, 3H), 4.01–4.30 (m, 6H), 6.68 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, C<u class="uu">H</u><sub>Ar(6)</sub>, 1H), 7.34 (s, 2H), 7.91 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 168.1 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 5.0, 1C), 145.9, 134.6, 131.0, 122.2, 120.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 17.7, 1C), 116.0, 114.9, 63.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 63.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 61.7, 44.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.5, 1C), 21.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 2.8, 1C), 21.0, 16.22 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.6, 1C) 16.18 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 13.8. <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 21.66. HRMS <i>m</i>/<i>z</i>: found 369.1582, calculated (M + H)<sup>+</sup> 369.1508.</div></div><div id="sec4_1_6_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Ethyl 3-(7-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9l</b>)</h5><div class="NLM_p last">Yield, 59%; scale, 0.4 g; <i>R</i><sub>f</sub> 0.09 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.15 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.19–3.42 (m, 2H), 3.47–3.63 (m, 1H), 4.03–4.26 (m, 6H), 6.79 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 2.1, 1H), 7.37 (s, 1H), 7.54 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 2.1, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H), 7.95 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>5</sup><i>J</i><sub>HH</sub> = 0.8, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 21.30. <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.40 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.7, 1C), 16.41 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.7, 1C), 21.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.3 1C), 44.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.4, 1C), 62.0, 63.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 114.0, 116.8, 121.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.3, 1C), 123.6, 130.5, 132.6, 145.4, 168.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 1C).</div></div><div id="sec4_1_6_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> Ethyl 3-(7-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9m</b>)</h5><div class="NLM_p last">Yield, 63%; scale, 0.24 g; <i>R</i><sub>f</sub> 0.10 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.19 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.27–3.39 (m, 2H), 3.54–3.62 (m, 1H), 4.08–4.24 (m, 6H), 6.95 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.40 (s, 1H), 7.78 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.93 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.34. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.5 (m, 2C), 21.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.5, 1C), 44.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.6, 1C), 62.1 (s, 1C), 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.1, 1C), 63.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 116.4, 117.9, 120.3, 121.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.0, 1C), 123.6, 132.6, 145.9, 168.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.0, 1C). HRMS <i>m</i>/<i>z</i>: calculated 433,0522 (M + H)<sup>+</sup>, found 433.0529 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> Ethyl 2-(Diethoxyphosphoryl)-3-(8-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9n</b>)</h5><div class="NLM_p last">Yield, 98%; scale, 0.2 g; <i>R</i><sub>f</sub> 0.16 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.24 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.31–3.50 (m, 2H), 3.56–3.70 (m, 1H), 4.30–4.07 (m, 6H), 6.97 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.31 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H), 7.38–7.57 (m, 4H), 7.91–7.98 (m, 2H), 8.04 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.60.</div></div><div id="sec4_1_6_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> Ethyl 2-(Diethoxyphosphoryl)-3-(8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9o</b>)</h5><div class="NLM_p last">Yield, 95%; scale, 3.0 mmol (purification by column chromatography not needed). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.20 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.29–1.42 (m, 6H), 2.59 (s, 3H), 3.15–3.73 (m, 3H), 4.03–4.32 (m, 6H), 6.77 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 6.97 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9 Hz, 1H), 7.41 (s, 1H), 7.89 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (250 MHz, CDCl<sub>3</sub>) δ: 21.33. HRMS <i>m</i>/<i>z</i> found 369.1585, theoretical (M + H)<sup>+</sup> 369.1508.</div></div><div id="sec4_1_6_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Ethyl 3-(8-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9p</b>)</h5><div class="NLM_p last">Yield, 36% (2 steps); scale, 0.19 g; <i>R</i><sub>f</sub> 0.19 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.19 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.28–3.39 (m, 2H), 3.55–3.64 (m, 1H), 4.08–4.23 (m, 6H), 6.73 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.44 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.49 (s, 1H), 8.04 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H). <sup>31</sup>P NMR (250 MHz, CDCl<sub>3</sub>) δ: 20.64. <sup>13</sup>C NMR (250 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.47 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 16.52 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 21.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.3, 1C), 44.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.5, 1C), 62.1, 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 63.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 112.3, 112.6, 122.7, 123.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.2, 1C), 126.5 132.4, 143.6, 168.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 1C).</div></div><div id="sec4_1_6_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> Ethyl 2-(Diethoxyphosphoryl)-3-(imidazo[2,1-<i>a</i>]isoquinolin-3-yl)propanoate (<b>9r</b>)</h5><div class="NLM_p last">Yield, 93%; scale, 0.2 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.19 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.33–1.42 (m, 6H), 3.31–3.45 (m, 2H), 3.56–3.69 (m, 1H), 4.09–4.18 (m, 2H), 4.19–4.24 (m, 4H), 7.10 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 7.38 (s, 1H), 7.56 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5, 1H), 7.62 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.6, 1H), 7.70 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.9, 1H), 7.78 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 1H), 8.60 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.0, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 21.67. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 16.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 21.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.6, 1C), 45.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.3, 1C), 62.0, 63.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.9, 1C), 63.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 113.3, 120.6, 123.3, 123.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 18.0, 1C), 124.1, 127.0, 128.3, 128.4, 129.2, 129.4, 145.4, 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.1, 1C).</div></div><div id="sec4_1_6_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i100" class="anchor-spacer"></div><h5 class="article-section__title" id="_i100"> Ethyl 2-(Ethoxy(phenyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9s</b>)</h5><div class="NLM_p last">Yield, 68%; scale, 1.1 g (CHCl<sub>3</sub>:MeOH 90:1 <i>R</i><sub>f</sub> 0.24). <sup>31</sup>P NMR: diastereoisomers 37.21 and 36.48 (ratio 1.2:1). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 7.93 and 7.87 (2d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.79–7.69 (m, 2H), 7.57–7.40 (m, 4H), 7.32 and 7.29 (2s, 2H), 7.04–7.08 (m, 1H), 6.79–6.69 (m, 1H), 4.19–3.81 (m, 4H), 3.60–3.28 (m, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.27 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 0.96 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 0.92 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: [168.4 (s), 168.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.1), 1C], [145.6 (s), 145.5 (s), 1C] [133.1 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 2.5) 133.0 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 2.3), 1C)], [132.4 (d, <i>J</i><sub>PC</sub> = 9.9, 2C), 132.0 (d, <i>J</i><sub>PC</sub> = 9.8, 2C)], [131.7, 131.6 (s, 1C)], [128.7 (d, <i>J</i><sub>PC</sub> = 12.8, 2C), 128.6 (d, <i>J</i><sub>PC</sub> = 12.9, 2C)], 128.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 131.1, 1C), [123.7 (s, 1C), 123.6 (s, 1C)], [123.03 (s, 1C), 122.94 (s, 1C)], [121.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.6, 1C), 120.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C)], 117.9 (s, 1C), [112.23 (s, 1C), 112.21 (s, 1C)], [62.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.3, 1C), 61.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.9, 1C)], [61.61 (s, 1C), 61.56 (s, 1C)], [47.8 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 85.6, 1C), 47. Five (d, <sup>1</sup><i>J</i><sub>PC</sub> = 85.2, 1C)], [20.9 (s, 1C), 20.7 (s, 1C)], [16.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.6, 1C), 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.4, 1C)], [13.8 (s, 1C), 13.7 (s, 1C)]. HRMS <i>m</i>/<i>z</i>: calculated 387.1476 (M + H)<sup>+</sup>, found 387.1480 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i101" class="anchor-spacer"></div><h5 class="article-section__title" id="_i101"> Ethyl 2-(Ethoxy(ethyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9t</b>)</h5><div class="NLM_p last">Yield, 69%; scale, 0.75 g (CHCl<sub>3</sub>:AcOEt 20:1 <i>R</i><sub>f</sub> 0.20). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: diastereoisomers 51.70 and 50.86 (ratio 1.1:1). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 7.95 (bt, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.45 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9, 1H), 7.29 (bs, 1H), 7.03 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 14.6, 6.3), 1H), 6.71 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 4.13–3.94 (m, 4H), 3.50–3.13 (m, 3H), 1.83–1.74 (m, 2H), [1.22 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.22 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H)], 1.14–1.09 (m, 3H), [1.08 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, 3H), 1.06 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, 3H)]. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: [168.9 (s, 1C), 168.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 2.5, 1C)], [145.5 (s, 1C), 145.4 (s, 1C)], 131.4 (s, 1C), [123.7 (s, 1C), 123.6 (s, 1C)], 122.9 (s, 1C), [121.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.8, 1C), 120.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.4,1C)], [117.8 (s, 1C), 117.7 (s, 1C)], [112.3 (s, 1C), 112.2 (s, 1C)], 61.7–61.6 (m, 1C), 61.3–61.2 (m, 1C), 46.2 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 71.8, 1C), 46.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 71.8, 1C), [20.9 (bs, 1C), 19.7 (bs, 1C)], [21.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 96.7, 1C), 19.4 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 96.4, 1C)], [16.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C), 16.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C)], 13.8 (s, 1C), [5.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 5.5,1C), 5.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.6, 1C)]. HRMS <i>m</i>/<i>z</i>: calculated 339.1476 (M + H)<sup>+</sup>, found 339.1405 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i102" class="anchor-spacer"></div><h5 class="article-section__title" id="_i102"> Ethyl 3-([1,1′-Biphenyl]-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9u</b>)</h5><div class="NLM_p last">Yield, 75%; scale, 1.10 g; <i>R</i><sub>f</sub> 0,22 (hexane:AcOEt 1:1). <sup>31</sup>P NMR δ: 22.29. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.11 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.35 and 1.36 (2dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>HP</sub> = 0.5, 6H), 3.18–3.42 (m, 3H), 4.03–4.26 (m, 6H), 7.15–7.20 (m, 1H), 7.27–7.47 and 7.50–7.59 (2m, 8H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.9, 2C), 32.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.2, 1C), 47.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.1, 1C), 61.2, 62.7, and 62.8 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.5, 2C), 126.9, 128.6 (2s, 4C), 125.4, 126.9, 127.2, 127.3, 128.8, 138.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.0, 1C), 140.8, 141.3 (2s, 2C), 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5).</div></div><div id="sec4_1_6_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i103" class="anchor-spacer"></div><h5 class="article-section__title" id="_i103"> Ethyl 3-([1,1′-Biphenyl]-4-yl)-2-(diethoxyphosphoryl)propanoate (<b>9w</b>)</h5><div class="NLM_p last">Yield, 85%; scale, 1.09 g; <i>R</i><sub>f</sub> 0,34 (hexane:AcOEt 1:1). <sup>31</sup>P NMR: δ 22.49. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.16 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.36 (2dt, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, <sup>4</sup><i>J</i><sub>PH</sub> = 0.5, 6H), 3.40–3.13 (m, 3H), 4.06–4.29 (m, 6H), 7.24–7.60 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 4.8, 2C), 32.4, 47.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 128.8, 1C), 61.1, 62.7, and 62.8 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.5, 2C), 126.9, 127.1 (2s, 5C), 128.7, 129.0 (2s, 4C), 137.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.0, 1C), 139.5 and 140.7 (2s, 2C), 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.7, 1C).</div></div><div id="sec4_1_6_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> Ethyl 3-(3-Benzylphenyl)-2-(diethoxyphosphoryl)propanoate (<b>9y</b>)</h5><div class="NLM_p last">Yield, 68%; scale, 0.76 g; <i>R</i><sub>f</sub> 0.21 (hexane:AcOEt 1:1). <sup>31</sup>P NMR δ: 21.81. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.02 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.25 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 2.99–3.24 (m, 3H), 3.84 (s, 2H), 3.88–4.17 (m, 6H), 7.23–6.91 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.8, 16.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.7, 2C), 32.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.1, 1C), 41.7, 47.5 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.0, 1C), 61.1, 62.6, 62.7 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 2C), 128.2, 128.6 (2s, 4C), 125.9, 126.2, 127.2, 128.5, 129.0, 138.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.1, 1C), 140.8, 141.2, 168.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5, 1C).</div></div><div id="sec4_1_6_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> Ethyl 3-([1,1′:4′,1″-Terphenyl]-3-yl)-2-(diethoxyphosphoryl)propanoate (<b>9z</b>)</h5><div class="NLM_p last">Yield, 62%; scale, 2.17 g; <i>R</i><sub>f</sub> 0.41 (hexane:AcOEt 2:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 22.61. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 7.72–7.59 (m, 6H), 7.54–7.31 (m, 6H), 7.23–7.17 (m, 1H), 4.27–4.04 (m, 6H), 3.44–3.18 (m, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.14 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 168.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.7, 1C), 140.8, 140.5, 140.1, 139.7, 139.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.0, 1C), 129.0, 128.7, 127.6, 127.4, 127.34, 127.28, 126.9, 125.4 (8s, 13C), 62.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 62.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 61.3 (s, 1C), 47.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 129.1, 1C), 32.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.3, 1C), 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.9, 1C), 16.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.1, 1C), 14.0 (s, 1C). HRMS <i>m</i>/<i>z</i>: calculated 489.1807 (M + H)<sup>+</sup>, found 489.1807 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> Route 2 (<b>9a</b>–<b>c</b>)</h5><div class="NLM_p last">Reaction was carried out under argon atmosphere using oven-dried glassware. A 50 mL round-bottom flask was charged with appropriate 2-substituted imidazo[1,2-<i>a</i>]pyridine <b>4</b> (0.474 mmol, 1 equiv), ethyl 2-(diethoxyphosphoryl)acrylate (134 mg, 0.569 mmol, 1.2 equiv), and dioxane 6 mL. The mixture was heated and stirred for 10 min. Then AlCl<sub>3</sub> (6.5 mg, 0.0474 mmol, 0.1 equiv) was added. The solution was stirred for 12 h at reflux. The crude mixture was evaporated under reduced pressure, dissolved in 5 mL of water, and made basic with saturated Na<sub>2</sub>CO<sub>3</sub> solution to pH > 9. The water layer was extracted with chloroform (5 × 25 mL). Organic layer was dried over anhydrous Mg<sub>2</sub>SO<sub>4</sub> and evaporated, and the residue was subjected to flash chromatography using DCM:acetone in gradient as eluent 0 = >40% of acetone in 40 min to give product as orange oil.</div></div><div id="sec4_1_6_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> Ethyl 2-(Diethoxyphosphoryl)-3-(2-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9a</b>)</h5><div class="NLM_p last">Yield, 55% yield; scale, 0.25 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 0.97 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.27 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 3.26 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 22.1, <sup>3</sup><i>J</i><sub>HH</sub> = 10.4, <sup>3</sup><i>J</i><sub>HH</sub> = 3.8, 1H), 3.66 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 15.8, <sup>3</sup><i>J</i><sub>PH</sub> = 10.0, <sup>3</sup><i>J</i><sub>HH</sub> = 3.8, 1H), 3.80–3.95 (m, 3H), 4.05–4.15 (m, 4H), 6.81 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.13–7.17 (m, 1H), 7.32 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 7.42 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, 2H), 7.58 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, 1H), 7.79 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 2H), 8.18 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H). <sup>31</sup>P NMR (250 MHz, CDCl<sub>3</sub>) δ: 20.97. <sup>13</sup>C NMR (700 MHz, CDCl<sub>3</sub>) δ: 13.8, 16.36 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.8, 1C), 16.38 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.8, 1C), 21.6 (bs, 1C), 44.3 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 128.8, 1C), 61.9, 63.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 63.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 112.3, 117.0 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 16.0, 1C), 117.5, 123.8, 124.3, 127.8, 128.2 (s, 2C), 128.6 (s, 2C), 134.4 (s, 1C), 143.2 (s, 1C), 144.8 (s, 1C), 168.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5, 1C).</div></div><div id="sec4_1_6_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> Ethyl 2-(Diethoxyphosphoryl)-3-(2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>9b</b>)</h5><div class="NLM_p last">Yield, 63%; scale, 0.3 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.14 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.36 (m, 6H), 2.43 (s, 3H), 3.20 (m, 1H), 3.39 (m, 1H), 3.66 (m, 1H), 4.00–4.31 (m, 6H), 6.80 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.13 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.50 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, 1H), 8.01 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 21.43. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.2, 13.8, 16.28 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0 1C), 16.33 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C), 20.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 3.5, 1C), 44.0 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 128.5, 1C), 61.8 (s, 1C), 63.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 63.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.2, 1C), 111.9 (s, 1C), 116.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.0, 1C), 116.7, 122.9, 123.5, 141.0, 144.4, 168.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.7, 1C).</div></div><div id="sec4_1_6_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i109" class="anchor-spacer"></div><h5 class="article-section__title" id="_i109"> Ethyl 3-(6-Bromo-2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-propanoate (<b>9c</b>)</h5><div class="NLM_p last">Yield, 60%; scale, 0.4 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.09 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.30 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 2.33 (s, 3H), 3.11 (ddd, <sup>2</sup><i>J</i><sub>PH</sub> = 22.7, <sup>3</sup><i>J</i><sub>HH</sub> = 10.5, <sup>3</sup><i>J</i><sub>HH</sub> = 3.5, 1H), 3.29 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.8, <sup>3</sup><i>J</i><sub>PH</sub> = 10.2, <sup>3</sup><i>J</i><sub>HH</sub> = 3.5, 1H), 3.55 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 15.8, <sup>3</sup><i>J</i><sub>HH</sub> = 10.5, <sup>3</sup><i>J</i><sub>PH</sub> = 7.9, 1H), 3.99–4.08 (m, 2H), 4.10–4.17 (m, 4H), 7.10 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.31 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.4, <sup>4</sup><i>J</i><sub>HH</sub> = 0.6, 1H), 8.08 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 20.70. <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.4, 13.9, 16.4 (m, 2C), 20.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.0, 1C), 44.1 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 128.7, 1C), 62.0, 63.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 63.2 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 106.6, 117.40 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.7, 1C), 117.41, 123.2, 126.8,, 142.1, 142.8, 168.3 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.7, 1C).</div></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> General Procedure for Fluorination: Synthesis of Compounds <b>10</b></h4><div class="NLM_p">Reaction was carried out under argon atmosphere using oven-dried glassware. A solution of the phosphonocarboxylate triester <b>9</b> (1 equiv, 1.01 mmol) in anhydrous THF (8 mL) was cooled to −78 °C, and <i>n</i>-BuLi (1.6 M in Hex, 1.5 equiv) was added via syringe. The solution was stirred for 10 min at −78 °C, allowed to warm up to 0 °C, and stirred for 1 h and then cooled back to −78 °C. Then, a solution of <i>N</i>-fluoro-<i>N</i>-(phenylsulfonyl)-benzenesulfonamide (1.2 equiv) in anhydrous THF (8 mL) was added dropwise via syringe. The reaction mixture was stirred at −78 °C for 10 min, warmed up to rt, and stirred for additional 4.5 h. The reaction mixture was quenched with saturated aqueous NH<sub>4</sub>Cl and concentrated under vacuum. It was basified with solution of Na<sub>2</sub>CO<sub>3</sub>, up to pH 9, and extracted with CHCl<sub>3</sub> (3×). The organic layer was dried over anhydrous MgSO<sub>4</sub>, concentrated to dryness under vacuum, and purified by column chromatography. The products were isolated as oils in 40–80% yields.</div><div id="sec4_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(2-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10a</b>)</h5><div class="NLM_p last">Yield, 72%; scale, 0.15 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 0.91 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.41–3.64 (m, 1H), 3.82–4.04 (m, 2H), 4.13–4.44 (m, 5H), 6.83 (dt, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.20 (ddd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.7, <sup>4</sup><i>J</i><sub>HH</sub> = 1.2, 1H), 7.29–7.40 (m, 1H), 7.41–7.50 (m, 2H), 7.57–7.68 (m, 1H), 7.69–7.79 (m, 2H), 8.21 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.15 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.3). HRMS <i>m</i>/<i>z</i>: calculated 449,1636 (M + H)<sup>+</sup>, found 449.1659 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10b</b>)</h5><div class="NLM_p last">Yield, 72%; scale, 0.15 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.15 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.15, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.15, 3H), 2.41 (s, 3H), 3.71 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.3, <sup>3</sup><i>J</i><sub>FH</sub> = 12.7, <sup>3</sup><i>J</i><sub>PH</sub> = 6.9, 1H), 3.87 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.3, <sup>3</sup><i>J</i><sub>FH</sub> = 35.5, <sup>3</sup><i>J</i><sub>PH</sub> = 6.5, 1H), 4.10–4.21 (m, 2H), 4.21–4.29 (m, 4H), 6.77 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.15 (m, 1H), 7.51 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, 1H), 8.10 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.6, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.74 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.7). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.5, 13.9, 16.49 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.3, 1C), 16.51 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.4, 1C), 28.1 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.4, 1C), 62.9, 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 64.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 96.4 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 200.2, <sup>1</sup><i>J</i><sub>PC</sub> = 160.6, 1C), 112.0, 112.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.6, 1C), 116.6 (s, 1C), 124.2 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 6.2, 1C), 124.6, 142.6, 145.0, 166.7 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.4, <sup>2</sup><i>J</i><sub>PC</sub> = 4.2, 1C).</div></div><div id="sec4_1_7_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> Ethyl-3-(6-bromo-2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10c</b>)</h5><div class="NLM_p last">Yield, 75%; scale, 0.2 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.18 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 2.38 (s, 3H), 3.56–3.98 (m, 2H), 4.07–4.38 (m, 6H), 7.17 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>4</sup><i>J</i><sub>HH</sub> = 1.8, 1H), 7.36 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, 1H), 8.20 (bs, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.82 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.0). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.6, 13.8, 16.36, 16.39, 28.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 21.0, 1C), 62.9, 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 64.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 95.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.9, <sup>1</sup><i>J</i><sub>PC</sub> = 160.7, 1C), 106.4, 113.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.0, 1C), 117.2, 124.1 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 6.5, 1C), 127.4, 143.5, 144.0, 166.5 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.6, <sup>2</sup><i>J</i><sub>PC</sub> = 4.0, 1C).</div></div><div id="sec4_1_7_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(5-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10e</b>)</h5><div class="NLM_p last">Yield, 51%; scale, 0.30 g (CHCl<sub>3</sub>:MeOH (20:1) + TEA (0.2%). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.20 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 2.85 (s, 3H), 4.16–4.35 (m, 8H), 6.52 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.05 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.5, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.5, 1H), 7.47 (s, 1H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.5, 2C), 21.1, 30.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 19.9, 1C), 62.8, 64.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 64.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.4, 1C), 96.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 201.1, <sup>1</sup><i>J</i><sub>PC</sub> = 158.5, 1C), 114.2, 116.2, 118.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.6, 1C), 124.6, 135.0, 136.4, 148.0, 166.5 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.1, <sup>2</sup><i>J</i><sub>PC</sub> = 3.5 1C). <sup>13</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.70 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.6).</div></div><div id="sec4_1_7_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(6-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10f</b>)</h5><div class="NLM_p last">Yield, 46%; scale, 0.1 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.18 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.33 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.34 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.66–4.04 (m, 2H), 4.08–4.23 (m, 6H), 7.31–7.70 (m, 8H), 8.26 (bs, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.76 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 81.9). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.4 (bd, 1C), 16.5 (bd, 1C), 28.6 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 18.8 1C), 62.8, 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 64.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.6, 1C), 96.2 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 200.5, <sup>1</sup><i>J</i><sub>PC</sub> = 160.1, 1C), 117.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.4, 1C), 117.6, 121.3 (s, <sup>5</sup><i>J</i><sub>PC</sub> = 4.9, 1C), 125.3, 127.0, 127.2 (s, 2C), 128.0 (s, 2C), 129.2 (s, 1C), 134.4 (s, 1C), 137.5 (s, 1C), 145.4 (s, 1C), 166.4 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.1, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C).</div></div><div id="sec4_1_7_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(6-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10g</b>)</h5><div class="NLM_p last">Yield, 41%; scale, 0.3 g (DCM:acetone (7:3) + TEA (0.2%). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.21 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 2.34 (s, 3H), 3.55–3.79 (m, 1H), 3.87 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 37.4, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 5.8, 1H), 4.10–4.36 (m, 6H), 7.03 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.44 (s, 1H), 7.49 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 1H), 7.89 (s, 1H). <sup>13</sup>C NMR (250 MHz, CDCl<sub>3</sub>) δ: 14.3, 16.42, 16.44, 20.7, 29.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.3, 1C), 61.5, 63.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.4, 1C), 63.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.2, 1C), 102.2 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 193.2, <sup>1</sup><i>J</i><sub>PC</sub> = 137.1, 1C), 116.9, 122.3, 125.0, 126.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.9, 1C), 133.2, 139.0, 146.7, 171.3 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 22.1, 1C). <sup>31</sup>P NMR (250 MHz, CDCl<sub>3</sub>) δ: 12.39 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.6).</div></div><div id="sec4_1_7_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> Ethyl 3-(6-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10h</b>)</h5><div class="NLM_p last">Yield, 72%; scale, 0.12 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.21 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 3.60–4.01 (m, 2H), 4.13–4.36 (m, 6H), 7.13 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.6, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.49–7.56 (m, 2H), 8.15 (bs, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.59, (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.1). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.4, 16.5, 28.5 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.8, 1C), 63.0, 64.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.1, 1C), 65.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 96.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.5, <sup>1</sup><i>J</i><sub>PC</sub> = 160.3, 1C), 117.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.1, 1C), 118.5, 120.9, 122.0 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 4.7, 1C), 125.8, 135.0, 144.5, 166.2 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 18.9, 1C).</div></div><div id="sec4_1_7_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> Ethyl 3-(6-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10i</b>)</h5><div class="NLM_p last">Yield, 44%; scale, 0.2 g; <i>R</i><sub>f</sub> 0.15 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.23 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 6H), 3.71 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>FH</sub> = 12.4, <sup>3</sup><i>J</i><sub>PH</sub> = 6.7, 1H), 3.87 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 37.0, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 6.1, 1H), 4.23 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 4.25–4.33 (m, 4H), 7.24 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.5, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H), 7.49 (m, 2H), 8.26 (bs, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.28 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.2). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.54 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.9, 1C), 16.56 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.9, 1C), 28.6 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.5, 1C), 63.0, 64.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 65.1 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.6, 1C), 95.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.5, <sup>1</sup><i>J</i><sub>PC</sub> = 152.9, 1C), 107.5, 117.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.2, 1C), 118.6, 124.2 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 4.9, 1C), 127.9, 135.0, 144.7, 166.3 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.0, <sup>2</sup><i>J</i><sub>PC</sub> = 3.7, 1C). HRMS <i>m</i>/<i>z</i>: calculated: 451.0428 (M + H)<sup>+</sup>, found 451.0443 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(7-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10j</b>)</h5><div class="NLM_p last">Yield, 66%; scale, 0.1 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.13 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.27–1.31 (m, 6H), 3.69 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.3, <sup>3</sup><i>J</i><sub>FH</sub> = 12.4, <sup>3</sup><i>J</i><sub>PH</sub> = 6.7, 1H), 3.87 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 37.3, <sup>2</sup><i>J</i><sub>HH</sub> = 16.1, <sup>3</sup><i>J</i><sub>PH</sub> = 5.9, 1H), 4.14 (q, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 2H), 4.17- 0.24 (m, 4H), 7.07 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, <sup>4</sup><i>J</i><sub>HH</sub> = 1.7, 1H), 7.28–7.33 (m, 1H), 7.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.7, 2H), 7.44 (s, 1H), 7.56 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 2H), 7.72 (bs, 1H), 8.26 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.37 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.3). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.29, 16.32, 28.3 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.7, 1C), 62.7, 64.5 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 64.8 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.6, 1C), 96.0 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.4, <sup>1</sup><i>J</i><sub>PC</sub> = 160.0, 1C), 112.3, 114.1, 116.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.5, 1C), 123.8 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 4.2, 1C), 126.7 (s, 2C), 128.2, 129.0 (s, 2C), 134.2, 137.4, 138.3, 146.3, 166.1 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.5, <sup>2</sup><i>J</i><sub>PC</sub> = 4.0, 1C).</div></div><div id="sec4_1_7_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(7-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10k</b>)</h5><div class="NLM_p last">Yield, 50%; scale, 0.30 g; DCM:MeOH (95:5) + TEA (0.2%). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.20 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 2.39 (s, 3H), 3.71 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 13.2, <sup>2</sup><i>J</i><sub>HH</sub> = 16.0, <sup>3</sup><i>J</i><sub>PH</sub> = 6.2, 1H), 3.87 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 36.8, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>2</sup><i>J</i><sub>PH</sub> = 5.8, 1 H), 4.16–4.33 (m, 6H), 6.66 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 1H), 7.34 (s, 1H), 7.41 (s, 1H), 8.0 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H). <sup>13</sup>C NMR (250 MHz, CDCl<sub>3</sub>) δ: 14.2, 16.46, 16.47, 17.0, 28.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 20.2, 1C), 62.3, 64.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 65.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.1, 1C), 98.4 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 196.4, <sup>1</sup><i>J</i><sub>PC</sub> = 149.8, 1C), 114.6, 115.4, 125.9 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.7, 1C), 128.7, 131.6, 138.2, 146.3, 168.4 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 21.0, 1C). <sup>13</sup>P NMR (250 MHz, CDCl<sub>3</sub>) δ: 12.41 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.3).</div></div><div id="sec4_1_7_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i121" class="anchor-spacer"></div><h5 class="article-section__title" id="_i121"> Ethyl 3-(7-Chloroimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10l</b>)</h5><div class="NLM_p last">Yield, 78%; scale, 0.1 g; <i>R</i><sub>f</sub> 0.14 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.16 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.30 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H), 1.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2, 3H), 3.67 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>FH</sub> = 12.6, <sup>3</sup><i>J</i><sub>PH</sub> = 6.6, 1H), 3.82 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>FH</sub> = 39.9, <sup>3</sup><i>J</i><sub>PH</sub> = 6.2, 1H), 4.08–4.29 (m, 6H), 6.77 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 2.1, 1H), 7.42 (s, 1H), 7.53 (dd, <sup>4</sup><i>J</i><sub>HH</sub> = 2.0, <sup>5</sup><i>J</i><sub>HH</sub> = 0.6, 1H), 8.01 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>5</sup><i>J</i><sub>HH</sub> = 0.6, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.69 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.2). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.4 (m, 2C), 28.4 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 20.4, <sup>2</sup><i>J</i><sub>PC</sub> = 1.6, 1C), 62.9 (s, 1C), 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.2, 1C), 64.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.5, 1C), 96.1 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.6, <sup>1</sup><i>J</i><sub>PC</sub> = 160.2, 1C), 114.0, 116.5, 117.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.1, 1C), 124.4 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 5.0, 1C), 131.0, 134.7, 145.8, 166.2 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.0, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C). HRMS <i>m</i>/<i>z</i>: calculated 407.0933 (M + H)<sup>+</sup>, found 407.0932 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i122" class="anchor-spacer"></div><h5 class="article-section__title" id="_i122"> Ethyl 3-(7-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10m</b>)</h5><div class="NLM_p last">Yield, 76%; scale, 0.1 g; <i>R</i><sub>f</sub> 0.17 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.21 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.376 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.62–4.02 (m, 2H), 4.15–4.34 (m, 6H), 6.93 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, 1H), 7.47 (s, 1H), 7.77 (dd, <sup>4</sup><i>J</i><sub>HH</sub> = 1.9, <sup>5</sup><i>J</i><sub>HH</sub> = 0.7, 1H), 8.00 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.3, <sup>5</sup><i>J</i><sub>HH</sub> = 0.7, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 12.15 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.2).</div></div><div id="sec4_1_7_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i123" class="anchor-spacer"></div><h5 class="article-section__title" id="_i123"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(8-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10n</b>)</h5><div class="NLM_p last">Yield, 98%; scale, 0.1 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15), <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.23 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.38 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.39 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 3.70–4.09 (m, 2H), 4.18–4.39 (m, 6H), 6.94 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 7.28–7.35 (m, 1H), 7.38–7.54 (m, 3H), 7.57 (s, 1H), 7.88–7.97 (m, 2H), 8.14 (bd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.35 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.7). HRMS <i>m</i>/<i>z</i>: calculated 449,1636 (M + H)<sup>+</sup>, found 449.1654 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i124" class="anchor-spacer"></div><h5 class="article-section__title" id="_i124"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10o</b>)</h5><div class="NLM_p last">Yield, 45%; scale, 0.3 g; DCM/acetone (85:15) + TEA (0.2%). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.19 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 2.56 (s, 3H), 4.01–3.55 (m, 1 H), 4.15–4.32 (m, 6H), 6.72 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 1H), 6.95 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H), 7.46 (s, 1H), 7.97 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, 1H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.1, 16.45, 16.54, 17.0, 28.6 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 20.3, <sup>2</sup><i>J</i><sub>PC</sub> = 2.0 1C), 62.9, 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C), 64.9 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 1C), 96.3 (bdd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.3, <sup>1</sup><i>J</i><sub>PC</sub> = 159.7, 1C), 112.4, 117.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 15.0, 1C), 121.8 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 4.8, 1C), 123.1 (s, 1C), 127.6 (s, 1C), 133.4 (s, 1C), 146.6 (s, 1C), 166.4 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.5, <sup>2</sup><i>J</i><sub>PC</sub> = 4.1, 1C). <sup>13</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.51 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.6).</div></div><div id="sec4_1_7_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i125" class="anchor-spacer"></div><h5 class="article-section__title" id="_i125"> Ethyl 3-(8-Bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10p</b>)</h5><div class="NLM_p last">Yield, 43%; scale, 0.13 g; <i>R</i><sub>f</sub> 0.27 (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.24 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, 3H), 1.37 (m, 6H), 3.71 (m, 1H), 3.90 (ddd, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>FH</sub> = 37.5, <sup>3</sup><i>J</i><sub>PH</sub> = 5.5, 1H), 4.14–4.34 (m, C<u class="uu">H</u><sub><u class="uu">2</u></sub>O)<sub>2</sub>P, 6H), 6.73 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H), 7.57 (s, 1H), 8.13 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 11.38 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.3). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 14.0, 16.4 (m, 2C), 28.7 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 20.4, <sup>2</sup><i>J</i><sub>PC</sub> = 1.8, 1C), 62.9, 64.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.6, 1C), 65.0 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.2, 1C), 96.1 (d, <sup>1</sup><i>J</i><sub>FC</sub> = 199.8, <sup>1</sup><i>J</i><sub>PC</sub> = 160.0, 1C), 111.8, 112.5, 118.8 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.3, 1C), 123.5 (d, <sup>5</sup><i>J</i><sub>FC</sub> = 5.0, 1C), 126.9 (s, 1C), 134.5, 144.0, 166.2 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.7, <sup>2</sup><i>J</i><sub>PC</sub> = 3.7, 1C). HRMS <i>m</i>/<i>z</i>: calculated 451.0428 (M + H)<sup>+</sup>, found 451.0443 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> Ethyl 2-(Diethoxyphosphoryl)-2-fluoro-3-(imidazo[2,1-<i>a</i>]isoquinolin-3-yl)propanoate (<b>10r</b>)</h5><div class="NLM_p last">Yield, 92%; scale, 0.1 g (CH<sub>2</sub>Cl<sub>2</sub>:acetone 85:15). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 1.10–1.56 (m, 9H), 3.66–4.15 (m, 2H), 4.14–4.46 (m, 6H), 7.10 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 7.20–7.37 (m, 1H), 7.49 (s, 1H), 7.55–7.66 (m, 1H), 7.68–7.78 (m, 1H), 7.94 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4, 1H), 8.61 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.6, 1H). <sup>31</sup>P NMR (283 MHz, CDCl<sub>3</sub>) δ: 12.38 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 82.7). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.2 (bd, 1C), 16.3 (bd, 1C), 28.2 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 19.3, 1C), 62.7, 64.4 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.1, 1C), 64.7 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.7, 1C), 95.8 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.4, <sup>1</sup><i>J</i><sub>PC</sub> = 160.1, 1C), 113.0, 118.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 14.5, 1C), 121.0 (d, <sup>5</sup><i>J</i><sub>PC</sub> = 4.6, 1C), 122.9, 123.3, 126.5, 127.9, 128.3, 129.1, 131.2, 143.4, 166.1 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.5, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C). HRMS <i>m</i>/<i>z</i>: calculated 423,1480 (M + H)<sup>+</sup>, found 423.1493 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i127" class="anchor-spacer"></div><h5 class="article-section__title" id="_i127"> Ethyl 2-(Ethoxy(phenyl)phosphoryl)-2-fluoro-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10s</b>)</h5><div class="NLM_p last">Yield, 64%; scale, 0.15 g (CHCl<sub>3</sub>:acetone 4:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>): diastereoisomers 32.34 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 78.8) and 30.24 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 66.7); for one diastereoisomer. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 7.87 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9, <sup>4</sup><i>J</i><sub>HH</sub> = 2.4, 1H), 7.75–7.68 (m, 2H), 7.59–7.50 (m, 1H), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, 1H), 7.44–7.39 (m, 2H), 7.37 (s, 1H), 7.06 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 9.0, <sup>3</sup><i>J</i><sub>HH</sub> = 6.7, 1H), 6.68 (td, <sup>3</sup><i>J</i><sub>HH</sub> = 6.8, <sup>4</sup><i>J</i><sub>HH</sub> = 1.1, 1H), 4.24–4.04 (m, 4H), 3.86 (ddd, <sup>3</sup><i>J</i><sub>FH</sub> = 36.6, <sup>2</sup><i>J</i><sub>HH</sub> = 16.2, <sup>3</sup><i>J</i><sub>PH</sub> = 6.4, 1H), 3.60–3.51 (m, 1H), 1.32 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 3H), 1.12 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: 166.3 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 22.9, <sup>2</sup><i>J</i><sub>PC</sub> = 2.4, 1C], 145.8 (s, 1C), 133.9 (s, 1C), 133.6 (d, <sup>4</sup><i>J</i><sub>PC</sub> = 2.8, 1C), 133.1 (d, <i>J</i><sub>PC</sub> = 9.9, 2C), 128.6 (d, <i>J</i><sub>PC</sub> = 13.3, 2C), 125.6 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 133.2, 1C), 124.1 (s, 1C), 123.8 (d, <i>J</i> = 4.8, 1C), 116.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.8, 1C), 117.5 (s, 1C), 112.1 (s, 1C), 97.1 (d, <sup>1</sup><i>J</i><sub>FC</sub> = 203.2, <sup>1</sup><i>J</i><sub>PC</sub> = 108.6, 1C)], 62.9–62.8 (m, 1C)], 62.6 (s, 1C), 27.9–27.7 (m, 1C), 16.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.8, 1C), 14.0 (s, 1C).</div></div><div id="sec4_1_7_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> Ethyl 2-(Ethoxy(ethyl)phosphoryl)-3-(imidazo[1,2-<i>a</i>]pyridin-3-yl)propanoate (<b>10t</b>)</h5><div class="NLM_p last">Yield, 71%; scale, 0.15 g (CHCl<sub>3</sub>:acetone 4:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: diastereoisomers 46.42 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 69.2) and 47.79 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 81.7). <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) δ: 8.10–8.04 (m, 1H), diastereoisomers 7.52 and 7.52 (2d, <sup>3</sup><i>J</i><sub>HH</sub> = 9.1, 1H), diastereoisomers 7.45 and 7.42 (2s, 1H), 7.14–7.07 (m, 1H), 6.79–6.74 (m, 1H), 4.30–4.05 (m, 4H), 3.86–3.59 (m, 3H), 1.91–1.79 (m, 2H), 1.32–1.29 (m, 3H), 1.22–1.10 (m, 6H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>) δ: [167.1 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.1, <sup>2</sup><i>J</i><sub>PC</sub> 5.7, 1C), 166.8 (dd, <sup>2</sup><i>J</i><sub>FC</sub> = 22.3, <sup>2</sup><i>J</i><sub>PC</sub> = 3.8, 1C)], [146.14, 146.08 (2s, 1C)], [134.0 and 133.9 (2s, 1C)], [124.2 (s, 1C), 124.1 (s, 1C)], 123.9 (m, 1C), 117.8 (bs, 1C), 116.6 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 11.6, 1C), 116.5 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 12.2, 1C), [112.3 (s, 1C), 112.2 (s, 1C)], [98.2 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 203.4, <sup>1</sup><i>J</i><sub>PC</sub> = 89.0, 1C), 97.8 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 200.6, <sup>1</sup><i>J</i><sub>PC</sub> = 92.5, 1C)], 63.2–62.5 (m, 1C), [27.9 (dd, <sup>3</sup><i>J</i><sub>FC</sub> = 20.8, <sup>3</sup><i>J</i><sub>PC</sub> = 4.0, 1C), 27.7 (dd, <sup>3</sup><i>J</i><sub>FC</sub> = 20.5, <sup>3</sup><i>J</i><sub>PC</sub> = 3.6, 1C)], [19.03 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 95.8, 1C), 18.97 (d, <sup>1</sup><i>J</i><sub>PC</sub> = 96.0, 1C)], [16.63 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C), 16.60 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 6.0, 1C)], [13.95 (s, 1C), 13.92 (s, 1C)], [4.94 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.5,1C), 4.86 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 7.0, 1C)].</div></div><div id="sec4_1_7_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> Ethyl 3-([1,1′-Biphenyl]-3-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10u</b>)</h5><div class="NLM_p last">Yield, 57%; scale, 0.3 g; <i>R</i><sub>f</sub> 0,42 (CH<sub>2</sub>Cl<sub>2</sub>:AcOEt 20:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.96 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.0). <sup>19</sup>F NMR (235 MHz) δ: −178.38 (m, <sup>2</sup><i>J</i><sub>PF</sub> = 82.9). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.13 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.36 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 6H), 3.38–3.71 (m, 2H), 4.05–4.35 (m, 6H), 7.19–7.58 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.6, 2C), 39.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 19.5, 1C), 62.3, 64.3, and 64.5 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.9, 2C), 95.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 200.0, <sup>1</sup><i>J</i><sub>PC</sub> = 162.0, 1C), 126.2 (1s, 2C), 127.1 (1s, 2C), 127.3 (1s, 1C), 128.7 (1s, <u class="uu">C</u>H<sub>Ar</sub>, 3C), 129.2 (1s, 2C), 133.7 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.0, 1C), 140.8, 141.2 (2s, 2C), 166.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5, <sup>2</sup><i>J</i><sub>FC</sub> = 22.7, 1C). HRMS <i>m</i>/<i>z</i>: calculated 409.1509 (M + H)<sup>+</sup>, found 409.1589 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i130" class="anchor-spacer"></div><h5 class="article-section__title" id="_i130"> Ethyl 3-([1,1′-Biphenyl]-4-yl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10w</b>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></h5><div class="NLM_p last">Yield, 80%; scale, 0.39 g; <i>R</i><sub>f</sub> 0.27 (CH<sub>2</sub>Cl<sub>2</sub>:AcOEt 20:1). <sup>31</sup>P NMR (101 MHz, CDCl<sub>3</sub>) δ: 12.99 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.00). <sup>19</sup>F NMR (235 MHz) δ: −178.51 (M part of ABMX spin system, <sup>2</sup><i>J</i><sub>PF</sub> = 83.03). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.18 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.10, 3H), 1.37 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.00, 6H), 3.49 and 3.54 (AB part of ABMX spin system, <sup>2</sup><i>J</i><sub>HH</sub> = −14.76, <sup>3</sup><i>J</i><sub>PHa</sub> = 6.05, <sup>3</sup><i>J</i><sub>PHb</sub> = 7.46, <sup>3</sup><i>J</i><sub>FHb</sub> = 13.83, <sup>3</sup><i>J</i><sub>FHa</sub> = 38.90, 2H), 4.12–4.36 (m, 6H), 7.27–7.59 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 14.0 (s, 1C), 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.6, 2C), 38.9 (d, <sup>2</sup><i>J</i><sub>FC</sub> = 19.7, 1C), 62.3 (s, 1C), 64.3 and 64.6 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.95, 2C), 95.7 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.6, <sup>1</sup><i>J</i><sub>PC</sub> = 161.8, 1C), 126.99 and 127.02 and 128.8 and 130.7 (2s, 8C), 127.3 (1s, 1C), 132.2 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.1, 1C), 140.4 and 140.7 (2s, 2C), 166.6 (d, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5, <sup>2</sup><i>J</i><sub>FC</sub> = 22.8, 1C). HRMS <i>m</i>/<i>z</i>: calculated 431.1400 (M + Na)<sup>+</sup>, found 431.1407 (M + Na)<sup>+</sup>.</div></div><div id="sec4_1_7_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i131" class="anchor-spacer"></div><h5 class="article-section__title" id="_i131"> Ethyl 3-(3-Benzylphenyl)-2-(diethoxyphosphoryl)-2-fluoropropanoate (<b>10y</b>)</h5><div class="NLM_p last">Yield, 72%; scale, 0.55 g; <i>R</i><sub>f</sub> 0.45 (CH<sub>2</sub>Cl<sub>2</sub>/AcOEt 20:1). P NMR (101 MHz, CDCl<sub>3</sub>) δ: 13.05 (d, <sup>2</sup><i>J</i><sub>PF</sub> = 83.0). <sup>19</sup>F NMR (235 MHz) δ: −178.55 (m, <sup>2</sup><i>J</i><sub>PF</sub> = 83.1). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ: 1.10 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.1, 3H), 1.35 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.0, 6H), 3.27–3.60 (m, 2H), 3.92 (s, 2H), 3.98–4.13 (m, 2H), 4.14–4.32 (m, 4H), 7.31–7.03 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ: 13.9, 16.4 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 5.3, 2C), 39.1 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 19.6, 1C), 41.8, 62.1, 64.2, and 64.4 (2d, <sup>2</sup><i>J</i><sub>PC</sub> = 6.8, 2C), 95.6 (dd, <sup>1</sup><i>J</i><sub>FC</sub> = 199.5, <sup>1</sup><i>J</i><sub>PC</sub> = 162.0, 1C), 128.1 (1s, 2C), 128.8 (1s, 2C), 128.4 (1s, 3C), 126.0, 130.8 (2s, 2C), 133.3 (d, <sup>3</sup><i>J</i><sub>PC</sub> = 13.2, 1C), 141.0 and 141.1 (2s, 2C), 166.4 (dd, <sup>2</sup><i>J</i><sub>PC</sub> = 4.5, <sup>2</sup><i>J</i><sub>FC</sub> = 23.0, 1C). HRMS <i>m</i>/<i>z</i>: calculated: 445.1556 (M + Na)<sup>+</sup>, found 445.1565 (M + Na)<sup>+</sup>.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> Determination of Cytotoxicity</h3><div class="NLM_p last">HeLa cells were seeded into 96-well cell culture plates at a density of 4 × 10<sup>3</sup> cells/well in 100 μL of complete culture medium. On the following day, cells were washed with phosphate-buffered saline (PBS) and 100 μL of fresh serum-containing or serum-free (fasting) medium was added. Subsequently HeLa cells were treated with PCs at eight concentrations and 72 h later PrestoBlue cell viability reagent was applied. Following 50 min incubation time at 37 °C and 5% CO<sub>2</sub>, cell viability was determined by measuring the fluorescent signal (Ex/Em = 530/590 nm) on a Synergy 2 microplate reader (BioTek, Vermont, USA). The obtained fluorescence magnitudes were used to calculate cell viability expressed as a percent of the viability of the untreated control cells. The data expressed as the mean of at least four independent experiments were used to calculate the IC<sub>50</sub> parameter.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> Assessment of Inhibition of Rab11 and Rap1A/Rap1B Prenylation</h3><div class="NLM_p last">HeLa cells were seeded into 6-well cell culture plates at a density of 4 × 10<sup>5</sup> cells/well in 3 mL of complete medium. On the following day, 1.5 mL of fresh serum-free medium was supplemented with PCs as well as lovastatin. After 48 h of incubation, cell monolayers were rinsed with PBS and detached using trypsin–EDTA solution. The cytosolic and membrane-rich fractions, containing protease inhibitor cocktail, were isolated from cell pellets using Mem-PER Plus membrane protein extraction kit according to the manufacturers’ instructions. The protein concentration in both fractions was determined using Bradford Protein Assay. Equal amounts of protein (20 μg) from cytosolic fractions were resolved by 12% SDS-PAGE gels and transferred on 0.2 μM nitrocellulose membrane. Membranes were probed with β-actin, Rab11A or Rap1A/Rap1B antibodies and detected using the appropriate HRP-conjugated secondary antibody, followed by an ECL assay. Visualization of the chemiluminescent protein bands was performed using ChemiDoc MP Imaging System (Bio-Rad). Densitometry analysis was performed with ImageLab Software (Bio-Rad) and relative unprenylated protein band intensity was normalized to β-actin and quantified with respect to controls (untreated cells).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> Statistical Analysis</h3><div class="NLM_p last">Unless stated otherwise, all the biological results are presented as means of 3–6 repeated experiments ± SEM. Statistical differences between mean values of inhibitor treated and untreated samples were analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons test using GraphPad Prism (version 6.01 for Windows, GraphPad Software, La Jolla California USA, <a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>). Confidence <i>p</i>-levels are indicated by asterisks, with * denoting <i>p</i> ≤ 0.05, ** denoting <i>p</i> ≤ 0.01, *** denoting <i>p</i> ≤ 0.001, and **** denoting <i>p</i> ≤ 0.0001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i135"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00811">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00811" class="ext-link">10.1021/acs.jmedchem.7b00811</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full experimental details, including spectra (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>31</sup>P NMR) of all compounds, data on separation of enantiomers (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Protein structures; cytotoxic efficacy on HeLa cell line of the studied compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_002.zip" class="ext-link">ZIP</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf">jm7b00811_si_001.pdf (25.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_002.zip">jm7b00811_si_002.zip (943.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_003.csv">jm7b00811_si_003.csv (2.38 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00811" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarzyna M. Błażewska</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego Street 116, 90-924 Łódź, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1218-7111" title="Orcid link">http://orcid.org/0000-0002-1218-7111</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#345f554055464e4d5a551a5658554e5143475f5574441a585b504e1a4458"><span class="__cf_email__" data-cfemail="d4bfb5a0b5a6aeadbab5fab6b8b5aeb1a3a7bfb594a4fab8bbb0aefaa4b8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleksandra Kaźmierczak</span> - <span class="hlFld-Affiliation affiliation">Institute
of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego Street 4/10, 90-924 Łódź, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damian Kusy</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego Street 116, 90-924 Łódź, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanna P. Niinivehmas</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological and Environmental Science & Nanoscience Center, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna Gmach</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego Street 116, 90-924 Łódź, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Łukasz Joachimiak</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego Street 116, 90-924 Łódź, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9962-2333" title="Orcid link">http://orcid.org/0000-0001-9962-2333</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olli T. Pentikäinen</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological and Environmental Science & Nanoscience Center, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Biomedicine, University of Turku, FI-20520 Turku, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edyta Gendaszewska-Darmach</span> - <span class="hlFld-Affiliation affiliation">Institute
of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego Street 4/10, 90-924 Łódź, Poland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.K. and D.K contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d166e18478-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i137">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was financially supported by the National Science Centre, Poland (2014/14/E/ST5/00491) and Ministry of Science and Higher Education, Poland (N N204 519839). We acknowledge CSC–IT Center for Science, Finland, for generous computational resources (O.T.P.: jyy2516 and jyy2585). We thank Jacek Reus, Aleksandra Stańczyk, and Marta Krysztof for technical assistance. We thank Dr. Marek Domin (Boston College) for HRMS of the esters <b>9</b> and <b>10</b>. We thank Prof. Edward Tate (Imperial College of London) for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i138" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i138"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i139" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i139"> Abbreviations Used</h2><tr><td class="NLM_term">RGGT (Rab GGTase, GGT-2)</td><td class="NLM_def"><p class="first last">Rab geranylgeranyl transferase</p></td></tr><tr><td class="NLM_term">FPPS</td><td class="NLM_def"><p class="first last">farnesyl pyrophosphate synthase</p></td></tr><tr><td class="NLM_term">GGPPS</td><td class="NLM_def"><p class="first last">geranylgeranyl pyrophosphate synthase</p></td></tr><tr><td class="NLM_term">FT</td><td class="NLM_def"><p class="first last">farnesyl transferase</p></td></tr><tr><td class="NLM_term">GGT-1</td><td class="NLM_def"><p class="first last">geranylgeranyl transferase 1</p></td></tr><tr><td class="NLM_term">FPP</td><td class="NLM_def"><p class="first last">farnesyl pyrophosphate</p></td></tr><tr><td class="NLM_term">GPP</td><td class="NLM_def"><p class="first last">geranyl pyrophosphate</p></td></tr><tr><td class="NLM_term">GGPP</td><td class="NLM_def"><p class="first last">geranylgeranyl pyrophosphate</p></td></tr><tr><td class="NLM_term">3-IPEHPC</td><td class="NLM_def"><p class="first last">3-(3-pyridyl)-2-hydroxy-2-phosphonopropanoic acid</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">phosphonocarboxylate</p></td></tr><tr><td class="NLM_term">NBP</td><td class="NLM_def"><p class="first last">nitrogen-containing bisphosphonate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i140">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horgan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, M. W.</span><span> </span><span class="NLM_article-title">Rab11 proteins in health and disease</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1360</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span><span class="refDoi"> DOI: 10.1042/BST20120157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1042%2FBST20120157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=23176481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1360-1367&author=E.+E.+Kellyauthor=C.+P.+Horganauthor=M.+W.+McCaffrey&title=Rab11+proteins+in+health+and+disease&doi=10.1042%2FBST20120157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Rab11 proteins in health and disease</span></div><div class="casAuthors">Kelly, Eoin E.; Horgan, Conor P.; McCaffrey, Mary W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1360-1367</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Comprising over 60 members, Rab proteins constitute the largest branch of the Ras superfamily of low-mol.-mass G-proteins.  This protein family have been primarily implicated in various aspects of intracellular membrane trafficking processes.  On the basis of distinct subfamily-specific sequence motifs, many Rabs have been grouped into subfamilies.  The Rab11 GTPase subfamily comprises three members: Rab11a, Rab11b and Rab25/Rab11c, which, between them, have been demonstrated to bind more than 30 proteins.  In the present paper, we review the function of the Rab11 subfamily.  We describe their localization and primary functional roles within the cell and their implication, to date, in disease processes.  We also summarize the protein machinery currently known to regulate or mediate their functions and the cargo mols. which they have been shown to transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5LDt09iGeObVg90H21EOLACvtfcHk0lhMSey8OrpsIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rJ&md5=1f6861370670e4bd2b62e3ff9b48f4ff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2FBST20120157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120157%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DHorgan%26aufirst%3DC.%2BP.%26aulast%3DMcCaffrey%26aufirst%3DM.%2BW.%26atitle%3DRab11%2520proteins%2520in%2520health%2520and%2520disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D1360%26epage%3D1367%26doi%3D10.1042%2FBST20120157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horgan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, M. W.</span><span> </span><span class="NLM_article-title">The Rab family of proteins: 25 years on</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span><span class="refDoi"> DOI: 10.1042/BST20120203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1042%2FBST20120203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=23176478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1337-1347&author=E.+E.+Kellyauthor=C.+P.+Horganauthor=B.+Goudauthor=M.+W.+McCaffrey&title=The+Rab+family+of+proteins%3A+25+years+on&doi=10.1042%2FBST20120203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Rab family of proteins: 25 years on</span></div><div class="casAuthors">Kelly, Eoin E.; Horgan, Conor P.; Goud, Bruno; McCaffrey, Mary W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1337-1347</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Intracellular membrane trafficking requires the complex interplay of several classes of trafficking proteins.  Rab proteins, the largest subfamily of the Ras superfamily of small G-proteins, are central regulators of all aspects of intracellular trafficking processes including vesicle budding and uncoating, motility, tethering and fusion.  In the present paper, we discuss the discovery, evolution and characterization of the Rab GTPase family.  We examine their basic functional roles, their important structural features and the regulatory proteins which mediate Rab function.  We speculate on outstanding issues in the field, such as the mechanisms of Rab membrane assocn. and the coordinated interplay between distinct Rab proteins.  Finally, we summarize the data implicating Rab proteins in an ever increasing no. of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRB5KbuTZEbVg90H21EOLACvtfcHk0lhMSey8OrpsIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rO&md5=28c8f5276044ca8fbaabd3d8a31984be</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2FBST20120203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120203%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DHorgan%26aufirst%3DC.%2BP.%26aulast%3DGoud%26aufirst%3DB.%26aulast%3DMcCaffrey%26aufirst%3DM.%2BW.%26atitle%3DThe%2520Rab%2520family%2520of%2520proteins%253A%252025%2520years%2520on%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D1337%26epage%3D1347%26doi%3D10.1042%2FBST20120203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Guichard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, E.</span><span> </span><span class="NLM_article-title">RAB11-mediated trafficking in host-pathogen interactions</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1038/nrmicro3325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1038%2Fnrmicro3325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25118884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGnt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=624-634&author=A.+Guichardauthor=V.+Nizetauthor=E.+Bier&title=RAB11-mediated+trafficking+in+host-pathogen+interactions&doi=10.1038%2Fnrmicro3325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">RAB11-mediated trafficking in host-pathogen interactions</span></div><div class="casAuthors">Guichard, Annabel; Nizet, Victor; Bier, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">624-634</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many bacterial and viral pathogens block or subvert host cellular processes to promote successful infection.  One host protein that is targeted by invading pathogens is the small GTPase RAB11, which functions in vesicular trafficking.  RAB11 functions in conjunction with a protein complex known as the exocyst to mediate terminal steps in cargo transport via the recycling endosome to cell-cell junctions, phagosomes and cellular protrusions.  These processes contribute to host innate immunity by promoting epithelial and endothelial barrier integrity, sensing and immobilizing pathogens and repairing pathogen-induced cellular damage.  In this Review, the various mechanisms that pathogens have evolved to disrupt or subvert RAB11-dependent pathways as part of their infection strategy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGml76nTbLbVg90H21EOLACvtfcHk0liN7_bp4dyraQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGnt7vL&md5=b83b00706cbbdbd692c3888da30bbd86</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3325%26sid%3Dliteratum%253Aachs%26aulast%3DGuichard%26aufirst%3DA.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DBier%26aufirst%3DE.%26atitle%3DRAB11-mediated%2520trafficking%2520in%2520host-pathogen%2520interactions%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D624%26epage%3D634%26doi%3D10.1038%2Fnrmicro3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hendrix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braems, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Broecke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Belle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocquyt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gespach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahl, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wever, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbroek, W.</span><span> </span><span class="NLM_article-title">Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span><span class="refDoi"> DOI: 10.1093/jnci/djq153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1093%2Fjnci%2Fdjq153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=20484105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVyju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=866-880&author=A.+Hendrixauthor=D.+Maynardauthor=P.+Pauwelsauthor=G.+Braemsauthor=H.+Denysauthor=R.+Van+den+Broeckeauthor=J.+Lambertauthor=S.+Van+Belleauthor=V.+Cocquytauthor=C.+Gespachauthor=M.+Brackeauthor=M.+C.+Seabraauthor=W.+A.+Gahlauthor=O.+De+Weverauthor=W.+Westbroek&title=Effect+of+the+secretory+small+GTPase+Rab27B+on+breast+cancer+growth%2C+invasion%2C+and+metastasis&doi=10.1093%2Fjnci%2Fdjq153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Secretory Small GTPase Rab27B on Breast Cancer Growth, Invasion, and Metastasis</span></div><div class="casAuthors">Hendrix, An; Maynard, Dawn; Pauwels, Patrick; Braems, Geert; Denys, Hannelore; Van den Broecke, Rudy; Lambert, Jo; Van Belle, Simon; Cocquyt, Veronique; Gespach, Christian; Bracke, Marc; Seabra, Miguel C.; Gahl, William A.; De Wever, Olivier; Westbroek, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">866-880</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Secretory GTPases like Rab27B control vesicle exocytosis and deliver crit. proinvasive growth regulators into the tumor microenvironment.  The expression and role of Rab27B in breast cancer were unknown.  Expression of green fluorescent protein (GFP) fused with wild-type Rab3D, Rab27A, or Rab27B, or Rab27B point mutants defective in GTP/GDP binding or geranylgeranylation, or transient silencing RNA to the same proteins was used to study Rab27B in estrogen receptor (ER)-pos. human breast cancer cell lines (MCF-7, T47D, and ZR75.1).  Cell cycle progression was evaluated by flow cytometry, western blotting, and measurement of cell proliferation rates, and invasion was assessed using Matrigel and native type I collagen substrates.  Orthotopic tumor growth, local invasion, and metastasis were analyzed in mouse xenograft models.  Mass spectrometry identified proinvasive growth regulators that were secreted in the presence of Rab27B.  Rab27B protein levels were evaluated by immunohistochem. in 59 clin. breast cancer specimens, and Rab3D, Rab27A, and Rab27B mRNA levels were analyzed by quant. real-time polymerase chain reaction in 20 specimens.  Statistical tests were two-sided.  Results Increased expression of Rab27B promoted G1 to S phase cell cycle transition, proliferation and invasiveness of cells in culture, and invasive tumor growth and hemorrhagic ascites prodn. in a xenograft mouse model (n = 10; at 10 wk, survival of MCF-7 GFP- vs GFP-Rab27B-injected mice was 100% vs 62.5%, hazard ratio = 0.26, 95% confidence interval = 0.08 to 0.88, P = .03).  Mass spectrometric anal. of purified Rab27B-secretory vesicles identified heat-shock protein 90α as key proinvasive growth regulator.  Heat-shock protein 90α secretion was Rab27B-dependent and was required for matrix metalloproteinase-2 activation.  All Rab27B-mediated functional responses were GTP- and geranylgeranyl-dependent.  Presence of endogenous Rab27B mRNA and protein, but not of Rab3D or Rab27A mRNA, was assocd. with lymph node metastasis (P < .001) and differentiation grade (P = .001) in ER-pos. human breast tumors.  Rab27B regulates invasive growth and metastasis in ER-pos. breast cancer cell lines, and increased expression is assocd. with poor prognosis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoygLI7rTFMhLVg90H21EOLACvtfcHk0liN7_bp4dyraQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVyju7o%253D&md5=ae8305e2c4198eb4e9bf9450713deba7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq153%26sid%3Dliteratum%253Aachs%26aulast%3DHendrix%26aufirst%3DA.%26aulast%3DMaynard%26aufirst%3DD.%26aulast%3DPauwels%26aufirst%3DP.%26aulast%3DBraems%26aufirst%3DG.%26aulast%3DDenys%26aufirst%3DH.%26aulast%3DVan%2Bden%2BBroecke%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DJ.%26aulast%3DVan%2BBelle%26aufirst%3DS.%26aulast%3DCocquyt%26aufirst%3DV.%26aulast%3DGespach%26aufirst%3DC.%26aulast%3DBracke%26aufirst%3DM.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DGahl%26aufirst%3DW.%2BA.%26aulast%3DDe%2BWever%26aufirst%3DO.%26aulast%3DWestbroek%26aufirst%3DW.%26atitle%3DEffect%2520of%2520the%2520secretory%2520small%2520GTPase%2520Rab27B%2520on%2520breast%2520cancer%2520growth%252C%2520invasion%252C%2520and%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D866%26epage%3D880%26doi%3D10.1093%2Fjnci%2Fdjq153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Rab GTPases implicated in inherited and acquired disorders</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.semcdb.2010.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.semcdb.2010.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=57-68&author=S.+Mitraauthor=K.+W.+Chengauthor=G.+B.+Mills&title=Rab+GTPases+implicated+in+inherited+and+acquired+disorders&doi=10.1016%2Fj.semcdb.2010.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%2BW.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DRab%2520GTPases%2520implicated%2520in%2520inherited%2520and%2520acquired%2520disorders%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2011%26volume%3D22%26spage%3D57%26epage%3D68%26doi%3D10.1016%2Fj.semcdb.2010.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamshidiha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon-Hogg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cota, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, E. W.</span><span> </span><span class="NLM_article-title">Direct targeting of the Ras GTPase superfamily through structure-based design</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.2174/1568026616666160719165633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.2174%2F1568026616666160719165633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=27530972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCmtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=16-29&author=W.+Zhaoauthor=M.+Jamshidihaauthor=T.+Lanyon-Hoggauthor=C.+Recchiauthor=E.+Cotaauthor=E.+W.+Tate&title=Direct+targeting+of+the+Ras+GTPase+superfamily+through+structure-based+design&doi=10.2174%2F1568026616666160719165633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design</span></div><div class="casAuthors">Zhao, Wenye; Jamshidiha, Mostafa; Lanyon-Hogg, Thomas; Recchi, Chiara; Cota, Ernesto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-29</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Ras superfamily of small monomeric GTPases includes some of the most prominent cancer targets for which no selective therapeutic agent has yet been successfully developed.  The turn of the millennium saw a resurgence of efforts to target these enzymes using new and improved biophys. techniques to overcome the perceived difficulties of insurmountably high affinity for guanosine nucleotides and flat, flexible topol. lacking suitable pockets for small mol. inhibitors.  Further, recent investigations have begun to probe the dynamic conformational status of GTP-bound Ras, opening up new mechanisms of inhibition.  While much of the literature has focused on the oncogenic Ras proteins, particularly K-Ras, these represent only a small minority of therapeutically interesting targets within the superfamily; for example, the Rab GTPases are the largest subfamily of about 70 members, and present an as yet untapped class of potential targets.  The present review documents the key methodologies employed to date in structure-guided attempts to drug the Ras GTPases, and forecasts their transferability to other similarly challenging proteins in the superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJkXDfx0frFrVg90H21EOLACvtfcHk0liDLBrRO9FBVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCmtb3K&md5=67305c36018cae000541586de8143875</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160719165633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160719165633%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DJamshidiha%26aufirst%3DM.%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DRecchi%26aufirst%3DC.%26aulast%3DCota%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDirect%2520targeting%2520of%2520the%2520Ras%2520GTPase%2520superfamily%2520through%2520structure-based%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D16%26epage%3D29%26doi%3D10.2174%2F1568026616666160719165633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bhuin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, J. K.</span><span> </span><span class="NLM_article-title">Rab11 in disease progression</span> <span class="citation_source-journal">Int. J. Mol. Cell. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25815277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A280%3ADC%252BC2MnosVSmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=1-8&author=T.+Bhuinauthor=J.+K.+Roy&title=Rab11+in+disease+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rab11 in disease progression</span></div><div class="casAuthors">Bhuin Tanmay; Roy Jagat Kumar</div><div class="citationInfo"><span class="NLM_cas:title">International journal of molecular and cellular medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>
        ISSN:<span class="NLM_cas:issn">2251-9637</span>.
    </div><div class="casAbstract">Membrane/protein trafficking in the secretory/biosynthetic and endocytic pathways is mediated by vesicles.  Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases: the Rab protein family.  Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular signalling pathways.  Rab11 (a subfamily of the Ypt/Rab gene family), an evolutionarily conserved ubiquitously expressed subfamily of Rab GTPases, has been implicated in regulating vesicular trafficking through the recycling of endosomes.  Rabs have been grouped into different subfamilies based on the distinct unambiguous sequence motifs.  Three members: Rab11a, Rab11b and Rab25 make up the Rab11 GTPase subfamily.  In this review article, we describe an overview over Rab11 subfamily with a brief structural aspect and its roles in implicating different disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnCExm7n-9QeRS7coPn-RtfW6udTcc2eb3HxBSqenjiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnosVSmtg%253D%253D&md5=0c1a878c9295cc9c4b019bf0e4b61b92</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhuin%26aufirst%3DT.%26aulast%3DRoy%26aufirst%3DJ.%2BK.%26atitle%3DRab11%2520in%2520disease%2520progression%26jtitle%3DInt.%2520J.%2520Mol.%2520Cell.%2520Med.%26date%3D2015%26volume%3D4%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingyoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takiguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, M.</span><span> </span><span class="NLM_article-title">Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1517</span><span class="refDoi"> DOI: 10.1038/cddis.2014.475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1038%2Fcddis.2014.475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25393473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1517&author=S.+Okamotoauthor=Y.+Jiangauthor=K.+Kawamuraauthor=M.+Shingyojiauthor=Y.+Tadaauthor=I.+Sekineauthor=Y.+Takiguchiauthor=K.+Tatsumiauthor=H.+Kobayashiauthor=H.+Shimadaauthor=K.+Hiroshimaauthor=M.+Tagawa&title=Zoledronic+acid+induces+apoptosis+and+S-phase+arrest+in+mesothelioma+through+inhibiting+Rab+family+proteins+and+topoisomerase+II+actions&doi=10.1038%2Fcddis.2014.475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions</span></div><div class="casAuthors">Okamoto, S.; Jiang, Y.; Kawamura, K.; Shingyoji, M.; Tada, Y.; Sekine, I.; Takiguchi, Y.; Tatsumi, K.; Kobayashi, H.; Shimada, H.; Hiroshima, K.; Tagawa, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1517</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Zoledronic acid (ZOL), a nitrogen-contg. bisphosphonate, produced anti-tumor effects through apoptosis induction or S-phase arrest depending on human mesothelioma cells tested.  An addn. of isoprenoid, geranylgeraniol but not farnesol, negated these ZOL-induced effects, indicating that the ZOL-mediated effects were attributable to depletion of geranylgeranyl pyrophosphates which were substrates for prenylation processes of small guanine-nucleotide-binding regulatory proteins (small G proteins).  ZOL-treated cells decreased a ratio of membrane to cytoplasmic fractions in RhoA, Cdc42 and Rab6 but less significantly Rac1 proteins, indicating that these proteins were possible targets for ZOL-induced actions.  We further analyzed which small G proteins were responsible for the three ZOL-induced effects, caspase-mediated apoptosis, S-phase arrest and morphol. changes, using inhibitors for resp. small G proteins and siRNA for Cdc42.  ZOL-induced apoptosis is due to insufficient prenylation of Rab proteins because an inhibitor of geranlygeranyl transferase II that was specific for Rab family proteins prenylation, but not others inhibitors, activated the same apoptotic pathways that ZOL did.  ZOL suppressed an endogenous topoisomerase II activity, which was assocd. with apoptosis and S-phase arrest in resp. cells because we detected the same cell cycle changes in etoposide-treated cells.  Inhibitors for geranlygeranyl transferase I and for RhoA produced morphol. changes and disrupted actin fiber structures, both of which were similar to those by ZOL treatments.  These data demonstrated that anti-tumor effects by ZOL were attributable to inhibited functions of resp. small G proteins and topoisomerase II activity, and suggested that cellular factors were involved in the differential cell cycle changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1V4pcnt-Xr7Vg90H21EOLACvtfcHk0liDLBrRO9FBVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7%252FM&md5=58d19666aee80a93af63ffec9c373602</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.475%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DShingyoji%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DSekine%26aufirst%3DI.%26aulast%3DTakiguchi%26aufirst%3DY.%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DHiroshima%26aufirst%3DK.%26aulast%3DTagawa%26aufirst%3DM.%26atitle%3DZoledronic%2520acid%2520induces%2520apoptosis%2520and%2520S-phase%2520arrest%2520in%2520mesothelioma%2520through%2520inhibiting%2520Rab%2520family%2520proteins%2520and%2520topoisomerase%2520II%2520actions%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1517%26doi%3D10.1038%2Fcddis.2014.475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurczyluk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tnimov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlos, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1080/21541248.2015.1085485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F21541248.2015.1085485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=26399387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=202-211&author=N.+Aliauthor=J.+Jurczylukauthor=G.+Shayauthor=Z.+Tnimovauthor=K.+Alexandrovauthor=M.+A.+Munozauthor=O.+P.+Skinnerauthor=N.+J.+Pavlosauthor=M.+J.+Rogers&title=A+highly+sensitive+prenylation+assay+reveals+in+vivo+effects+of+bisphosphonate+drug+on+the+Rab+prenylome+of+macrophages+outside+the+skeleton&doi=10.1080%2F21541248.2015.1085485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton</span></div><div class="casAuthors">Ali, Naveid; Jurczyluk, Julie; Shay, Gemma; Tnimov, Zakir; Alexandrov, Kirill; Munoz, Marcia A.; Skinner, Oliver P.; Pavlos, Nathan J.; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-211</span>CODEN:
                <span class="NLM_cas:coden">SGMTBK</span>;
        ISSN:<span class="NLM_cas:issn">2154-1256</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Bisphosphonate drugs such as zoledronic acid (ZOL), used for the treatment of common bone disorders, target the skeleton and inhibit bone resorption by preventing the prenylation of small GTPases in bone-destroying osteoclasts.  Increasing evidence indicates that bisphosphonates also have pleiotropic effects outside the skeleton, most likely via cells of the monocyte/macrophage lineage exposed to nanomolar circulating drug concns.  However, no effects of such low concns. of ZOL have been reported using existing approaches.  We have optimized a highly sensitive in vitro prenylation assay utilizing recombinant geranylgeranyltransferases to enable the detection of subtle effects of ZOL on the prenylation of Rab- and Rho-family GTPases.  Using this assay, we found for the first time that concns. of ZOL as low as 10nM caused inhibition of Rab prenylation in J774 macrophages following prolonged cell culture.  By combining the assay with quant. mass spectrometry we identified an accumulation of 18 different unprenylated Rab proteins in J774 cells after nanomolar ZOL treatment, with a >7-fold increase in the unprenylated form of Rab proteins assocd. with the endophagosome pathway (Rab1, Rab5, Rab6, Rab7, Rab11, Rab14 and Rab21).  Finally, we also detected a clear effect of s.c. ZOL administration in vivo on the prenylation of Rab1A, Rab5B, Rab7A and Rab14 in mouse peritoneal macrophages, confirming that systemic treatment with bisphosphonate drug can inhibit prenylation in myeloid cells in vivo outside the skeleton.  These observations begin a new era in defining the precise pharmacol. actions of bisphosphonate drugs on the prenylation of small GTPases in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_HwAEOm-rK7Vg90H21EOLACvtfcHk0liw6dj7ix7T_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKqsL4%253D&md5=d021419ee39a72bd44deac6f0e10923c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F21541248.2015.1085485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21541248.2015.1085485%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DN.%26aulast%3DJurczyluk%26aufirst%3DJ.%26aulast%3DShay%26aufirst%3DG.%26aulast%3DTnimov%26aufirst%3DZ.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DMunoz%26aufirst%3DM.%2BA.%26aulast%3DSkinner%26aufirst%3DO.%2BP.%26aulast%3DPavlos%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DA%2520highly%2520sensitive%2520prenylation%2520assay%2520reveals%2520in%2520vivo%2520effects%2520of%2520bisphosphonate%2520drug%2520on%2520the%2520Rab%2520prenylome%2520of%2520macrophages%2520outside%2520the%2520skeleton%26jtitle%3DSmall%2520GTPases%26date%3D2015%26volume%3D6%26spage%3D202%26epage%3D211%26doi%3D10.1080%2F21541248.2015.1085485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Agabiti, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, A. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation</span> <span class="citation_source-journal">Mol. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1080/09687688.2016.1213432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F09687688.2016.1213432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=27537059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=1-11&author=S.+S.+Agabitiauthor=Y.+Liangauthor=A.+J.+Wiemer&title=Molecular+mechanisms+linking+geranylgeranyl+diphosphate+synthase+to+cell+survival+and+proliferation&doi=10.1080%2F09687688.2016.1213432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation</span></div><div class="casAuthors">Agabiti, Sherry S.; Liang, Yilan; Wiemer, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Membrane Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">MMEBE7</span>;
        ISSN:<span class="NLM_cas:issn">0968-7688</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Geranylgeranyl diphosphate is a 20-carbon isoprenoid phospholipid whose lipid moiety can be post-translationally incorporated into proteins to promote membrane assocn.  The process of geranylgeranylation has been implicated in anti-proliferative effects of clin. agents that inhibit enzymes of the mevalonate pathway (i.e. statins and nitrogenous bisphosphonates) as well as exptl. agents that deplete geranylgeranyl diphosphate.  Inhibitors of geranylgeranyl diphosphate synthase are an attractive way to block geranylgeranylation because they possess a calcium-chelating substructure to allow localization to bone and take advantage of a unique position of the enzyme within the biosynthetic pathway.  Here, we describe recent advances in geranylgeranyl diphosphate synthase expression and inhibitor development with a particular focus on the mol. mechanisms that link geranylgeranyl diphosphate to cell proliferation via geranylgeranylated small GTPases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwaF-h_j547Vg90H21EOLACvtfcHk0liw6dj7ix7T_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmtL3P&md5=447b75d5da4970d89206b826181983aa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F09687688.2016.1213432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09687688.2016.1213432%26sid%3Dliteratum%253Aachs%26aulast%3DAgabiti%26aufirst%3DS.%2BS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520linking%2520geranylgeranyl%2520diphosphate%2520synthase%2520to%2520cell%2520survival%2520and%2520proliferation%26jtitle%3DMol.%2520Membr.%2520Biol.%26date%3D2016%26volume%3D33%26spage%3D1%26epage%3D11%26doi%3D10.1080%2F09687688.2016.1213432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ochocki, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M. D.</span><span> </span><span class="NLM_article-title">Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span><span class="refDoi"> DOI: 10.1039/C2MD20299A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1039%2FC2MD20299A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25530833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=476-492&author=J.+D.+Ochockiauthor=M.+D.+Distefano&title=Prenyltransferase+inhibitors%3A+treating+human+ailments+from+cancer+to+parasitic+infections&doi=10.1039%2FC2MD20299A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections</span></div><div class="casAuthors">Ochocki, Joshua D.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">476-492</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The posttranslational modification of protein prenylation is a covalent lipid modification on the C-terminus of substrate proteins that serves to enhance membrane affinity.  Oncogenic proteins such as Ras have this modification and significant effort has been placed into developing inhibitors of the prenyltransferase enzymes for clin. therapy.  In addn. to cancer therapy, prenyltransferase inhibitors have begun to find important therapeutic uses in other diseases, including progeria, hepatitis C and D, parasitic infections, and other maladies.  This review will trace the evolution of prenyltransferase inhibitors from their initial use as cancer therapeutics to their expanded applications for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wdOpk9scqLVg90H21EOLACvtfcHk0liw6dj7ix7T_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtbg%253D&md5=d228d5dabd83865fbc35ab4b58088aa7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2FC2MD20299A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20299A%26sid%3Dliteratum%253Aachs%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DPrenyltransferase%2520inhibitors%253A%2520treating%2520human%2520ailments%2520from%2520cancer%2520to%2520parasitic%2520infections%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D476%26epage%3D492%26doi%3D10.1039%2FC2MD20299A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhimnathwala, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brucker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSolms, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis-Hutchings, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumma, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machotka, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rands, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliff, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span> </span><span class="NLM_article-title">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8758</span><span class="NLM_x">–</span> <span class="NLM_lpage">8768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=11751396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8758-8768&author=R.+B.+Lobellauthor=C.+A.+Omerauthor=M.+T.+Abramsauthor=H.+G.+Bhimnathwalaauthor=M.+J.+Bruckerauthor=C.+A.+Buserauthor=J.+P.+Davideauthor=S.+J.+DeSolmsauthor=C.+J.+Dinsmoreauthor=M.+S.+Ellis-Hutchingsauthor=A.+M.+Kralauthor=D.+Liuauthor=W.+C.+Lummaauthor=S.+V.+Machotkaauthor=E.+Randsauthor=T.+M.+Williamsauthor=S.+L.+Grahamauthor=G.+D.+Hartmanauthor=A.+I.+Oliffauthor=D.+C.+Heimbrookauthor=N.+E.+Kohl&title=Evaluation+of+farnesyl%3Aprotein+transferase+and+geranylgeranyl%3Aprotein+transferase+inhibitor+combinations+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span></div><div class="casAuthors">Lobell, Robert B.; Omer, Charles A.; Abrams, Marc T.; Bhimnathwala, Hema G.; Brucker, Mary Jo; Buser, Carolyn A.; Davide, Joseph P.; DeSolms, S. Jane; Dinsmore, Christopher J.; Ellis-Hutchings, Michelle S.; Kral, Astrid M.; Liu, Dongming; Lumma, William C.; Machotka, Samuel V.; Rands, Elaine; Williams, Theresa M.; Graham, Samuel L.; Hartman, George D.; Oliff, Allen I.; Heimbrook, David C.; Kohl, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8758-8768</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Farnesyl:protein transferase (FPTase) inhibitors (FTIs) were originally developed as potential anticancer agents targeting the ras oncogene and are currently in clin. trials.  Whereas FTIs inhibit the farnesylation of Ha-Ras, they do not completely inhibit the prenylation of Ki-Ras, the allele most frequently mutated in human cancers.  Whereas farnesylation of Ki-Ras is blocked by FTIs, Ki-Ras remains prenylated in FTI-treated cells because of its modification by the related prenyltransferase, geranylgeranyl:protein transferase type I (GGPTase-I).  Hence, cells transformed with Ki-ras tend to be more resistant to FTIs than Ha-ras-transformed cells.  To det. whether Ki-ras-transformed cells can be targeted by combining an FTI with a GGPTase-I inhibitor (GGTI), we evaluated potent, selective FTIs, GGTIs, and dual prenylation inhibitors (DPIs) that have both FTI and GGTI activity.  We find that in human PSN-1 pancreatic tumor cells, which harbor oncogenic Ki-ras, and in other tumor lines having either wild-type or oncogenic Ki-ras, treatment with an FTI/GGTI combination or with a DPI blocks Ki-Ras prenylation and induces markedly higher levels of apoptosis relative to FTI or GGTI alone.  We demonstrate that these compds. can inhibit their enzyme targets in mice by monitoring pancreatic and tumor tissues from treated animals for inhibition of prenylation of Ki-Ras, HDJ2, a substrate specific for FPTase, and Rap1A, a substrate specific for GGPTase-I.  Continuous infusion (72 h) of varying doses of GGTI in conjunction with a high, fixed dose of FTI causes a dose-dependent inhibition of Ki-Ras prenylation.  However, a 72-h infusion of a GGTI, at a dose sufficient to inhibit Ki-Ras prenylation in the presence of an FTI, causes death within 2 wk of the infusion when administered either as monotherapy or in combination with an FTI.  DPIs are also lethal after a 72-h infusion at doses that inhibit Ki-Ras prenylation.  Because 24 h infusion of a high dose of DPI is tolerated and inhibits Ki-Ras prenylation, we compared the antitumor efficacy from a 24-h FTI infusion to that of a DPI in a nude mouse/PSN-1 tumor cell xenograft model and in Ki-ras transgenic mice with mammary tumors.  The FTI and DPI were dosed at a level that provided comparable inhibition of FPTase.  The FTI and the DPI displayed comparable efficacy, causing a decrease in growth rate of the PSN-1 xenograft tumors and tumor regression in the transgenic model, but neither treatment regimen induced a statistically significant increase in tumor cell apoptosis.  Although FTI/GGTI combinations elicit a greater apoptotic response than either agent alone in vitro, the toxicity assocd. with GGTI treatment in vivo limits the duration of treatment and, thus, may limit the therapeutic benefit that might be gained by inhibiting oncogenic Ki-Ras through dual prenyltransferase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8692wSeB0bVg90H21EOLACvtfcHk0lgStizEdHpfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D&md5=a6bec938c55d2a308cadbce460d5f098</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBhimnathwala%26aufirst%3DH.%2BG.%26aulast%3DBrucker%26aufirst%3DM.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DDeSolms%26aufirst%3DS.%2BJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEllis-Hutchings%26aufirst%3DM.%2BS.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DMachotka%26aufirst%3DS.%2BV.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DOliff%26aufirst%3DA.%2BI.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26atitle%3DEvaluation%2520of%2520farnesyl%253Aprotein%2520transferase%2520and%2520geranylgeranyl%253Aprotein%2520transferase%2520inhibitor%2520combinations%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8758%26epage%3D8768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larijani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzylak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48213</span><span class="NLM_x">–</span> <span class="NLM_lpage">48222</span><span class="refDoi"> DOI: 10.1074/jbc.M106473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M106473200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48213-48222&author=F.+P.+Coxonauthor=M.+H.+Helfrichauthor=B.+Larijaniauthor=M.+Muzylakauthor=J.+E.+Dunfordauthor=D.+Marshallauthor=A.+D.+McKinnonauthor=S.+A.+Nesbittauthor=M.+A.+Hortonauthor=M.+C.+Seabraauthor=F.+H.+Ebetinoauthor=M.+J.+Rogers&title=Identification+of+a+novel+phosphonocarboxylate+inhibitor+of+Rab+geranylgeranyl+transferase+that+specifically+prevents+Rab+prenylation+in+osteoclasts+and+macrophages&doi=10.1074%2Fjbc.M106473200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106473200%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DHelfrich%26aufirst%3DM.%2BH.%26aulast%3DLarijani%26aufirst%3DB.%26aulast%3DMuzylak%26aufirst%3DM.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMcKinnon%26aufirst%3DA.%2BD.%26aulast%3DNesbitt%26aufirst%3DS.%2BA.%26aulast%3DHorton%26aufirst%3DM.%2BA.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520novel%2520phosphonocarboxylate%2520inhibitor%2520of%2520Rab%2520geranylgeranyl%2520transferase%2520that%2520specifically%2520prevents%2520Rab%2520prenylation%2520in%2520osteoclasts%2520and%2520macrophages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48213%26epage%3D48222%26doi%3D10.1074%2Fjbc.M106473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiji, H. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinderman, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span> </span><span class="NLM_article-title">Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">9571</span><span class="NLM_x">–</span> <span class="NLM_lpage">9579</span><span class="refDoi"> DOI: 10.1074/jbc.M706229200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M706229200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=18230616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1aks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=9571-9579&author=M.+Watanabeauthor=H.+D.+G.+Fijiauthor=L.+Guoauthor=L.+Chanauthor=S.+S.+Kindermanauthor=D.+J.+Slamonauthor=O.+Kwonauthor=F.+Tamanoi&title=Inhibitors+of+protein+geranylgeranyltransferase+I+and+Rab+geranylgeranyltransferase+identified+from+a+library+of+allenoate-derived+compounds&doi=10.1074%2Fjbc.M706229200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Protein Geranylgeranyltransferase I and Rab Geranylgeranyltransferase Identified from a Library of Allenoate-derived Compounds</span></div><div class="casAuthors">Watanabe, Masaru; Fiji, Hannah D. G.; Guo, Lea; Chan, Lai; Kinderman, Sape S.; Slamon, Dennis J.; Kwon, Ohyun; Tamanoi, Fuyuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">9571-9579</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein geranylgeranylation is crit. for the function of a no. of proteins such as RhoA, Rac, and Rab.  Protein geranylgeranyltransferase I (GGTase-I) and Rab geranylgeranyltransferase (RabGGTase) catalyze these modifications.  In this work, we first describe the identification and characterization of small mol. inhibitors of GGTase-I (GGTI) with two novel scaffolds from a library consisting of allenoate-derived compds.  These compds. exhibit specific inhibition of GGTase-I and act by competing with a substrate protein.  Derivatization of a carboxylic acid emanating from the core ring of one of the GGTI compds. dramatically improves their cellular activity.  The improved GGTI compds. inhibit proliferation of a variety of human cancer cell lines and cause G1 cell cycle arrest and induction of p21CIP1/WAF1.  We also report the identification of novel small mol. inhibitors of RabGGTase.  These compds. were identified first by screening our GGTI compds. for those that also exhibited RabGGTase inhibition.  This led to the discovery of a common structural feature for RabGGTase inhibitors: the presence of a characteristic six-atom aliph. tail attached to the penta-substituted pyrrolidine core.  Further screening led to the identification of compds. with preferential inhibition of RabGGTase.  These compds. inhibit RabGGTase activity by competing with the substrate protein.  These novel compds. may provide valuable reagents to study protein geranylgeranylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkCWVFXGF17Vg90H21EOLACvtfcHk0lgStizEdHpfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1aks70%253D&md5=2a215804301c0eaa5221bd7563bcfa18</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M706229200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M706229200%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DFiji%26aufirst%3DH.%2BD.%2BG.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DKinderman%26aufirst%3DS.%2BS.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DKwon%26aufirst%3DO.%26aulast%3DTamanoi%26aufirst%3DF.%26atitle%3DInhibitors%2520of%2520protein%2520geranylgeranyltransferase%2520I%2520and%2520Rab%2520geranylgeranyltransferase%2520identified%2520from%2520a%2520library%2520of%2520allenoate-derived%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D9571%26epage%3D9579%26doi%3D10.1074%2Fjbc.M706229200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tan, K.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiu-Rozas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of peptide-based Rab geranylgeranyl transferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8025</span><span class="NLM_x">–</span> <span class="NLM_lpage">8037</span><span class="refDoi"> DOI: 10.1021/jm901117d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901117d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8025-8037&author=K.-T.+Tanauthor=E.+Guiu-Rozasauthor=R.+S.+Bonauthor=Z.+Guoauthor=C.+Delonauthor=S.+Wetzelauthor=S.+Arndtauthor=K.+Alexandrovauthor=H.+Waldmannauthor=R.+S.+Goodyauthor=Y.-W.+Wuauthor=W.+Blankenfeldt&title=Design%2C+synthesis%2C+and+characterization+of+peptide-based+Rab+geranylgeranyl+transferase+inhibitors&doi=10.1021%2Fjm901117d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of Peptide-Based Rab Geranylgeranyl Transferase Inhibitors</span></div><div class="casAuthors">Tan, Kui-Thong; Guiu-Rozas, Ester; Bon, Robin S.; Guo, Zhong; Delon, Christine; Wetzel, Stefan; Arndt, Sabine; Alexandrov, Kirill; Waldmann, Herbert; Goody, Roger S.; Wu, Yao-Wen; Blankenfeldt, Wulf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8025-8037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rab geranylgeranyl transferase (RabGGTase) catalyzes the attachment of geranylgeranyl isoprenoids to Rab guanine triphosphatases, which are key regulators in vesicular transport.  Because geranylgeranylation is required for proper function and overexpression of Rabs has been obsd. in various cancers, RabGGTase may be a target for novel therapeutics.  The development of selective inhibitors is, however, difficult because two related enzymes involved in other cellular processes exist in eukaryotes and because RabGGTase recognizes protein substrates indirectly, resulting in relaxed specificity.  The authors report the synthesis of a peptidic library based on the farnesyl transferase inhibitor pepticinnamin E.  Of 469 compds. investigated, several were identified as selective for RabGGTase with low micromolar IC50 values.  The compds. were not generally cytotoxic and inhibited Rab isoprenylation in COS-7 cells.  Crystal structure anal. revealed that selective inhibitors interact with a tunnel unique to RabGGTase, implying that this structural motif is an attractive target for improved RabGGTase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql3mQReP6ZLrVg90H21EOLACvtfcHk0lirkumhvS4mdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksr%252FK&md5=2636eb9658d9c563bb46ca06dcc133a1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901117d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901117d%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.-T.%26aulast%3DGuiu-Rozas%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DDelon%26aufirst%3DC.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DArndt%26aufirst%3DS.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520peptide-based%2520Rab%2520geranylgeranyl%2520transferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8025%26epage%3D8037%26doi%3D10.1021%2Fjm901117d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span> </span><span class="NLM_article-title">Development of selective, potent RabGGTase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8330</span><span class="NLM_x">–</span> <span class="NLM_lpage">8340</span><span class="refDoi"> DOI: 10.1021/jm300624s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300624s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlags73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8330-8340&author=E.+A.+Stigterauthor=Z.+Guoauthor=R.+S.+Bonauthor=Y.-W.+Wuauthor=A.+Choidasauthor=A.+Wolfauthor=S.+Menningerauthor=H.+Waldmannauthor=W.+Blankenfeldtauthor=R.+S.+Goody&title=Development+of+selective%2C+potent+RabGGTase+inhibitors&doi=10.1021%2Fjm300624s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective, Potent RabGGTase Inhibitors</span></div><div class="casAuthors">Stigter, E. Anouk; Guo, Zhong; Bon, Robin S.; Wu, Yao-Wen; Choidas, Axel; Wolf, Alexander; Menninger, Sascha; Waldmann, Herbert; Blankenfeldt, Wulf; Goody, Roger S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8330-8340</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the Ras superfamily of small GTPases are frequently mutated in cancer.  Therefore, inhibitors have been developed to address the activity of these GTPases by inhibiting their prenylating enzymes FTase, GGTase I, and RabGGTase.  In contrast to FTase and GGTase I, only a handful of RabGGTase inhibitors have been developed.  The most active RabGGTase inhibitor known until recently was an FTase inhibitor which hit RabGGTase as an off-target.  We recently reported our efforts to tune the selectivity of these inhibitors toward RabGGTase.  Here we describe an extended set of selective inhibitors.  The requirements for selective RabGGTase inhibitors are described in detail, guided by multiple crystal structures.  In order to relate in vitro and cellular activity, a high-throughput assay system to detect the attachment of [3H]geranylgeranyl groups to Rab was used.  Selective RabGGTase inhibition allows the establishment of novel drug discovery programs aimed at the development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-15HKuegUrVg90H21EOLACvtfcHk0lirkumhvS4mdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlags73P&md5=022aa7d6b3f6321a379d20ff28f11513</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm300624s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300624s%26sid%3Dliteratum%253Aachs%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26atitle%3DDevelopment%2520of%2520selective%252C%2520potent%2520RabGGTase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8330%26epage%3D8340%26doi%3D10.1021%2Fjm300624s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Structure-guided development of selective RabGGTase inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4957</span><span class="NLM_x">–</span> <span class="NLM_lpage">4961</span><span class="refDoi"> DOI: 10.1002/anie.201101210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2Fanie.201101210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4957-4961&author=R.+S.+Bonauthor=Z.+Guoauthor=E.+A.+Stigterauthor=S.+Wetzelauthor=S.+Menningerauthor=A.+Wolfauthor=A.+Choidasauthor=K.+Alexandrovauthor=W.+Blankenfeldtauthor=R.+S.+Goodyauthor=H.+Waldmann&title=Structure-guided+development+of+selective+RabGGTase+inhibitors&doi=10.1002%2Fanie.201101210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201101210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201101210%26sid%3Dliteratum%253Aachs%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DStructure-guided%2520development%2520of%2520selective%2520RabGGTase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D4957%26epage%3D4961%26doi%3D10.1002%2Fanie.201101210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Deraeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiLucrezia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span> </span><span class="NLM_article-title">Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">7384</span><span class="NLM_x">–</span> <span class="NLM_lpage">7391</span><span class="refDoi"> DOI: 10.1021/ja211305j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja211305j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7384-7391&author=C.+Deraeveauthor=Z.+Guoauthor=R.+S.+Bonauthor=W.+Blankenfeldtauthor=R.+DiLucreziaauthor=A.+Wolfauthor=S.+Menningerauthor=E.+A.+Stigterauthor=S.+Wetzelauthor=A.+Choidasauthor=K.+Alexandrovauthor=H.+Waldmannauthor=R.+S.+Goodyauthor=Y.-W.+Wu&title=Psoromic+acid+is+a+selective+and+covalent+Rab-prenylation+inhibitor+targeting+autoinhibited+RabGGTase&doi=10.1021%2Fja211305j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Psoromic Acid is a Selective and Covalent Rab-Prenylation Inhibitor Targeting Autoinhibited RabGGTase</span></div><div class="casAuthors">Deraeve, Celine; Guo, Zhong; Bon, Robin S.; Blankenfeldt, Wulf; DiLucrezia, Raffaella; Wolf, Alexander; Menninger, Sascha; Stigter, E. Anouk; Wetzel, Stefan; Choidas, Axel; Alexandrov, Kirill; Waldmann, Herbert; Goody, Roger S.; Wu, Yao-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7384-7391</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Post-translational attachment of geranylgeranyl isoprenoids to Rab GTPases, the key organizers of intracellular vesicular transport, is essential for their function.  Rab geranylgeranyl transferase (RabGGTase) is responsible for prenylation of Rab proteins.  Recently, RabGGTase inhibitors have been proposed to be potential therapeutics for treatment of cancer and osteoporosis.  However, the development of RabGGTase selective inhibitors is complicated by its structural and functional similarity to other protein prenyltransferases.  Herein we report identification of the natural product psoromic acid (PA) that potently and selectively inhibits RabGGTase with an IC50 of 1.3 μM.  Structure-activity relationship anal. suggested a minimal structure involving the depsidone core with a 3-hydroxyl and 4-aldehyde motif for binding to RabGGTase.  Anal. of the crystal structure of the RabGGTase:PA complex revealed that PA forms largely hydrophobic interactions with the isoprenoid binding site of RabGGTase and that it attaches covalently to the N-terminus of the α subunit.  We found that in contrast to other protein prenyltransferases, RabGGTase is autoinhibited through N-terminal αHis2 coordination with the catalytic zinc ion.  Mutation of αHis dramatically enhances the reaction rate, indicating that the activity of RabGGTase is likely regulated in vivo.  The covalent binding of PA to the N-terminus of the RabGGTase α subunit seems to potentiate its interaction with the active site and explains the selectivity of PA for RabGGTase.  Therefore, psoromic acid provides a new starting point for the development of selective RabGGTase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppe_-HUfnkhbVg90H21EOLACvtfcHk0ljnJ8_HivL0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFGisr4%253D&md5=5542dd49f315b5feb0d547a96d658f30</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja211305j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja211305j%26sid%3Dliteratum%253Aachs%26aulast%3DDeraeve%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DDiLucrezia%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26atitle%3DPsoromic%2520acid%2520is%2520a%2520selective%2520and%2520covalent%2520Rab-prenylation%2520inhibitor%2520targeting%2520autoinhibited%2520RabGGTase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D7384%26epage%3D7391%26doi%3D10.1021%2Fja211305j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span> </span><span class="NLM_article-title">Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">6861</span><span class="NLM_x">–</span> <span class="NLM_lpage">6868</span><span class="refDoi"> DOI: 10.1074/jbc.M806952200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M806952200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=19074143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=6861-6868&author=R.+A.+Baronauthor=R.+Tavareauthor=A.+C.+Figueiredoauthor=K.+M.+B%C5%82a%C5%BCewskaauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=F.+H.+Ebetinoauthor=A.+Taylorauthor=M.+J.+Rogersauthor=F.+P.+Coxonauthor=M.+C.+Seabra&title=Phosphonocarboxylates+inhibit+the+second+geranylgeranyl+addition+by+Rab+geranylgeranyl+transferase&doi=10.1074%2Fjbc.M806952200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase</span></div><div class="casAuthors">Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.; Ebetino, Frank H.; Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.; Seabra, Miguel C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6861-6868</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Rab geranylgeranyl transferase (RGGT) catalyzes the post-translational geranylgeranyl (GG) modification of (usually) two C-terminal cysteines in Rab GTPases.  Here we studied the mechanism of the Rab geranylgeranylation reaction by bisphosphonate analogs in which one phosphonate group is replaced by a carboxylate (phosphonocarboxylate, PC).  The phosphonocarboxylates used were 3-PEHPC, which was previously reported, and 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid ((+)-3-IPEHPC), a >25-fold more potent related compd. as measured by both IC50 and Ki.  (+)-3-IPEHPC behaves as a mixed-type inhibitor with respect to GG pyrophosphate (GGPP) and an uncompetitive inhibitor with respect to Rab substrates.  We propose that phosphonocarboxylates prevent only the second GG transfer onto Rabs based on the following evidence.  First, geranylgeranylation of Rab proteins ending with a single cysteine motif such as CAAX, is not affected by the inhibitors, either in vitro or in vivo.  Second, the addn. of an -AAX sequence onto Rab-CC proteins protects the substrate from inhibition by the inhibitors.  Third, we demonstrate directly that in the presence of (+)-3-IPEHPC, Rab-CC and Rab-CXC proteins are modified by only a single GG addn.  The presence of (+)-3-IPEHPC resulted in a preference for the Rab N-terminal cysteine to be modified first, suggesting an order of cysteine geranylgeranylation in RGGT catalysis.  Our results further suggest that the inhibitor binds to a site distinct from the GGPP-binding site on RGGT.  We suggest that phosphonocarboxylate inhibitors bind to a GG-cysteine binding site adjacent to the active site, which is necessary to align the mono-GG-Rab for the second GG addn.  These inhibitors may represent a novel therapeutic approach in Rab-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxdjzU5KNkqLVg90H21EOLACvtfcHk0ljnJ8_HivL0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislWrurc%253D&md5=3ca6c13644b28cdf5c8f504ad2064833</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806952200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806952200%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DTavare%26aufirst%3DR.%26aulast%3DFigueiredo%26aufirst%3DA.%2BC.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26atitle%3DPhosphonocarboxylates%2520inhibit%2520the%2520second%2520geranylgeranyl%2520addition%2520by%2520Rab%2520geranylgeranyl%2520transferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D6861%26epage%3D6868%26doi%3D10.1074%2Fjbc.M806952200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard-Favier, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundy, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsten, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bala, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marma, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span> </span><span class="NLM_article-title">Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3454</span><span class="NLM_x">–</span> <span class="NLM_lpage">3464</span><span class="refDoi"> DOI: 10.1021/jm900232u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900232u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVahsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3454-3464&author=C.+E.+McKennaauthor=B.+A.+Kashemirovauthor=K.+M.+B%C5%82a%C5%BCewskaauthor=I.+Mallard-Favierauthor=C.+A.+Stewartauthor=J.+Rojasauthor=M.+W.+Lundyauthor=F.+H.+Ebetinoauthor=R.+A.+Baronauthor=J.+E.+Dunfordauthor=M.+L.+Kirstenauthor=M.+C.+Seabraauthor=J.+L.+Balaauthor=M.+S.+Marmaauthor=M.+J.+Rogersauthor=F.+P.+Coxon&title=Synthesis%2C+chiral+high+performance+liquid+chromatographic+resolution+and+enantiospecific+activity+of+a+potent+new+geranylgeranyl+transferase+inhibitor%2C+2-hydroxy-3-imidazo%5B1%2C2-a%5Dpyridin-3-yl-2-phosphonopropionic+acid&doi=10.1021%2Fjm900232u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Chiral High Performance Liquid Chromatographic Resolution and Enantiospecific Activity of a Potent New Geranylgeranyl Transferase Inhibitor, 2-Hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid</span></div><div class="casAuthors">McKenna, Charles E.; Kashemirov, Boris A.; Blazewska, Katarzyna M.; Mallard-Favier, Isabelle; Stewart, Charlotte A.; Rojas, Javier; Lundy, Mark W.; Ebetino, Frank H.; Baron, Rudi A.; Dunford, James E.; Kirsten, Marie L.; Seabra, Miguel C.; Bala, Joy L.; Marma, Mong S.; Rogers, Michael J.; Coxon, Fraser P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3454-3464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(3-Pyridyl)-2-hydroxy-2-phosphonopropanoic acid (3-PEHPC, I) is a phosphonocarboxylate (PC) analog of 2-(3-pyridyl)-1-hydroxyethylidenebis(phosphonic acid) (risedronic acid, II), an osteoporosis drug that decreases bone resorption by inhibiting farnesyl pyrophosphate synthase (FPPS) in osteoclasts, preventing protein prenylation.  I has lower bone affinity than II and weakly inhibits Rab geranylgeranyl transferase (RGGT), selectively preventing prenylation of Rab GTPases.  Herein is reported the synthesis and biol. studies of 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid (3-IPEHPC, III), the PC analog of minodronic acid IV.  Like I, III selectively inhibited Rab11 vs. Rap 1A prenylation in J774 cells, and decreased cell viability, but was 33-60× more active in these assays.  After resolving III by chiral HPLC (>98% ee), it was found that (+)-III-E1 was much more potent than (-)-III-E2 in an isolated RGGT inhibition assay, ∼17× more potent (LED 3 μM) than (-)-III-E2 in inhibiting Rab prenylation in J774 cells and >26× more active in the cell viability assay.  The enantiomers of I exhibited a 4-fold or smaller potency difference in the RGGT and prenylation inhibition assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQ1Lns8200bVg90H21EOLACvtfcHk0ljnJ8_HivL0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVahsrw%253D&md5=d9b22461df25e9f061aac6c5503790ad</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900232u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900232u%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DMallard-Favier%26aufirst%3DI.%26aulast%3DStewart%26aufirst%3DC.%2BA.%26aulast%3DRojas%26aufirst%3DJ.%26aulast%3DLundy%26aufirst%3DM.%2BW.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DKirsten%26aufirst%3DM.%2BL.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DBala%26aufirst%3DJ.%2BL.%26aulast%3DMarma%26aufirst%3DM.%2BS.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26atitle%3DSynthesis%252C%2520chiral%2520high%2520performance%2520liquid%2520chromatographic%2520resolution%2520and%2520enantiospecific%2520activity%2520of%2520a%2520potent%2520new%2520geranylgeranyl%2520transferase%2520inhibitor%252C%25202-hydroxy-3-imidazo%255B1%252C2-a%255Dpyridin-3-yl-2-phosphonopropionic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3454%26epage%3D3464%26doi%3D10.1021%2Fjm900232u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haiges, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry and SAR of a series of minodronate analogues as RGGT inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4826</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.04.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2011.04.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4820-4826&author=K.+M.+B%C5%82a%C5%BCewskaauthor=F.+Niauthor=R.+Haigesauthor=B.+A.+Kashemirovauthor=F.+P.+Coxonauthor=C.+A.+Stewartauthor=R.+Baronauthor=M.+J.+Rogersauthor=M.+C.+Seabraauthor=F.+H.+Ebetinoauthor=C.+E.+McKenna&title=Synthesis%2C+stereochemistry+and+SAR+of+a+series+of+minodronate+analogues+as+RGGT+inhibitors&doi=10.1016%2Fj.ejmech.2011.04.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.063%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DNi%26aufirst%3DF.%26aulast%3DHaiges%26aufirst%3DR.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DStewart%26aufirst%3DC.%2BA.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%252C%2520stereochemistry%2520and%2520SAR%2520of%2520a%2520series%2520of%2520minodronate%2520analogues%2520as%2520RGGT%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4820%26epage%3D4826%26doi%3D10.1016%2Fj.ejmech.2011.04.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najumudeen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oetken-Lindholm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Way, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abankwa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.06.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2014.06.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25016230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=77-89&author=F.+P.+Coxonauthor=L.+Joachimiakauthor=A.+K.+Najumudeenauthor=G.+Breenauthor=J.+Gmachauthor=C.+Oetken-Lindholmauthor=R.+Wayauthor=J.+E.+Dunfordauthor=D.+Abankwaauthor=K.+M.+B%C5%82a%C5%BCewska&title=Synthesis+and+characterization+of+novel+phosphonocarboxylate+inhibitors+of+RGGT&doi=10.1016%2Fj.ejmech.2014.06.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT</span></div><div class="casAuthors">Coxon, Fraser P.; Joachimiak, Lukasz; Najumudeen, Arafath Kaja; Breen, George; Gmach, Joanna; Oetken-Lindholm, Christina; Way, Rebecca; Dunford, James E.; Abankwa, Daniel; Blazewska, Katarzyna M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-89</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphonocarboxylate (PC) analogs of the anti-osteoporotic drugs, bisphosphonates, represent the first class of selective inhibitors of Rab geranylgeranyl transferase (RabGGTase, RGGT), an enzyme implicated in several diseases including ovarian, breast and skin cancer.  Here we present the synthesis and biol. characterization of an extended set of this class of compds., including lipophilic derivs. of the known RGGT inhibitors.  From this new panel of PCs, we have identified an inhibitor of RGGT that is of similar potency as the most active published phosphonocarboxylate, but of higher selectivity towards this enzyme compared to prenyl pyrophosphate synthases.  New insights into structural requirements are also presented, showing that only PC analogs of the most potent 3rd generation bisphosphonates inhibit RGGT.  In addn., the first phosphonocarboxylate-derived GGPPS inhibitor is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHuQvk6JcRLVg90H21EOLACvtfcHk0lglfCb8dGDAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKktLfK&md5=6e3e4a74d8887fa2619d678bae5e8327</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.06.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.06.062%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DJoachimiak%26aufirst%3DL.%26aulast%3DNajumudeen%26aufirst%3DA.%2BK.%26aulast%3DBreen%26aufirst%3DG.%26aulast%3DGmach%26aufirst%3DJ.%26aulast%3DOetken-Lindholm%26aufirst%3DC.%26aulast%3DWay%26aufirst%3DR.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DAbankwa%26aufirst%3DD.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520novel%2520phosphonocarboxylate%2520inhibitors%2520of%2520RGGT%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D77%26epage%3D89%26doi%3D10.1016%2Fj.ejmech.2014.06.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holstein, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, D. F.</span><span> </span><span class="NLM_article-title">N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.bmcl.2015.04.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2331-2334&author=X.+Zhouauthor=E.+J.+Bornauthor=C.+Allenauthor=S.+A.+Holsteinauthor=D.+F.+Wiemer&title=N-Oxide+derivatives+of+3-%283-pyridyl%29-2-phosphonopropanoic+acids+as+potential+inhibitors+of+Rab+geranylgeranylation&doi=10.1016%2Fj.bmcl.2015.04.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DBorn%26aufirst%3DE.%2BJ.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DHolstein%26aufirst%3DS.%2BA.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DN-Oxide%2520derivatives%2520of%25203-%25283-pyridyl%2529-2-phosphonopropanoic%2520acids%2520as%2520potential%2520inhibitors%2520of%2520Rab%2520geranylgeranylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2331%26epage%3D2334%26doi%3D10.1016%2Fj.bmcl.2015.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues Poveda, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkamala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Pacanowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jm801023u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801023u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=976-988&author=Y.+Songauthor=F.-Y.+Linauthor=F.+Yinauthor=M.+Henslerauthor=C.+A.+Rodrigues+Povedaauthor=D.+Mukkamalaauthor=R.+Caoauthor=H.+Wangauthor=C.+T.+Moritaauthor=D.+Gonzalez+Pacanowskaauthor=V.+Nizetauthor=E.+Oldfield&title=Phosphonosulfonates+are+potent%2C+selective+inhibitors+of+dehydrosqualene+synthase+and+staphyloxanthin+biosynthesis+in+Staphylococcus+aureus&doi=10.1021%2Fjm801023u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801023u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801023u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.-Y.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DRodrigues%2BPoveda%26aufirst%3DC.%2BA.%26aulast%3DMukkamala%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DC.%2BT.%26aulast%3DGonzalez%2BPacanowska%26aufirst%3DD.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DPhosphonosulfonates%2520are%2520potent%252C%2520selective%2520inhibitors%2520of%2520dehydrosqualene%2520synthase%2520and%2520staphyloxanthin%2520biosynthesis%2520in%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjm801023u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">The synthesis of phosphinic acid analogues (<b>1s</b>, <b>2s</b>, <b>1t</b>, <b>2t</b>) involved prior synthesis of phosphinates (<b>6s</b>, <b>6t</b>) from P(III) precursors (for details, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Matviiuk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lherbet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorichko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitenko, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltas, M.</span><span> </span><span class="NLM_article-title">Synthesis of 3-heteroaryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2013.10.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=46-52&author=T.+Matviiukauthor=G.+Moriauthor=C.+Lherbetauthor=F.+Rodriguezauthor=M.+R.+Pascaauthor=M.+Gorichkoauthor=B.+Guidettiauthor=Z.+Voitenkoauthor=M.+Baltas&title=Synthesis+of+3-heteroaryl+substituted+pyrrolidine-2%2C5-diones+via+catalytic+Michael+reaction+and+evaluation+of+their+inhibitory+activity+against+InhA+and+Mycobacterium+tuberculosis&doi=10.1016%2Fj.ejmech.2013.10.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DMatviiuk%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DLherbet%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DF.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DGorichko%26aufirst%3DM.%26aulast%3DGuidetti%26aufirst%3DB.%26aulast%3DVoitenko%26aufirst%3DZ.%26aulast%3DBaltas%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25203-heteroaryl%2520substituted%2520pyrrolidine-2%252C5-diones%2520via%2520catalytic%2520Michael%2520reaction%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520activity%2520against%2520InhA%2520and%2520Mycobacterium%2520tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D71%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.ejmech.2013.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.bmc.2006.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=17049248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=403-412&author=M.+Hayakawaauthor=H.+Kaizawaauthor=K.-i.+Kawaguchiauthor=N.+Ishikawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.-i.+Tsukamotoauthor=F.+I.+Raynaudauthor=M.+D.+Waterfieldauthor=P.+Parkerauthor=P.+Workman&title=Synthesis+and+biological+evaluation+of+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors&doi=10.1016%2Fj.bmc.2006.09.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors</span></div><div class="casAuthors">Hayakawa, Masahiko; Kaizawa, Hiroyuki; Kawaguchi, Ken-ichi; Ishikawa, Noriko; Koizumi, Tomonobu; Ohishi, Takahide; Yamano, Mayumi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi; Raynaud, Florence I.; Waterfield, Michael D.; Parker, Peter; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">403-412</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">3-{1-[(4-Fluorophenyl)sulfonyl]-1H-pyrazol-3-yl}-2-methylimidazo[1,2-a]pyridine, 2a, was discovered in our chem. library as a novel p110α inhibitor with an IC50 of 0.67 μM, through screening in a scintillation proximity assay.  Optimization of the substituents of 2a increased the p110α inhibitory activity by more than 300-fold (2g: IC50 = 0.0018 μM).  Further structural modification of 2g afforded thiazole deriv. 12 (I), which has potent p110α inhibitory activity (IC50 of 0.0028 μM) and is highly selective for p110α over other PI3K isoforms.  Compd. 12 also inhibited serum-induced cell proliferation of A375 and HeLa cells in vitro with IC50 values of 0.14 μM and 0.21 μM, resp., and suppressed tumor growth by 37% in a mouse HeLa xenograft model when dosed i.p. at 25 mg/kg.  These results suggest that selective p110α inhibitors may have potential as cancer therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtD0faWirHM7Vg90H21EOLACvtfcHk0liuqbjmU-O--w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cmt77L&md5=775c2f4e69fd565d13df597610ec44dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DK.-i.%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D403%26epage%3D412%26doi%3D10.1016%2Fj.bmc.2006.09.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Enguehard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thery, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauvelle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">(Hetero)arylation of 6-halogenoimidazo[1,2-a]pyridines differently substituted at C(2): influence of the 2-substituent on the Suzuki cross-coupling reaction</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">3610</span><span class="NLM_x">–</span> <span class="NLM_lpage">3615</span><span class="refDoi"> DOI: 10.1002/1522-2675(20011219)84:12<3610::AID-HLCA3610>3.0.CO;2-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2001&pages=3610-3615&author=C.+Enguehardauthor=M.+Hervetauthor=I.+Theryauthor=J.-L.+Renouauthor=F.+Fauvelleauthor=A.+Gueiffier&title=%28Hetero%29arylation+of+6-halogenoimidazo%5B1%2C2-a%5Dpyridines+differently+substituted+at+C%282%29%3A+influence+of+the+2-substituent+on+the+Suzuki+cross-coupling+reaction&doi=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1522-2675%252820011219%252984%253A12%253C3610%253A%253AAID-HLCA3610%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard%26aufirst%3DC.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DThery%26aufirst%3DI.%26aulast%3DRenou%26aufirst%3DJ.-L.%26aulast%3DFauvelle%26aufirst%3DF.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3D%2528Hetero%2529arylation%2520of%25206-halogenoimidazo%255B1%252C2-a%255Dpyridines%2520differently%2520substituted%2520at%2520C%25282%2529%253A%2520influence%2520of%2520the%25202-substituent%2520on%2520the%2520Suzuki%2520cross-coupling%2520reaction%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2001%26volume%3D84%26spage%3D3610%26epage%3D3615%26doi%3D10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span><span class="refDoi"> DOI: 10.1021/jm101405t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101405t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1365-1378&author=S.+Sasakiauthor=S.+Kitamuraauthor=N.+Negoroauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=N.+Suzukiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Haradaauthor=Y.+Tanakaauthor=M.+Kobayashiauthor=N.+Tadaauthor=M.+Funamiauthor=T.+Tanakaauthor=Y.+Yamamotoauthor=K.+Fukatsuauthor=T.+Yasumaauthor=Y.+Momose&title=Design%2C+synthesis%2C+and+biological+activity+of+potent+and+orally+available+G+protein-coupled+receptor+40+agonists&doi=10.1021%2Fjm101405t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm101405t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101405t%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520potent%2520and%2520orally%2520available%2520G%2520protein-coupled%2520receptor%252040%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1365%26epage%3D1378%26doi%3D10.1021%2Fjm101405t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Maegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udzu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bora, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sajiki, H.</span><span> </span><span class="NLM_article-title">Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki–Miyaura coupling reactions in aqueous media</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5937</span><span class="NLM_x">–</span> <span class="NLM_lpage">5943</span><span class="refDoi"> DOI: 10.1002/chem.200601795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2Fchem.200601795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=17444548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVShsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5937-5943&author=T.+Maegawaauthor=Y.+Kitamuraauthor=S.+Sakoauthor=T.+Udzuauthor=A.+Sakuraiauthor=A.+Tanakaauthor=Y.+Kobayashiauthor=K.+Endoauthor=U.+Boraauthor=T.+Kuritaauthor=A.+Kozakiauthor=Y.+Monguchiauthor=H.+Sajiki&title=Heterogeneous+Pd%2FC-catalyzed+ligand-free%2C+room-temperature+Suzuki%E2%80%93Miyaura+coupling+reactions+in+aqueous+media&doi=10.1002%2Fchem.200601795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki-Miyaura coupling reactions in aqueous media</span></div><div class="casAuthors">Maegawa, Tomohiro; Kitamura, Yoshiaki; Sako, Satoko; Udzu, Takahiro; Sakurai, Ai; Tanaka, Asami; Kobayashi, Yusuke; Endo, Koichi; Bora, Utpal; Kurita, Takanori; Kozaki, Atsushi; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5937-5943</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A mild and efficient ligand-free Suzuki-Miyaura coupling reaction catalyzed by heterogeneous Pd/C was developed.  Aryl bromides and triflates undergo the cross-coupling with aryl boronic acids in excellent yields without the presence of any additives in aq. media at room temp.  (Arylvinyl)boronic acids are also applicable to this coupling reaction and provide the trans-stilbene derivs. in high yields.  The application of wet-type Pd/C to the coupling reaction was achieved without any loss of activity under aerobic conditions, and the reuse of Pd/C is feasible for a fifth run without significant loss of activity.  Inductively coupled plasma (ICP) mass-spectrometric anal. of the filtrate from the reaction mixt. of 4-bromonitrobenzene with phenylboronic acid demonstrated that the palladium metal hardly leached into the soln. within the limits of the detector (< 1 ppm), thus suggesting that the present Suzuki-Miyaura reaction proceeded by heterogeneous catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_7xlhOb_DnrVg90H21EOLACvtfcHk0lhyFECnxUVP-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVShsbw%253D&md5=94183aadfac6c97edaeeec4fd22571ad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchem.200601795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200601795%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DSako%26aufirst%3DS.%26aulast%3DUdzu%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DBora%26aufirst%3DU.%26aulast%3DKurita%26aufirst%3DT.%26aulast%3DKozaki%26aufirst%3DA.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DHeterogeneous%2520Pd%252FC-catalyzed%2520ligand-free%252C%2520room-temperature%2520Suzuki%25E2%2580%2593Miyaura%2520coupling%2520reactions%2520in%2520aqueous%2520media%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2007%26volume%3D13%26spage%3D5937%26epage%3D5943%26doi%3D10.1002%2Fchem.200601795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Katayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitarai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span> </span><span class="NLM_article-title">Isolation of intermediary anti-aldol adducts of the Horner-Wadsworth-Emmons reaction utilizing direct titanium-aldol addition and Successive Bronsted acid promoted stereoselective elimination leading to (Z)-α,β-unsaturated esters</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">0129</span><span class="NLM_x">–</span> <span class="NLM_lpage">0132</span><span class="refDoi"> DOI: 10.1055/s-2005-922787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1055%2Fs-2005-922787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=0129-0132&author=M.+Katayamaauthor=R.+Nagaseauthor=K.+Mitaraiauthor=T.+Misakiauthor=Y.+Tanabe&title=Isolation+of+intermediary+anti-aldol+adducts+of+the+Horner-Wadsworth-Emmons+reaction+utilizing+direct+titanium-aldol+addition+and+Successive+Bronsted+acid+promoted+stereoselective+elimination+leading+to+%28Z%29-%CE%B1%2C%CE%B2-unsaturated+esters&doi=10.1055%2Fs-2005-922787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-922787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-922787%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DM.%26aulast%3DNagase%26aufirst%3DR.%26aulast%3DMitarai%26aufirst%3DK.%26aulast%3DMisaki%26aufirst%3DT.%26aulast%3DTanabe%26aufirst%3DY.%26atitle%3DIsolation%2520of%2520intermediary%2520anti-aldol%2520adducts%2520of%2520the%2520Horner-Wadsworth-Emmons%2520reaction%2520utilizing%2520direct%2520titanium-aldol%2520addition%2520and%2520Successive%2520Bronsted%2520acid%2520promoted%2520stereoselective%2520elimination%2520leading%2520to%2520%2528Z%2529-%25CE%25B1%252C%25CE%25B2-unsaturated%2520esters%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D0129%26epage%3D0132%26doi%3D10.1055%2Fs-2005-922787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">This strategy also worked for condensation of nicotinaldehyde with triethyl phosphonoacetate, showing applicability of this method also to pyridine analogues. Reduction of thus obtained compound leads to desoxy analogue of the first RGGT inhibitor, compound 3-PEHPC.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Misra, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhaduri, A. P.</span><span> </span><span class="NLM_article-title">In search of imidazo[1,2-a]pyridine derivatives exhibiting resistance for catalytic hydrogenation</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3236</span><span class="refDoi"> DOI: 10.1080/00397919908085948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F00397919908085948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=3227-3236&author=A.+P.+Misraauthor=K.+Rajauthor=A.+P.+Bhaduri&title=In+search+of+imidazo%5B1%2C2-a%5Dpyridine+derivatives+exhibiting+resistance+for+catalytic+hydrogenation&doi=10.1080%2F00397919908085948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In search of imidazo[1,2-a]pyridine derivatives exhibiting resistance for catalytic hydrogenation</span></div><div class="casAuthors">Misra, Anju P.; Raj, K.; Bhaduri, A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3227-3236</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Effect of substituents on the pyridine ring of imidazo[1,2-a]pyridine derivs. have been studied to ascertain the structural requirement for offering resistance towards catalytic hydrogenation of the title compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGramQlhMmesZrVg90H21EOLACvtfcHk0lhyFECnxUVP-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFChs7c%253D&md5=2f9c76d9be307cab4c08d0d728393602</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919908085948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919908085948%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DA.%2BP.%26aulast%3DRaj%26aufirst%3DK.%26aulast%3DBhaduri%26aufirst%3DA.%2BP.%26atitle%3DIn%2520search%2520of%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520exhibiting%2520resistance%2520for%2520catalytic%2520hydrogenation%26jtitle%3DSynth.%2520Commun.%26date%3D1999%26volume%3D29%26spage%3D3227%26epage%3D3236%26doi%3D10.1080%2F00397919908085948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">In two out of twenty cases (<b>9k</b>, <b>9p</b>), yields were ∼35%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lin, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Schutter, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghuis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3201</span><span class="NLM_x">–</span> <span class="NLM_lpage">3215</span><span class="refDoi"> DOI: 10.1021/jm201657x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201657x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Srtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3201-3215&author=Y.-S.+Linauthor=J.+Parkauthor=J.+W.+De+Schutterauthor=X.+F.+Huangauthor=A.+M.+Berghuisauthor=M.+Sebagauthor=Y.+S.+Tsantrizos&title=Design+and+synthesis+of+active+site+inhibitors+of+the+human+farnesyl+pyrophosphate+synthase%3A+apoptosis+and+inhibition+of+ERK+phosphorylation+in+multiple+myeloma+cells&doi=10.1021%2Fjm201657x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells</span></div><div class="casAuthors">Lin, Yih-Shyan; Park, Jaeok; De Schutter, Joris W.; Huang, Xian Fang; Berghuis, Albert M.; Sebag, Michael; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3201-3215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of N-BPs inhibitors I and II (R1, R3 = thienyl, Ph, naphthyl, pyridinyl, substituted Ph, pyrazolyl, etc.; R2 = H, F; X = CH, N; Y = CH2, NH) of human farnesyl pyrophosphate synthase (hFPPS) was designed that interact with a larger portion of the GPP subpocket, as compared to the current therapeutic drugs, and rigidify the 364KRRK367 tail of hFPPS in the closed conformation in the absence of IPP.  The compds. I (Y = CH2) were prepd. by reaction of the corresponding bromo-3-chloromethylpyridines with methylenediphosphonate CH2[PO(OEt)2]2 with subsequent optional fluorination with N-fluoro-N-(phenylsulfonyl)benzenesulfonamide, and Suzuki coupling with boronates R1B(OH)2 or R1Bpin; the aminophosphonates (I, Y = NH, II) were prepd. by reaction of the corresponding bromo-2-pyridinamine or bromoaniline with di-Et phosphonate with subsequent Suzuki coupling.  The resulting diphosphonate tetraesters were hydrolyzed to free acids and tested for inhibition of the hFPPS.  Human farnesyl pyrophosphate synthase (hFPPS) controls intracellular levels of FPP and post-translational prenylation of small GTPase proteins, which are essential for cell signaling and cell proliferation.  Clin. investigations provide evidence that N-BP inhibitors of hFPPS are disease modifying agents that improve survival of multiple myeloma (MM) patients via mechanisms unrelated to their skeletal effects.  An analog of this series was used to demonstrate inhibition of the intended biol. target, resulting in apoptosis and down-regulation of ERK phosphorylation in human MM cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_8acK6CKzzrVg90H21EOLACvtfcHk0ljMuIwqNcwvTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Srtro%253D&md5=ff5aafd5c764169176133928e94c3551</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm201657x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201657x%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BF.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520active%2520site%2520inhibitors%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%253A%2520apoptosis%2520and%2520inhibition%2520of%2520ERK%2520phosphorylation%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3201%26epage%3D3215%26doi%3D10.1021%2Fjm201657x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">In four out of thirty three cases (<b>2k</b>, <b>2i</b>, <b>2d</b>, <b>1r</b>), yields were in the range 27–45%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Paolini, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Aromaticity in heterocyclic systems. IV. Substitution reactions of imidazo [1,2-a]pyridine and related methyl derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span><span class="refDoi"> DOI: 10.1021/jo01023a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01023a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=4085-4090&author=J.+P.+Paoliniauthor=R.+K.+Robins&title=Aromaticity+in+heterocyclic+systems.+IV.+Substitution+reactions+of+imidazo+%5B1%2C2-a%5Dpyridine+and+related+methyl+derivatives&doi=10.1021%2Fjo01023a024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo01023a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01023a024%26sid%3Dliteratum%253Aachs%26aulast%3DPaolini%26aufirst%3DJ.%2BP.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DAromaticity%2520in%2520heterocyclic%2520systems.%2520IV.%2520Substitution%2520reactions%2520of%2520imidazo%2520%255B1%252C2-a%255Dpyridine%2520and%2520related%2520methyl%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D4085%26epage%3D4090%26doi%3D10.1021%2Fjo01023a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Enguehard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6575</span><span class="refDoi"> DOI: 10.1021/jo000698z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000698z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlCisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6572-6575&author=C.+Enguehardauthor=J.-L.+Renouauthor=V.+Collotauthor=M.+Hervetauthor=S.+Raultauthor=A.+Gueiffier&title=Reactivity+of+3-iodoimidazo%5B1%2C2-a%5Dpyridines+using+a+Suzuki-type+cross-coupling+reaction&doi=10.1021%2Fjo000698z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reaction</span></div><div class="casAuthors">Enguehard, Cecile; Renou, Jean-Louis; Collot, Valerie; Hervet, Maud; Rault, Sylvain; Gueiffier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6572-6575</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influence of base and solvent in Suzuki cross-coupling reaction of various 2-substituted-3-iodoimidazo[1,2-a]pyridines I (R1 = H, Me; R2 = H, Me, Me3C, EtO2C, Ph, 4-FC6H4) with boronic acids R3B(OH)2 (R3 = Me, Ph, 2-thienyl, 3-thienyl) providing imidazopyridines II was reported.  The reactivity was largely influenced by the nature of the substituents.  Optimized yields and shortened times of reaction were obtained using strong bases in DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjoH37Xzg6LVg90H21EOLACvtfcHk0ljMuIwqNcwvTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlCisbk%253D&md5=a19d17da72256f93571fb7e16fa5a04e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo000698z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000698z%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard%26aufirst%3DC.%26aulast%3DRenou%26aufirst%3DJ.-L.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3DReactivity%2520of%25203-iodoimidazo%255B1%252C2-a%255Dpyridines%2520using%2520a%2520Suzuki-type%2520cross-coupling%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D6572%26epage%3D6575%26doi%3D10.1021%2Fjo000698z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Laemmerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, W.</span><span> </span><span class="NLM_article-title">Quinine and quinidine derivatives as chiral selectors. I. Brush type chiral stationary phases for high-performance liquid chromatography based on cinchonan carbamates and their application as chiral anion exchangers</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">741</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/0021-9673(96)00137-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2F0021-9673%2896%2900137-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=741&publication_year=1996&pages=33-48&author=M.+Laemmerhoferauthor=W.+Lindner&title=Quinine+and+quinidine+derivatives+as+chiral+selectors.+I.+Brush+type+chiral+stationary+phases+for+high-performance+liquid+chromatography+based+on+cinchonan+carbamates+and+their+application+as+chiral+anion+exchangers&doi=10.1016%2F0021-9673%2896%2900137-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0021-9673%2896%2900137-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9673%252896%252900137-9%26sid%3Dliteratum%253Aachs%26aulast%3DLaemmerhofer%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DW.%26atitle%3DQuinine%2520and%2520quinidine%2520derivatives%2520as%2520chiral%2520selectors.%2520I.%2520Brush%2520type%2520chiral%2520stationary%2520phases%2520for%2520high-performance%2520liquid%2520chromatography%2520based%2520on%2520cinchonan%2520carbamates%2520and%2520their%2520application%2520as%2520chiral%2520anion%2520exchangers%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D1996%26volume%3D741%26spage%3D33%26epage%3D48%26doi%3D10.1016%2F0021-9673%2896%2900137-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dudakovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonnahme, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1124/jpet.107.132217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1124%2Fjpet.107.132217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=18083912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=1028-1036&author=A.+Dudakovicauthor=A.+J.+Wiemerauthor=K.+M.+Lambauthor=L.+A.+Vonnahmeauthor=S.+E.+Dietzauthor=R.+J.+Hohl&title=Inhibition+of+geranylgeranyl+diphosphate+synthase+induces+apoptosis+through+multiple+mechanisms+and+displays+synergy+with+inhibition+of+other+isoprenoid+biosynthetic+enzymes&doi=10.1124%2Fjpet.107.132217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes</span></div><div class="casAuthors">Dudakovic, Amel; Wiemer, Andrew J.; Lamb, Kimberly M.; Vonnahme, Laura A.; Dietz, Sara E.; Hohl, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1028-1036</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitors of isoprenoid synthesis are widely used for treatment of human diseases, including hypercholesterolemia and osteoporosis, and they have the potential to be useful for treatment of cancer.  Statin drugs inhibit the enzyme HMG-CoA reductase, whereas nitrogenous bisphosphonates have more recently been shown to inhibit farnesyl disphosphate synthase.  In addn., our lab. has recently developed several potent and specific bisphosphonate inhibitors of geranylgeranyl diphosphate synthase, including digeranyl bisphosphonate.  Because all three enzymes fall in the same biosynthetic pathway and many of the biol. effects are due to depletion of downstream products, we hypothesized that simultaneous inhibition of these enzymes would result in synergistic growth inhibition.  In this study, we show that inhibition of geranylgeranyl diphosphate synthase induces apoptosis in K562 leukemia cells.  This induction of apoptosis is in part dependent upon both geranylgeranyl diphosphate depletion and accumulation of farnesyl diphosphate.  Combinations of either lovastatin or zoledronate with digeranyl bisphosphonate synergistically inhibited growth and induced apoptosis.  These combinations also potently inhibited cellular geranylgeranylation.  These results support the potential for combinations of multiple inhibitors of isoprene biosynthesis to inhibit cancer cell growth or metastasis at clin. achievable concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNp7BB_fJ-srVg90H21EOLACvtfcHk0liXvavMhEBNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajs7c%253D&md5=a74030eb704b2bf2fb5fe44cd668eee8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.132217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.132217%26sid%3Dliteratum%253Aachs%26aulast%3DDudakovic%26aufirst%3DA.%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26aulast%3DLamb%26aufirst%3DK.%2BM.%26aulast%3DVonnahme%26aufirst%3DL.%2BA.%26aulast%3DDietz%26aufirst%3DS.%2BE.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520geranylgeranyl%2520diphosphate%2520synthase%2520induces%2520apoptosis%2520through%2520multiple%2520mechanisms%2520and%2520displays%2520synergy%2520with%2520inhibition%2520of%2520other%2520isoprenoid%2520biosynthetic%2520enzymes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D1028%26epage%3D1036%26doi%3D10.1124%2Fjpet.107.132217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Wiemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, D. F.</span><span> </span><span class="NLM_article-title">The intermediate enzymes of isoprenoid metabolism as anticancer targets</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.2174/187152009788451860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.2174%2F187152009788451860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=526-542&author=A.+J.+Wiemerauthor=R.+J.+Hohlauthor=D.+F.+Wiemer&title=The+intermediate+enzymes+of+isoprenoid+metabolism+as+anticancer+targets&doi=10.2174%2F187152009788451860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F187152009788451860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152009788451860%26sid%3Dliteratum%253Aachs%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DThe%2520intermediate%2520enzymes%2520of%2520isoprenoid%2520metabolism%2520as%2520anticancer%2520targets%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D526%26epage%3D542%26doi%3D10.2174%2F187152009788451860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ehrick, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puleo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachas, L. G.</span><span> </span><span class="NLM_article-title">Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1021/bc700196q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700196q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=315-321&author=R.+S.+Ehrickauthor=M.+Capaccioauthor=D.+A.+Puleoauthor=L.+G.+Bachas&title=Ligand-modified+aminobisphosphonate+for+linking+proteins+to+hydroxyapatite+and+bone+surface&doi=10.1021%2Fbc700196q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Modified Aminobisphosphonate for Linking Proteins to Hydroxyapatite and Bone Surface</span></div><div class="casAuthors">Ehrick, Robin S.; Capaccio, Marcello; Puleo, David A.; Bachas, Leonidas G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An increase in bone resorption is one of the main symptoms of osteoporosis, a disease that affects more and more individuals every day.  Bisphosphonates are known to inhibit bone resorption and thus are being used as a treatment for osteoporosis.  Aminobisphosphonates present a functionality that can be easily used for conjugation to other mols., such as peptides, proteins, and ligands for protein recognition.  In this study, an aminobisphosphonate conjugated with biotin was used as a model linker for protein attachment to bone.  With this system, the interaction of biotinylated aminobisphosphonate with hydroxyapatite, a major mineral component of bone, was investigated.  Quantification of the binding of aminobisphosphonate to hydroxyapatite was performed using a fluorescently labeled antibody for biotin.  Addnl., the interaction of the biotinylated aminobisphosphonate with multiple treatments of cortical bone from the mid-shaft of a cow femur was studied.  It was demonstrated that modified aminobisphosphonate reagents can bind hydroxyapatite and bone at high levels, while the biotin functionality is free to be recognized by the fluorescently labeled antibiotin antibody, suggesting that modified aminobisphosphonates could be used to link other peptides or proteins to the bone surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX4nV2KZRrTLVg90H21EOLACvtfcHk0liXvavMhEBNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjE&md5=b342469f717686b32b5d5be6b0f9dfd0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbc700196q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700196q%26sid%3Dliteratum%253Aachs%26aulast%3DEhrick%26aufirst%3DR.%2BS.%26aulast%3DCapaccio%26aufirst%3DM.%26aulast%3DPuleo%26aufirst%3DD.%2BA.%26aulast%3DBachas%26aufirst%3DL.%2BG.%26atitle%3DLigand-modified%2520aminobisphosphonate%2520for%2520linking%2520proteins%2520to%2520hydroxyapatite%2520and%2520bone%2520surface%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D315%26epage%3D321%26doi%3D10.1021%2Fbc700196q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Marma, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triffitt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of α-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5967</span><span class="NLM_x">–</span> <span class="NLM_lpage">5975</span><span class="refDoi"> DOI: 10.1021/jm0702884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0702884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5967-5975&author=M.+S.+Marmaauthor=Z.+Xiaauthor=C.+Stewartauthor=F.+Coxonauthor=J.+E.+Dunfordauthor=R.+Baronauthor=B.+A.+Kashemirovauthor=F.+H.+Ebetinoauthor=J.+T.+Triffittauthor=R.+G.+G.+Russellauthor=C.+E.+McKenna&title=Synthesis+and+biological+evaluation+of+%CE%B1-halogenated+bisphosphonate+and+phosphonocarboxylate+analogues+of+risedronate&doi=10.1021%2Fjm0702884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0702884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0702884%26sid%3Dliteratum%253Aachs%26aulast%3DMarma%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DStewart%26aufirst%3DC.%26aulast%3DCoxon%26aufirst%3DF.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%25CE%25B1-halogenated%2520bisphosphonate%2520and%2520phosphonocarboxylate%2520analogues%2520of%2520risedronate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5967%26epage%3D5975%26doi%3D10.1021%2Fjm0702884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Palsuledesai, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochocki, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowski, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M. D.</span><span> </span><span class="NLM_article-title">A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1039/C3MB70593E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1039%2FC3MB70593E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=24577581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1094-1103&author=C.+C.+Palsuledesaiauthor=J.+D.+Ochockiauthor=T.+W.+Markowskiauthor=M.+D.+Distefano&title=A+combination+of+metabolic+labeling+and+2D-DIGE+analysis+in+response+to+a+farnesyltransferase+inhibitor+facilitates+the+discovery+of+new+prenylated+proteins&doi=10.1039%2FC3MB70593E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins</span></div><div class="casAuthors">Palsuledesai, Charuta C.; Ochocki, Joshua D.; Markowski, Todd W.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein prenylation is a post-translational modification required for proper cellular localization and activity of many important eukaryotic proteins.  Farnesyltransferase inhibitors (FTIs) have been explored extensively for their antitumor activity.  To assist in identifying potentially new and more useful markers for therapeutic applications, we developed a strategy that uses a combination of metabolic labeling and 2D DIGE (differential gel electrophoresis) to discover new prenylated proteins whose cellular levels are influenced by FTIs.  In this approach, metabolic labeling of prenylated proteins was first carried out with an alkyne-modified isoprenoid analog, C15Alk, in the presence or absence of the FTI L-744,832.  The resulting alkyne-tagged proteins were then labeled with Cy3-N3 and Cy5-N3 and subjected to 2D-DIGE.  Multiple spots having altered levels of labeling in presence of the FTI were obsd.  Mass spectrometric anal. of some of the differentially labeled spots identified several known prenylated proteins, along with HisRS, PACN-3, GNAI-1 and GNAI-2, which are not known to be prenylated.  In vitro farnesylation of a C-terminal peptide sequence derived from GNAI-1 and GNAI-2 produced a farnesylated product, suggesting GNAI-1 and GNAI-2 are potential novel farnesylated proteins.  These results suggest that this new strategy could be useful for the identification of prenylated proteins whose level of post-translational modification has been modulated by the presence of an FTI.  Addnl., this approach, which decreases sample complexity and thereby facilitates anal., should be applicable to studies of other post-translational modifications as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHeFeK67Hx7Vg90H21EOLACvtfcHk0lgjHRKSNhgXtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlyksLw%253D&md5=cc624951893bdad5204484e1337869bb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC3MB70593E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MB70593E%26sid%3Dliteratum%253Aachs%26aulast%3DPalsuledesai%26aufirst%3DC.%2BC.%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DMarkowski%26aufirst%3DT.%2BW.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DA%2520combination%2520of%2520metabolic%2520labeling%2520and%25202D-DIGE%2520analysis%2520in%2520response%2520to%2520a%2520farnesyltransferase%2520inhibitor%2520facilitates%2520the%2520discovery%2520of%2520new%2520prenylated%2520proteins%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D1094%26epage%3D1103%26doi%3D10.1039%2FC3MB70593E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lgjHRKSNhgXtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerutti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lgjHRKSNhgXtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gmach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huben, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span> </span><span class="NLM_article-title">α-Fluoro phosphonocarboxylates: the NMR analysis of the heteronuclear ABMX spin system</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span><span class="refDoi"> DOI: 10.1080/10426507.2014.909427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F10426507.2014.909427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&pages=1216-1225&author=J.+Gmachauthor=K.+Hubenauthor=K.+M.+B%C5%82a%C5%BCewska&title=%CE%B1-Fluoro+phosphonocarboxylates%3A+the+NMR+analysis+of+the+heteronuclear+ABMX+spin+system&doi=10.1080%2F10426507.2014.909427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">α-Fluoro Phosphonocarboxylates: the NMR Analysis of the Heteronuclear ABMX Spin System</span></div><div class="casAuthors">Gmach, Joanna; Huben, Krzysztof; Blazewska, Katarzyna M.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1216-1225</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1563-5325</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The α-fluoro phosphonocarboxylate analogs of bisphosphonates have recently received attention due to their activity against Rab geranylgeranyl transferase, an enzyme implicated in a no. of disease conditions.  Most of the NMR data reported in the literature describing dialkyl α-fluorophosphonates are defined as first-order spectra.  Here, we report a second-order pattern obsd. in 19F NMR spectrum, being a part of heteronuclear ABMX spin system.  Such a spin system, CH2C(F)P, was subjected to NMR anal. supported by iteration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XA7B26U-f7Vg90H21EOLACvtfcHk0lj6RlbSSzB3FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWju7zN&md5=f31cd0752fe43659a09e60fd3665036f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F10426507.2014.909427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426507.2014.909427%26sid%3Dliteratum%253Aachs%26aulast%3DGmach%26aufirst%3DJ.%26aulast%3DHuben%26aufirst%3DK.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26atitle%3D%25CE%25B1-Fluoro%2520phosphonocarboxylates%253A%2520the%2520NMR%2520analysis%2520of%2520the%2520heteronuclear%2520ABMX%2520spin%2520system%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem.%26date%3D2014%26volume%3D189%26spage%3D1216%26epage%3D1225%26doi%3D10.1080%2F10426507.2014.909427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':[],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':[],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Edyta Gendaszewska-Darmach, Malgorzata A. Garstka, <span class="NLM_string-name hlFld-ContribAuthor">Katarzyna M. Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Small GTPases and Their Prenylation in Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9677-9710. <a href="https://doi.org/10.1021/acs.jmedchem.1c00410" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00410%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSmall%252BGTPases%252Band%252BTheir%252BPrenylation%252Bin%252BDiabetes%252BMellitus%26aulast%3DGendaszewska-Darmach%26aufirst%3DEdyta%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07032021%26date%3D08072021%26volume%3D64%26issue%3D14%26spage%3D9677%26epage%3D9710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Rojek</span>, <span class="hlFld-ContribAuthor ">Matthew R  Tucker</span>, <span class="hlFld-ContribAuthor ">Sara C  Pinto</span>, <span class="hlFld-ContribAuthor ">Michał  Rychłowski</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Lichocka</span>, <span class="hlFld-ContribAuthor ">Hana  Soukupova</span>, <span class="hlFld-ContribAuthor ">Julita  Nowakowska</span>, <span class="hlFld-ContribAuthor ">Jerzy  Bohdanowicz</span>, <span class="hlFld-ContribAuthor ">Gabriela  Surmacz</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Gutkowska</span>, . </span><span class="cited-content_cbyCitation_article-title">Rab-dependent vesicular traffic affects female gametophyte development in Arabidopsis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Botany</span><span> <strong>2021,</strong> <em>72 </em>
                                    (2)
                                     , 320-340. <a href="https://doi.org/10.1093/jxb/eraa430" title="DOI URL">https://doi.org/10.1093/jxb/eraa430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jxb/eraa430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjxb%2Feraa430%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Botany%26atitle%3DRab-dependent%252Bvesicular%252Btraffic%252Baffects%252Bfemale%252Bgametophyte%252Bdevelopment%252Bin%252BArabidopsis%26aulast%3DRojek%26aufirst%3DJoanna%26date%3D2021%26date%3D2020%26volume%3D72%26issue%3D2%26spage%3D320%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Kusy</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Marchwicka</span>, <span class="hlFld-ContribAuthor ">Joanna  Małolepsza</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Justyna</span>, <span class="hlFld-ContribAuthor ">Edyta  Gendaszewska-Darmach</span>, <span class="hlFld-ContribAuthor ">Katarzyna Magdalena  Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the 6-Substituted Imidazo[1,2-a]Pyridine-3-yl-2- Phosphonopropionic Acids as Potential Inhibitors of Rab Geranylgeranyl Transferase. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.596162" title="DOI URL">https://doi.org/10.3389/fchem.2020.596162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.596162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.596162%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252B6-Substituted%252BImidazo%25255B1%25252C2-a%25255DPyridine-3-yl-2-%252BPhosphonopropionic%252BAcids%252Bas%252BPotential%252BInhibitors%252Bof%252BRab%252BGeranylgeranyl%252BTransferase%26aulast%3DKusy%26aufirst%3DDamian%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Bing  Hu</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">FeCl3-catalyzed C-3 functionalization of imidazo[1,2-a]pyridines with diazoacetonitrile under oxidant- and ligand-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (16)
                                     , 151774. <a href="https://doi.org/10.1016/j.tetlet.2020.151774" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151774%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFeCl3-catalyzed%252BC-3%252Bfunctionalization%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%252Bwith%252Bdiazoacetonitrile%252Bunder%252Boxidant-%252Band%252Bligand-free%252Bconditions%26aulast%3DChen%26aufirst%3DGuang%26date%3D2020%26volume%3D61%26issue%3D16%26spage%3D151774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dattatraya A.  Babar</span>, <span class="hlFld-ContribAuthor ">Haridas B.  Rode</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt-Catalyzed Direct Arylation of Imidazo[1,2-
              a
              ]pyridine with Aryl Iodides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (12)
                                     , 1823-1827. <a href="https://doi.org/10.1002/ejoc.202000006" title="DOI URL">https://doi.org/10.1002/ejoc.202000006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCobalt-Catalyzed%252BDirect%252BArylation%252Bof%252BImidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridine%252Bwith%252BAryl%252BIodides%26aulast%3DBabar%26aufirst%3DDattatraya%2BA.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D12%26spage%3D1823%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Nana  Shen</span>, <span class="hlFld-ContribAuthor ">Yujie  Yang</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of naphtho[1′,2′:4,5]imidazo[1,2-
              a
              ]pyridines
              via
              Rh(
              iii
              )-catalyzed C–H functionalization of 2-arylimidazo[1,2-
              a
              ]pyridines with cyclic 2-diazo-1,3-diketones featuring with a ring opening and reannulation. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (7)
                                     , 919-925. <a href="https://doi.org/10.1039/D0QO00073F" title="DOI URL">https://doi.org/10.1039/D0QO00073F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00073F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00073F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Bof%252Bnaphtho%25255B1%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A4%25252C5%25255Dimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bvia%252BRh%252528%252Biii%252B%252529-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252B2-arylimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bwith%252Bcyclic%252B2-diazo-1%25252C3-diketones%252Bfeaturing%252Bwith%252Ba%252Bring%252Bopening%252Band%252Breannulation%26aulast%3DLi%26aufirst%3DBin%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D7%26spage%3D919%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Justyna</span>, <span class="hlFld-ContribAuthor ">Joanna  Małolepsza</span>, <span class="hlFld-ContribAuthor ">Damian  Kusy</span>, <span class="hlFld-ContribAuthor ">Waldemar  Maniukiewicz</span>, <span class="hlFld-ContribAuthor ">Katarzyna M  Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">The McKenna reaction – avoiding side reactions in phosphonate deprotection. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 1436-1446. <a href="https://doi.org/10.3762/bjoc.16.119" title="DOI URL">https://doi.org/10.3762/bjoc.16.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.119%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThe%252BMcKenna%252Breaction%252B%2525E2%252580%252593%252Bavoiding%252Bside%252Breactions%252Bin%252Bphosphonate%252Bdeprotection%26aulast%3DJustyna%26aufirst%3DKatarzyna%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D1436%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Kusy</span>, <span class="hlFld-ContribAuthor ">Agata  Wojciechowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Małolepsza</span>, <span class="hlFld-ContribAuthor ">Katarzyna M  Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of the imidazo[1,2-
              a
              ]pyridine ring in α-phosphonoacrylates and α-phosphonopropionates via microwave-assisted Mizoroki–Heck reaction. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 15-21. <a href="https://doi.org/10.3762/bjoc.16.3" title="DOI URL">https://doi.org/10.3762/bjoc.16.3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.3%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFunctionalization%252Bof%252Bthe%252Bimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridine%252Bring%252Bin%252B%2525CE%2525B1-phosphonoacrylates%252Band%252B%2525CE%2525B1-phosphonopropionates%252Bvia%252Bmicrowave-assisted%252BMizoroki%2525E2%252580%252593Heck%252Breaction%26aulast%3DKusy%26aufirst%3DDamian%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazmul H.  Bhuiyan</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Varney</span>, <span class="hlFld-ContribAuthor ">David F.  Wiemer</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Holstein</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzimidazole phosphonates as potential inhibitors of protein prenylation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (24)
                                     , 126757. <a href="https://doi.org/10.1016/j.bmcl.2019.126757" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126757%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bbenzimidazole%252Bphosphonates%252Bas%252Bpotential%252Binhibitors%252Bof%252Bprotein%252Bprenylation%26aulast%3DBhuiyan%26aufirst%3DNazmul%2BH.%26date%3D2019%26volume%3D29%26issue%3D24%26spage%3D126757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Kusy</span>, <span class="hlFld-ContribAuthor ">Waldemar  Maniukiewicz</span>, <span class="hlFld-ContribAuthor ">Katarzyna M.  Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of 3-formyl substituted imidazo[1,2-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (45)
                                     , 151244. <a href="https://doi.org/10.1016/j.tetlet.2019.151244" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151244%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252B3-formyl%252Bsubstituted%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%26aulast%3DKusy%26aufirst%3DDamian%26date%3D2019%26volume%3D60%26issue%3D45%26spage%3D151244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah A.  Holstein</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of bisphosphonates in treating bone disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (5)
                                     , 315-325. <a href="https://doi.org/10.1080/13543776.2019.1608180" title="DOI URL">https://doi.org/10.1080/13543776.2019.1608180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1608180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1608180%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bbisphosphonates%252Bin%252Btreating%252Bbone%252Bdisease%26aulast%3DHolstein%26aufirst%3DSarah%2BA.%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D5%26spage%3D315%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajaa  Boulahjar</span>, <span class="hlFld-ContribAuthor ">Angela  Rincon Arias</span>, <span class="hlFld-ContribAuthor ">Raphaël  Bolteau</span>, <span class="hlFld-ContribAuthor ">Nicolas  Renault</span>, <span class="hlFld-ContribAuthor ">Mathilde  Coevoet</span>, <span class="hlFld-ContribAuthor ">Amélie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Romain  Duroux</span>, <span class="hlFld-ContribAuthor ">Saïd  Yous</span>, <span class="hlFld-ContribAuthor ">Patricia  Melnyk</span>, <span class="hlFld-ContribAuthor ">Laurence  Agouridas</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3296-3307. <a href="https://doi.org/10.1016/j.bmc.2018.04.057" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B2%25252C6-disubstituted-8-amino%252Bimidazo%25255B1%25252C2a%25255Dpyridines%25252C%252Ba%252Bpromising%252Bprivileged%252Bstructure%26aulast%3DBoulahjar%26aufirst%3DRajaa%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3296%26epage%3D3307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Łukasz  Joachimiak</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Marchwicka</span>, <span class="hlFld-ContribAuthor ">Edyta  Gendaszewska-Darmach</span>, <span class="hlFld-ContribAuthor ">Katarzyna M.  Błażewska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Imidazole-Bearing α-Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (8)
                                     , 842-851. <a href="https://doi.org/10.1002/cmdc.201700791" title="DOI URL">https://doi.org/10.1002/cmdc.201700791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700791%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BImidazole-Bearing%252B%2525CE%2525B1-Phosphonocarboxylates%252Bas%252BInhibitors%252Bof%252BRab%252BGeranylgeranyl%252BTransferase%252B%252528RGGT%252529%26aulast%3DJoachimiak%26aufirst%3D%25C5%2581ukasz%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D8%26spage%3D842%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Isoprenoid biosynthesis pathway. NBP, nitrogen-containing bisphosphonates; FPPS, farnesyl pyrophosphate synthase; GGPPS, geranylgeranyl pyrophosphate synthase; FT, farnesyl transferase; GGT-1, geranylgeranyl transferase 1; FPP, farnesyl pyrophosphate; GPP, geranyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; RGGT, Rab geranylgeranyl transferase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of studied compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Two Strategies Used for the Synthesis of Phosphonocarboxylates, Presented on the Example of 3-IPEHPC Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triethyl phosphonoacetate, TiCl<sub>4</sub>, TEA, DCM, −20 °C to rt; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, −40 °C; (c) <b>7</b>, 1,4-dioxane, AlCl<sub>3</sub> (cat), reflux; (d) NFSI, BuLi, THF, −70 °C/20 min, −20 °C/1 h; (e) 12 M HCl, reflux.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Starting materials for the synthesis of target compounds representing: (a) heterocycle and aromatic part; (b) phosphonoacetate and phosphinoacetate derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of 6-substituted analogues of 3-IPEHPC (<b>1f</b>–<b>i</b>) on Rab11A and Rap1A/Rap1B prenylation in HeLa cells. Cells were treated for 48 h with the indicated concentrations of PCs (μM) and 10 μM lovastatin (Lov) acting as a positive control in serum-free medium. Subsequently, cells were lysed and fractionated into cytosolic and membrane-rich fractions. Cytosolic fractions containing unprenylated proteins were Western blotted for Rab11A, Rap1A/Rap1B, and β-actin (A), and the immunoblot bands were quantified by densitometry analysis, normalized to β-actin, and displayed as a percentage of controls (B). Data represented mean ± SEM from at least three independent experiments, *<i>p</i> ≤ 0.05, **<i>p</i> ≤ 0.01, ***<i>p</i> ≤ 0.001, and ****<i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/medium/jm-2017-00811t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Example of the binding interactions of the novel RGGT inhibitors suggested by docking simulations. The phosphonic and the carboxylic acid groups guide the novel RGGT inhibitors to the close proximity of the catalytic zinc ion and several amino acids with hydrogen bonding ability (K235B, D238B, Y241B, and K105A). In the binding of compound <b>1c</b> (purple) and compound <b>1g</b> (turquoise), K105A has a crucial role. When a methyl group is added to position 2 (compound <b>1c</b>), this substitution prevents K105A from forming a hydrogen bond to the carboxylic acid, weakening the binding (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The black dashed lines indicate interactions between the inhibitor and the protein. Used atom colors: C in compounds <b>1c</b> and <b>1g</b> are in purple and in turquoise, respectively. O = red, N = blue, P = orange, S = yellow, F = bright green, Zn = dark green, Br = burgundy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00811/20171103/images/large/jm-2017-00811t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00811&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i140">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horgan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, M. W.</span><span> </span><span class="NLM_article-title">Rab11 proteins in health and disease</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1360</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span><span class="refDoi"> DOI: 10.1042/BST20120157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1042%2FBST20120157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=23176481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1360-1367&author=E.+E.+Kellyauthor=C.+P.+Horganauthor=M.+W.+McCaffrey&title=Rab11+proteins+in+health+and+disease&doi=10.1042%2FBST20120157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Rab11 proteins in health and disease</span></div><div class="casAuthors">Kelly, Eoin E.; Horgan, Conor P.; McCaffrey, Mary W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1360-1367</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Comprising over 60 members, Rab proteins constitute the largest branch of the Ras superfamily of low-mol.-mass G-proteins.  This protein family have been primarily implicated in various aspects of intracellular membrane trafficking processes.  On the basis of distinct subfamily-specific sequence motifs, many Rabs have been grouped into subfamilies.  The Rab11 GTPase subfamily comprises three members: Rab11a, Rab11b and Rab25/Rab11c, which, between them, have been demonstrated to bind more than 30 proteins.  In the present paper, we review the function of the Rab11 subfamily.  We describe their localization and primary functional roles within the cell and their implication, to date, in disease processes.  We also summarize the protein machinery currently known to regulate or mediate their functions and the cargo mols. which they have been shown to transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5LDt09iGeObVg90H21EOLACvtfcHk0ljO1hfAoLde4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rJ&md5=1f6861370670e4bd2b62e3ff9b48f4ff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2FBST20120157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120157%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DHorgan%26aufirst%3DC.%2BP.%26aulast%3DMcCaffrey%26aufirst%3DM.%2BW.%26atitle%3DRab11%2520proteins%2520in%2520health%2520and%2520disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D1360%26epage%3D1367%26doi%3D10.1042%2FBST20120157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horgan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, M. W.</span><span> </span><span class="NLM_article-title">The Rab family of proteins: 25 years on</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span><span class="refDoi"> DOI: 10.1042/BST20120203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1042%2FBST20120203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=23176478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1337-1347&author=E.+E.+Kellyauthor=C.+P.+Horganauthor=B.+Goudauthor=M.+W.+McCaffrey&title=The+Rab+family+of+proteins%3A+25+years+on&doi=10.1042%2FBST20120203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Rab family of proteins: 25 years on</span></div><div class="casAuthors">Kelly, Eoin E.; Horgan, Conor P.; Goud, Bruno; McCaffrey, Mary W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1337-1347</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Intracellular membrane trafficking requires the complex interplay of several classes of trafficking proteins.  Rab proteins, the largest subfamily of the Ras superfamily of small G-proteins, are central regulators of all aspects of intracellular trafficking processes including vesicle budding and uncoating, motility, tethering and fusion.  In the present paper, we discuss the discovery, evolution and characterization of the Rab GTPase family.  We examine their basic functional roles, their important structural features and the regulatory proteins which mediate Rab function.  We speculate on outstanding issues in the field, such as the mechanisms of Rab membrane assocn. and the coordinated interplay between distinct Rab proteins.  Finally, we summarize the data implicating Rab proteins in an ever increasing no. of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRB5KbuTZEbVg90H21EOLACvtfcHk0ljO1hfAoLde4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgt7rO&md5=28c8f5276044ca8fbaabd3d8a31984be</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2FBST20120203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20120203%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DHorgan%26aufirst%3DC.%2BP.%26aulast%3DGoud%26aufirst%3DB.%26aulast%3DMcCaffrey%26aufirst%3DM.%2BW.%26atitle%3DThe%2520Rab%2520family%2520of%2520proteins%253A%252025%2520years%2520on%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D1337%26epage%3D1347%26doi%3D10.1042%2FBST20120203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Guichard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, E.</span><span> </span><span class="NLM_article-title">RAB11-mediated trafficking in host-pathogen interactions</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1038/nrmicro3325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1038%2Fnrmicro3325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25118884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGnt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=624-634&author=A.+Guichardauthor=V.+Nizetauthor=E.+Bier&title=RAB11-mediated+trafficking+in+host-pathogen+interactions&doi=10.1038%2Fnrmicro3325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">RAB11-mediated trafficking in host-pathogen interactions</span></div><div class="casAuthors">Guichard, Annabel; Nizet, Victor; Bier, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">624-634</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many bacterial and viral pathogens block or subvert host cellular processes to promote successful infection.  One host protein that is targeted by invading pathogens is the small GTPase RAB11, which functions in vesicular trafficking.  RAB11 functions in conjunction with a protein complex known as the exocyst to mediate terminal steps in cargo transport via the recycling endosome to cell-cell junctions, phagosomes and cellular protrusions.  These processes contribute to host innate immunity by promoting epithelial and endothelial barrier integrity, sensing and immobilizing pathogens and repairing pathogen-induced cellular damage.  In this Review, the various mechanisms that pathogens have evolved to disrupt or subvert RAB11-dependent pathways as part of their infection strategy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGml76nTbLbVg90H21EOLACvtfcHk0lgimWBkV9rbdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGnt7vL&md5=b83b00706cbbdbd692c3888da30bbd86</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3325%26sid%3Dliteratum%253Aachs%26aulast%3DGuichard%26aufirst%3DA.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DBier%26aufirst%3DE.%26atitle%3DRAB11-mediated%2520trafficking%2520in%2520host-pathogen%2520interactions%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D624%26epage%3D634%26doi%3D10.1038%2Fnrmicro3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hendrix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braems, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Broecke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Belle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocquyt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gespach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahl, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wever, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbroek, W.</span><span> </span><span class="NLM_article-title">Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span><span class="refDoi"> DOI: 10.1093/jnci/djq153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1093%2Fjnci%2Fdjq153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=20484105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVyju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=866-880&author=A.+Hendrixauthor=D.+Maynardauthor=P.+Pauwelsauthor=G.+Braemsauthor=H.+Denysauthor=R.+Van+den+Broeckeauthor=J.+Lambertauthor=S.+Van+Belleauthor=V.+Cocquytauthor=C.+Gespachauthor=M.+Brackeauthor=M.+C.+Seabraauthor=W.+A.+Gahlauthor=O.+De+Weverauthor=W.+Westbroek&title=Effect+of+the+secretory+small+GTPase+Rab27B+on+breast+cancer+growth%2C+invasion%2C+and+metastasis&doi=10.1093%2Fjnci%2Fdjq153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Secretory Small GTPase Rab27B on Breast Cancer Growth, Invasion, and Metastasis</span></div><div class="casAuthors">Hendrix, An; Maynard, Dawn; Pauwels, Patrick; Braems, Geert; Denys, Hannelore; Van den Broecke, Rudy; Lambert, Jo; Van Belle, Simon; Cocquyt, Veronique; Gespach, Christian; Bracke, Marc; Seabra, Miguel C.; Gahl, William A.; De Wever, Olivier; Westbroek, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">866-880</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Secretory GTPases like Rab27B control vesicle exocytosis and deliver crit. proinvasive growth regulators into the tumor microenvironment.  The expression and role of Rab27B in breast cancer were unknown.  Expression of green fluorescent protein (GFP) fused with wild-type Rab3D, Rab27A, or Rab27B, or Rab27B point mutants defective in GTP/GDP binding or geranylgeranylation, or transient silencing RNA to the same proteins was used to study Rab27B in estrogen receptor (ER)-pos. human breast cancer cell lines (MCF-7, T47D, and ZR75.1).  Cell cycle progression was evaluated by flow cytometry, western blotting, and measurement of cell proliferation rates, and invasion was assessed using Matrigel and native type I collagen substrates.  Orthotopic tumor growth, local invasion, and metastasis were analyzed in mouse xenograft models.  Mass spectrometry identified proinvasive growth regulators that were secreted in the presence of Rab27B.  Rab27B protein levels were evaluated by immunohistochem. in 59 clin. breast cancer specimens, and Rab3D, Rab27A, and Rab27B mRNA levels were analyzed by quant. real-time polymerase chain reaction in 20 specimens.  Statistical tests were two-sided.  Results Increased expression of Rab27B promoted G1 to S phase cell cycle transition, proliferation and invasiveness of cells in culture, and invasive tumor growth and hemorrhagic ascites prodn. in a xenograft mouse model (n = 10; at 10 wk, survival of MCF-7 GFP- vs GFP-Rab27B-injected mice was 100% vs 62.5%, hazard ratio = 0.26, 95% confidence interval = 0.08 to 0.88, P = .03).  Mass spectrometric anal. of purified Rab27B-secretory vesicles identified heat-shock protein 90α as key proinvasive growth regulator.  Heat-shock protein 90α secretion was Rab27B-dependent and was required for matrix metalloproteinase-2 activation.  All Rab27B-mediated functional responses were GTP- and geranylgeranyl-dependent.  Presence of endogenous Rab27B mRNA and protein, but not of Rab3D or Rab27A mRNA, was assocd. with lymph node metastasis (P < .001) and differentiation grade (P = .001) in ER-pos. human breast tumors.  Rab27B regulates invasive growth and metastasis in ER-pos. breast cancer cell lines, and increased expression is assocd. with poor prognosis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoygLI7rTFMhLVg90H21EOLACvtfcHk0lgimWBkV9rbdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVyju7o%253D&md5=ae8305e2c4198eb4e9bf9450713deba7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq153%26sid%3Dliteratum%253Aachs%26aulast%3DHendrix%26aufirst%3DA.%26aulast%3DMaynard%26aufirst%3DD.%26aulast%3DPauwels%26aufirst%3DP.%26aulast%3DBraems%26aufirst%3DG.%26aulast%3DDenys%26aufirst%3DH.%26aulast%3DVan%2Bden%2BBroecke%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DJ.%26aulast%3DVan%2BBelle%26aufirst%3DS.%26aulast%3DCocquyt%26aufirst%3DV.%26aulast%3DGespach%26aufirst%3DC.%26aulast%3DBracke%26aufirst%3DM.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DGahl%26aufirst%3DW.%2BA.%26aulast%3DDe%2BWever%26aufirst%3DO.%26aulast%3DWestbroek%26aufirst%3DW.%26atitle%3DEffect%2520of%2520the%2520secretory%2520small%2520GTPase%2520Rab27B%2520on%2520breast%2520cancer%2520growth%252C%2520invasion%252C%2520and%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D866%26epage%3D880%26doi%3D10.1093%2Fjnci%2Fdjq153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Rab GTPases implicated in inherited and acquired disorders</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.semcdb.2010.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.semcdb.2010.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=57-68&author=S.+Mitraauthor=K.+W.+Chengauthor=G.+B.+Mills&title=Rab+GTPases+implicated+in+inherited+and+acquired+disorders&doi=10.1016%2Fj.semcdb.2010.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%2BW.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DRab%2520GTPases%2520implicated%2520in%2520inherited%2520and%2520acquired%2520disorders%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2011%26volume%3D22%26spage%3D57%26epage%3D68%26doi%3D10.1016%2Fj.semcdb.2010.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamshidiha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon-Hogg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cota, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, E. W.</span><span> </span><span class="NLM_article-title">Direct targeting of the Ras GTPase superfamily through structure-based design</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.2174/1568026616666160719165633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.2174%2F1568026616666160719165633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=27530972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCmtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=16-29&author=W.+Zhaoauthor=M.+Jamshidihaauthor=T.+Lanyon-Hoggauthor=C.+Recchiauthor=E.+Cotaauthor=E.+W.+Tate&title=Direct+targeting+of+the+Ras+GTPase+superfamily+through+structure-based+design&doi=10.2174%2F1568026616666160719165633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design</span></div><div class="casAuthors">Zhao, Wenye; Jamshidiha, Mostafa; Lanyon-Hogg, Thomas; Recchi, Chiara; Cota, Ernesto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-29</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Ras superfamily of small monomeric GTPases includes some of the most prominent cancer targets for which no selective therapeutic agent has yet been successfully developed.  The turn of the millennium saw a resurgence of efforts to target these enzymes using new and improved biophys. techniques to overcome the perceived difficulties of insurmountably high affinity for guanosine nucleotides and flat, flexible topol. lacking suitable pockets for small mol. inhibitors.  Further, recent investigations have begun to probe the dynamic conformational status of GTP-bound Ras, opening up new mechanisms of inhibition.  While much of the literature has focused on the oncogenic Ras proteins, particularly K-Ras, these represent only a small minority of therapeutically interesting targets within the superfamily; for example, the Rab GTPases are the largest subfamily of about 70 members, and present an as yet untapped class of potential targets.  The present review documents the key methodologies employed to date in structure-guided attempts to drug the Ras GTPases, and forecasts their transferability to other similarly challenging proteins in the superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJkXDfx0frFrVg90H21EOLACvtfcHk0lgn78IE9TG7Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCmtb3K&md5=67305c36018cae000541586de8143875</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160719165633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160719165633%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DJamshidiha%26aufirst%3DM.%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DRecchi%26aufirst%3DC.%26aulast%3DCota%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDirect%2520targeting%2520of%2520the%2520Ras%2520GTPase%2520superfamily%2520through%2520structure-based%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D16%26epage%3D29%26doi%3D10.2174%2F1568026616666160719165633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bhuin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, J. K.</span><span> </span><span class="NLM_article-title">Rab11 in disease progression</span> <span class="citation_source-journal">Int. J. Mol. Cell. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25815277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A280%3ADC%252BC2MnosVSmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=1-8&author=T.+Bhuinauthor=J.+K.+Roy&title=Rab11+in+disease+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rab11 in disease progression</span></div><div class="casAuthors">Bhuin Tanmay; Roy Jagat Kumar</div><div class="citationInfo"><span class="NLM_cas:title">International journal of molecular and cellular medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>
        ISSN:<span class="NLM_cas:issn">2251-9637</span>.
    </div><div class="casAbstract">Membrane/protein trafficking in the secretory/biosynthetic and endocytic pathways is mediated by vesicles.  Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases: the Rab protein family.  Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular signalling pathways.  Rab11 (a subfamily of the Ypt/Rab gene family), an evolutionarily conserved ubiquitously expressed subfamily of Rab GTPases, has been implicated in regulating vesicular trafficking through the recycling of endosomes.  Rabs have been grouped into different subfamilies based on the distinct unambiguous sequence motifs.  Three members: Rab11a, Rab11b and Rab25 make up the Rab11 GTPase subfamily.  In this review article, we describe an overview over Rab11 subfamily with a brief structural aspect and its roles in implicating different disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnCExm7n-9QeRS7coPn-RtfW6udTcc2eb_WaEs6UVMF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnosVSmtg%253D%253D&md5=0c1a878c9295cc9c4b019bf0e4b61b92</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhuin%26aufirst%3DT.%26aulast%3DRoy%26aufirst%3DJ.%2BK.%26atitle%3DRab11%2520in%2520disease%2520progression%26jtitle%3DInt.%2520J.%2520Mol.%2520Cell.%2520Med.%26date%3D2015%26volume%3D4%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingyoji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takiguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, M.</span><span> </span><span class="NLM_article-title">Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1517</span><span class="refDoi"> DOI: 10.1038/cddis.2014.475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1038%2Fcddis.2014.475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25393473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1517&author=S.+Okamotoauthor=Y.+Jiangauthor=K.+Kawamuraauthor=M.+Shingyojiauthor=Y.+Tadaauthor=I.+Sekineauthor=Y.+Takiguchiauthor=K.+Tatsumiauthor=H.+Kobayashiauthor=H.+Shimadaauthor=K.+Hiroshimaauthor=M.+Tagawa&title=Zoledronic+acid+induces+apoptosis+and+S-phase+arrest+in+mesothelioma+through+inhibiting+Rab+family+proteins+and+topoisomerase+II+actions&doi=10.1038%2Fcddis.2014.475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions</span></div><div class="casAuthors">Okamoto, S.; Jiang, Y.; Kawamura, K.; Shingyoji, M.; Tada, Y.; Sekine, I.; Takiguchi, Y.; Tatsumi, K.; Kobayashi, H.; Shimada, H.; Hiroshima, K.; Tagawa, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1517</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Zoledronic acid (ZOL), a nitrogen-contg. bisphosphonate, produced anti-tumor effects through apoptosis induction or S-phase arrest depending on human mesothelioma cells tested.  An addn. of isoprenoid, geranylgeraniol but not farnesol, negated these ZOL-induced effects, indicating that the ZOL-mediated effects were attributable to depletion of geranylgeranyl pyrophosphates which were substrates for prenylation processes of small guanine-nucleotide-binding regulatory proteins (small G proteins).  ZOL-treated cells decreased a ratio of membrane to cytoplasmic fractions in RhoA, Cdc42 and Rab6 but less significantly Rac1 proteins, indicating that these proteins were possible targets for ZOL-induced actions.  We further analyzed which small G proteins were responsible for the three ZOL-induced effects, caspase-mediated apoptosis, S-phase arrest and morphol. changes, using inhibitors for resp. small G proteins and siRNA for Cdc42.  ZOL-induced apoptosis is due to insufficient prenylation of Rab proteins because an inhibitor of geranlygeranyl transferase II that was specific for Rab family proteins prenylation, but not others inhibitors, activated the same apoptotic pathways that ZOL did.  ZOL suppressed an endogenous topoisomerase II activity, which was assocd. with apoptosis and S-phase arrest in resp. cells because we detected the same cell cycle changes in etoposide-treated cells.  Inhibitors for geranlygeranyl transferase I and for RhoA produced morphol. changes and disrupted actin fiber structures, both of which were similar to those by ZOL treatments.  These data demonstrated that anti-tumor effects by ZOL were attributable to inhibited functions of resp. small G proteins and topoisomerase II activity, and suggested that cellular factors were involved in the differential cell cycle changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1V4pcnt-Xr7Vg90H21EOLACvtfcHk0lghB2FMFCUvgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7%252FM&md5=58d19666aee80a93af63ffec9c373602</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.475%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DShingyoji%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DSekine%26aufirst%3DI.%26aulast%3DTakiguchi%26aufirst%3DY.%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DHiroshima%26aufirst%3DK.%26aulast%3DTagawa%26aufirst%3DM.%26atitle%3DZoledronic%2520acid%2520induces%2520apoptosis%2520and%2520S-phase%2520arrest%2520in%2520mesothelioma%2520through%2520inhibiting%2520Rab%2520family%2520proteins%2520and%2520topoisomerase%2520II%2520actions%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1517%26doi%3D10.1038%2Fcddis.2014.475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurczyluk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tnimov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlos, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1080/21541248.2015.1085485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F21541248.2015.1085485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=26399387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=202-211&author=N.+Aliauthor=J.+Jurczylukauthor=G.+Shayauthor=Z.+Tnimovauthor=K.+Alexandrovauthor=M.+A.+Munozauthor=O.+P.+Skinnerauthor=N.+J.+Pavlosauthor=M.+J.+Rogers&title=A+highly+sensitive+prenylation+assay+reveals+in+vivo+effects+of+bisphosphonate+drug+on+the+Rab+prenylome+of+macrophages+outside+the+skeleton&doi=10.1080%2F21541248.2015.1085485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton</span></div><div class="casAuthors">Ali, Naveid; Jurczyluk, Julie; Shay, Gemma; Tnimov, Zakir; Alexandrov, Kirill; Munoz, Marcia A.; Skinner, Oliver P.; Pavlos, Nathan J.; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-211</span>CODEN:
                <span class="NLM_cas:coden">SGMTBK</span>;
        ISSN:<span class="NLM_cas:issn">2154-1256</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Bisphosphonate drugs such as zoledronic acid (ZOL), used for the treatment of common bone disorders, target the skeleton and inhibit bone resorption by preventing the prenylation of small GTPases in bone-destroying osteoclasts.  Increasing evidence indicates that bisphosphonates also have pleiotropic effects outside the skeleton, most likely via cells of the monocyte/macrophage lineage exposed to nanomolar circulating drug concns.  However, no effects of such low concns. of ZOL have been reported using existing approaches.  We have optimized a highly sensitive in vitro prenylation assay utilizing recombinant geranylgeranyltransferases to enable the detection of subtle effects of ZOL on the prenylation of Rab- and Rho-family GTPases.  Using this assay, we found for the first time that concns. of ZOL as low as 10nM caused inhibition of Rab prenylation in J774 macrophages following prolonged cell culture.  By combining the assay with quant. mass spectrometry we identified an accumulation of 18 different unprenylated Rab proteins in J774 cells after nanomolar ZOL treatment, with a >7-fold increase in the unprenylated form of Rab proteins assocd. with the endophagosome pathway (Rab1, Rab5, Rab6, Rab7, Rab11, Rab14 and Rab21).  Finally, we also detected a clear effect of s.c. ZOL administration in vivo on the prenylation of Rab1A, Rab5B, Rab7A and Rab14 in mouse peritoneal macrophages, confirming that systemic treatment with bisphosphonate drug can inhibit prenylation in myeloid cells in vivo outside the skeleton.  These observations begin a new era in defining the precise pharmacol. actions of bisphosphonate drugs on the prenylation of small GTPases in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_HwAEOm-rK7Vg90H21EOLACvtfcHk0lghB2FMFCUvgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKqsL4%253D&md5=d021419ee39a72bd44deac6f0e10923c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F21541248.2015.1085485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21541248.2015.1085485%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DN.%26aulast%3DJurczyluk%26aufirst%3DJ.%26aulast%3DShay%26aufirst%3DG.%26aulast%3DTnimov%26aufirst%3DZ.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DMunoz%26aufirst%3DM.%2BA.%26aulast%3DSkinner%26aufirst%3DO.%2BP.%26aulast%3DPavlos%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DA%2520highly%2520sensitive%2520prenylation%2520assay%2520reveals%2520in%2520vivo%2520effects%2520of%2520bisphosphonate%2520drug%2520on%2520the%2520Rab%2520prenylome%2520of%2520macrophages%2520outside%2520the%2520skeleton%26jtitle%3DSmall%2520GTPases%26date%3D2015%26volume%3D6%26spage%3D202%26epage%3D211%26doi%3D10.1080%2F21541248.2015.1085485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Agabiti, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, A. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation</span> <span class="citation_source-journal">Mol. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1080/09687688.2016.1213432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F09687688.2016.1213432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=27537059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=1-11&author=S.+S.+Agabitiauthor=Y.+Liangauthor=A.+J.+Wiemer&title=Molecular+mechanisms+linking+geranylgeranyl+diphosphate+synthase+to+cell+survival+and+proliferation&doi=10.1080%2F09687688.2016.1213432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation</span></div><div class="casAuthors">Agabiti, Sherry S.; Liang, Yilan; Wiemer, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Membrane Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">MMEBE7</span>;
        ISSN:<span class="NLM_cas:issn">0968-7688</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Geranylgeranyl diphosphate is a 20-carbon isoprenoid phospholipid whose lipid moiety can be post-translationally incorporated into proteins to promote membrane assocn.  The process of geranylgeranylation has been implicated in anti-proliferative effects of clin. agents that inhibit enzymes of the mevalonate pathway (i.e. statins and nitrogenous bisphosphonates) as well as exptl. agents that deplete geranylgeranyl diphosphate.  Inhibitors of geranylgeranyl diphosphate synthase are an attractive way to block geranylgeranylation because they possess a calcium-chelating substructure to allow localization to bone and take advantage of a unique position of the enzyme within the biosynthetic pathway.  Here, we describe recent advances in geranylgeranyl diphosphate synthase expression and inhibitor development with a particular focus on the mol. mechanisms that link geranylgeranyl diphosphate to cell proliferation via geranylgeranylated small GTPases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwaF-h_j547Vg90H21EOLACvtfcHk0lgz6Jt9IaUI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmtL3P&md5=447b75d5da4970d89206b826181983aa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F09687688.2016.1213432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09687688.2016.1213432%26sid%3Dliteratum%253Aachs%26aulast%3DAgabiti%26aufirst%3DS.%2BS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520linking%2520geranylgeranyl%2520diphosphate%2520synthase%2520to%2520cell%2520survival%2520and%2520proliferation%26jtitle%3DMol.%2520Membr.%2520Biol.%26date%3D2016%26volume%3D33%26spage%3D1%26epage%3D11%26doi%3D10.1080%2F09687688.2016.1213432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ochocki, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M. D.</span><span> </span><span class="NLM_article-title">Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span><span class="refDoi"> DOI: 10.1039/C2MD20299A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1039%2FC2MD20299A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25530833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=476-492&author=J.+D.+Ochockiauthor=M.+D.+Distefano&title=Prenyltransferase+inhibitors%3A+treating+human+ailments+from+cancer+to+parasitic+infections&doi=10.1039%2FC2MD20299A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections</span></div><div class="casAuthors">Ochocki, Joshua D.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">476-492</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The posttranslational modification of protein prenylation is a covalent lipid modification on the C-terminus of substrate proteins that serves to enhance membrane affinity.  Oncogenic proteins such as Ras have this modification and significant effort has been placed into developing inhibitors of the prenyltransferase enzymes for clin. therapy.  In addn. to cancer therapy, prenyltransferase inhibitors have begun to find important therapeutic uses in other diseases, including progeria, hepatitis C and D, parasitic infections, and other maladies.  This review will trace the evolution of prenyltransferase inhibitors from their initial use as cancer therapeutics to their expanded applications for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wdOpk9scqLVg90H21EOLACvtfcHk0lgz6Jt9IaUI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtbg%253D&md5=d228d5dabd83865fbc35ab4b58088aa7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2FC2MD20299A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20299A%26sid%3Dliteratum%253Aachs%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DPrenyltransferase%2520inhibitors%253A%2520treating%2520human%2520ailments%2520from%2520cancer%2520to%2520parasitic%2520infections%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D476%26epage%3D492%26doi%3D10.1039%2FC2MD20299A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhimnathwala, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brucker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSolms, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis-Hutchings, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumma, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machotka, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rands, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliff, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span> </span><span class="NLM_article-title">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8758</span><span class="NLM_x">–</span> <span class="NLM_lpage">8768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=11751396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8758-8768&author=R.+B.+Lobellauthor=C.+A.+Omerauthor=M.+T.+Abramsauthor=H.+G.+Bhimnathwalaauthor=M.+J.+Bruckerauthor=C.+A.+Buserauthor=J.+P.+Davideauthor=S.+J.+DeSolmsauthor=C.+J.+Dinsmoreauthor=M.+S.+Ellis-Hutchingsauthor=A.+M.+Kralauthor=D.+Liuauthor=W.+C.+Lummaauthor=S.+V.+Machotkaauthor=E.+Randsauthor=T.+M.+Williamsauthor=S.+L.+Grahamauthor=G.+D.+Hartmanauthor=A.+I.+Oliffauthor=D.+C.+Heimbrookauthor=N.+E.+Kohl&title=Evaluation+of+farnesyl%3Aprotein+transferase+and+geranylgeranyl%3Aprotein+transferase+inhibitor+combinations+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span></div><div class="casAuthors">Lobell, Robert B.; Omer, Charles A.; Abrams, Marc T.; Bhimnathwala, Hema G.; Brucker, Mary Jo; Buser, Carolyn A.; Davide, Joseph P.; DeSolms, S. Jane; Dinsmore, Christopher J.; Ellis-Hutchings, Michelle S.; Kral, Astrid M.; Liu, Dongming; Lumma, William C.; Machotka, Samuel V.; Rands, Elaine; Williams, Theresa M.; Graham, Samuel L.; Hartman, George D.; Oliff, Allen I.; Heimbrook, David C.; Kohl, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8758-8768</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Farnesyl:protein transferase (FPTase) inhibitors (FTIs) were originally developed as potential anticancer agents targeting the ras oncogene and are currently in clin. trials.  Whereas FTIs inhibit the farnesylation of Ha-Ras, they do not completely inhibit the prenylation of Ki-Ras, the allele most frequently mutated in human cancers.  Whereas farnesylation of Ki-Ras is blocked by FTIs, Ki-Ras remains prenylated in FTI-treated cells because of its modification by the related prenyltransferase, geranylgeranyl:protein transferase type I (GGPTase-I).  Hence, cells transformed with Ki-ras tend to be more resistant to FTIs than Ha-ras-transformed cells.  To det. whether Ki-ras-transformed cells can be targeted by combining an FTI with a GGPTase-I inhibitor (GGTI), we evaluated potent, selective FTIs, GGTIs, and dual prenylation inhibitors (DPIs) that have both FTI and GGTI activity.  We find that in human PSN-1 pancreatic tumor cells, which harbor oncogenic Ki-ras, and in other tumor lines having either wild-type or oncogenic Ki-ras, treatment with an FTI/GGTI combination or with a DPI blocks Ki-Ras prenylation and induces markedly higher levels of apoptosis relative to FTI or GGTI alone.  We demonstrate that these compds. can inhibit their enzyme targets in mice by monitoring pancreatic and tumor tissues from treated animals for inhibition of prenylation of Ki-Ras, HDJ2, a substrate specific for FPTase, and Rap1A, a substrate specific for GGPTase-I.  Continuous infusion (72 h) of varying doses of GGTI in conjunction with a high, fixed dose of FTI causes a dose-dependent inhibition of Ki-Ras prenylation.  However, a 72-h infusion of a GGTI, at a dose sufficient to inhibit Ki-Ras prenylation in the presence of an FTI, causes death within 2 wk of the infusion when administered either as monotherapy or in combination with an FTI.  DPIs are also lethal after a 72-h infusion at doses that inhibit Ki-Ras prenylation.  Because 24 h infusion of a high dose of DPI is tolerated and inhibits Ki-Ras prenylation, we compared the antitumor efficacy from a 24-h FTI infusion to that of a DPI in a nude mouse/PSN-1 tumor cell xenograft model and in Ki-ras transgenic mice with mammary tumors.  The FTI and DPI were dosed at a level that provided comparable inhibition of FPTase.  The FTI and the DPI displayed comparable efficacy, causing a decrease in growth rate of the PSN-1 xenograft tumors and tumor regression in the transgenic model, but neither treatment regimen induced a statistically significant increase in tumor cell apoptosis.  Although FTI/GGTI combinations elicit a greater apoptotic response than either agent alone in vitro, the toxicity assocd. with GGTI treatment in vivo limits the duration of treatment and, thus, may limit the therapeutic benefit that might be gained by inhibiting oncogenic Ki-Ras through dual prenyltransferase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8692wSeB0bVg90H21EOLACvtfcHk0lgz6Jt9IaUI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D&md5=a6bec938c55d2a308cadbce460d5f098</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBhimnathwala%26aufirst%3DH.%2BG.%26aulast%3DBrucker%26aufirst%3DM.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DDeSolms%26aufirst%3DS.%2BJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEllis-Hutchings%26aufirst%3DM.%2BS.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DMachotka%26aufirst%3DS.%2BV.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DOliff%26aufirst%3DA.%2BI.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26atitle%3DEvaluation%2520of%2520farnesyl%253Aprotein%2520transferase%2520and%2520geranylgeranyl%253Aprotein%2520transferase%2520inhibitor%2520combinations%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8758%26epage%3D8768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larijani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzylak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48213</span><span class="NLM_x">–</span> <span class="NLM_lpage">48222</span><span class="refDoi"> DOI: 10.1074/jbc.M106473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M106473200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48213-48222&author=F.+P.+Coxonauthor=M.+H.+Helfrichauthor=B.+Larijaniauthor=M.+Muzylakauthor=J.+E.+Dunfordauthor=D.+Marshallauthor=A.+D.+McKinnonauthor=S.+A.+Nesbittauthor=M.+A.+Hortonauthor=M.+C.+Seabraauthor=F.+H.+Ebetinoauthor=M.+J.+Rogers&title=Identification+of+a+novel+phosphonocarboxylate+inhibitor+of+Rab+geranylgeranyl+transferase+that+specifically+prevents+Rab+prenylation+in+osteoclasts+and+macrophages&doi=10.1074%2Fjbc.M106473200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106473200%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DHelfrich%26aufirst%3DM.%2BH.%26aulast%3DLarijani%26aufirst%3DB.%26aulast%3DMuzylak%26aufirst%3DM.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMcKinnon%26aufirst%3DA.%2BD.%26aulast%3DNesbitt%26aufirst%3DS.%2BA.%26aulast%3DHorton%26aufirst%3DM.%2BA.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520novel%2520phosphonocarboxylate%2520inhibitor%2520of%2520Rab%2520geranylgeranyl%2520transferase%2520that%2520specifically%2520prevents%2520Rab%2520prenylation%2520in%2520osteoclasts%2520and%2520macrophages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48213%26epage%3D48222%26doi%3D10.1074%2Fjbc.M106473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiji, H. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinderman, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span> </span><span class="NLM_article-title">Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">9571</span><span class="NLM_x">–</span> <span class="NLM_lpage">9579</span><span class="refDoi"> DOI: 10.1074/jbc.M706229200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M706229200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=18230616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1aks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=9571-9579&author=M.+Watanabeauthor=H.+D.+G.+Fijiauthor=L.+Guoauthor=L.+Chanauthor=S.+S.+Kindermanauthor=D.+J.+Slamonauthor=O.+Kwonauthor=F.+Tamanoi&title=Inhibitors+of+protein+geranylgeranyltransferase+I+and+Rab+geranylgeranyltransferase+identified+from+a+library+of+allenoate-derived+compounds&doi=10.1074%2Fjbc.M706229200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Protein Geranylgeranyltransferase I and Rab Geranylgeranyltransferase Identified from a Library of Allenoate-derived Compounds</span></div><div class="casAuthors">Watanabe, Masaru; Fiji, Hannah D. G.; Guo, Lea; Chan, Lai; Kinderman, Sape S.; Slamon, Dennis J.; Kwon, Ohyun; Tamanoi, Fuyuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">9571-9579</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein geranylgeranylation is crit. for the function of a no. of proteins such as RhoA, Rac, and Rab.  Protein geranylgeranyltransferase I (GGTase-I) and Rab geranylgeranyltransferase (RabGGTase) catalyze these modifications.  In this work, we first describe the identification and characterization of small mol. inhibitors of GGTase-I (GGTI) with two novel scaffolds from a library consisting of allenoate-derived compds.  These compds. exhibit specific inhibition of GGTase-I and act by competing with a substrate protein.  Derivatization of a carboxylic acid emanating from the core ring of one of the GGTI compds. dramatically improves their cellular activity.  The improved GGTI compds. inhibit proliferation of a variety of human cancer cell lines and cause G1 cell cycle arrest and induction of p21CIP1/WAF1.  We also report the identification of novel small mol. inhibitors of RabGGTase.  These compds. were identified first by screening our GGTI compds. for those that also exhibited RabGGTase inhibition.  This led to the discovery of a common structural feature for RabGGTase inhibitors: the presence of a characteristic six-atom aliph. tail attached to the penta-substituted pyrrolidine core.  Further screening led to the identification of compds. with preferential inhibition of RabGGTase.  These compds. inhibit RabGGTase activity by competing with the substrate protein.  These novel compds. may provide valuable reagents to study protein geranylgeranylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkCWVFXGF17Vg90H21EOLACvtfcHk0ljYFyPAuNcvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1aks70%253D&md5=2a215804301c0eaa5221bd7563bcfa18</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M706229200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M706229200%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DFiji%26aufirst%3DH.%2BD.%2BG.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DKinderman%26aufirst%3DS.%2BS.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DKwon%26aufirst%3DO.%26aulast%3DTamanoi%26aufirst%3DF.%26atitle%3DInhibitors%2520of%2520protein%2520geranylgeranyltransferase%2520I%2520and%2520Rab%2520geranylgeranyltransferase%2520identified%2520from%2520a%2520library%2520of%2520allenoate-derived%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D9571%26epage%3D9579%26doi%3D10.1074%2Fjbc.M706229200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tan, K.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiu-Rozas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of peptide-based Rab geranylgeranyl transferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8025</span><span class="NLM_x">–</span> <span class="NLM_lpage">8037</span><span class="refDoi"> DOI: 10.1021/jm901117d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901117d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8025-8037&author=K.-T.+Tanauthor=E.+Guiu-Rozasauthor=R.+S.+Bonauthor=Z.+Guoauthor=C.+Delonauthor=S.+Wetzelauthor=S.+Arndtauthor=K.+Alexandrovauthor=H.+Waldmannauthor=R.+S.+Goodyauthor=Y.-W.+Wuauthor=W.+Blankenfeldt&title=Design%2C+synthesis%2C+and+characterization+of+peptide-based+Rab+geranylgeranyl+transferase+inhibitors&doi=10.1021%2Fjm901117d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of Peptide-Based Rab Geranylgeranyl Transferase Inhibitors</span></div><div class="casAuthors">Tan, Kui-Thong; Guiu-Rozas, Ester; Bon, Robin S.; Guo, Zhong; Delon, Christine; Wetzel, Stefan; Arndt, Sabine; Alexandrov, Kirill; Waldmann, Herbert; Goody, Roger S.; Wu, Yao-Wen; Blankenfeldt, Wulf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8025-8037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rab geranylgeranyl transferase (RabGGTase) catalyzes the attachment of geranylgeranyl isoprenoids to Rab guanine triphosphatases, which are key regulators in vesicular transport.  Because geranylgeranylation is required for proper function and overexpression of Rabs has been obsd. in various cancers, RabGGTase may be a target for novel therapeutics.  The development of selective inhibitors is, however, difficult because two related enzymes involved in other cellular processes exist in eukaryotes and because RabGGTase recognizes protein substrates indirectly, resulting in relaxed specificity.  The authors report the synthesis of a peptidic library based on the farnesyl transferase inhibitor pepticinnamin E.  Of 469 compds. investigated, several were identified as selective for RabGGTase with low micromolar IC50 values.  The compds. were not generally cytotoxic and inhibited Rab isoprenylation in COS-7 cells.  Crystal structure anal. revealed that selective inhibitors interact with a tunnel unique to RabGGTase, implying that this structural motif is an attractive target for improved RabGGTase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql3mQReP6ZLrVg90H21EOLACvtfcHk0lgCmndd7qrHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksr%252FK&md5=2636eb9658d9c563bb46ca06dcc133a1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901117d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901117d%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.-T.%26aulast%3DGuiu-Rozas%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DDelon%26aufirst%3DC.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DArndt%26aufirst%3DS.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520peptide-based%2520Rab%2520geranylgeranyl%2520transferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8025%26epage%3D8037%26doi%3D10.1021%2Fjm901117d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span> </span><span class="NLM_article-title">Development of selective, potent RabGGTase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8330</span><span class="NLM_x">–</span> <span class="NLM_lpage">8340</span><span class="refDoi"> DOI: 10.1021/jm300624s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300624s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlags73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8330-8340&author=E.+A.+Stigterauthor=Z.+Guoauthor=R.+S.+Bonauthor=Y.-W.+Wuauthor=A.+Choidasauthor=A.+Wolfauthor=S.+Menningerauthor=H.+Waldmannauthor=W.+Blankenfeldtauthor=R.+S.+Goody&title=Development+of+selective%2C+potent+RabGGTase+inhibitors&doi=10.1021%2Fjm300624s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective, Potent RabGGTase Inhibitors</span></div><div class="casAuthors">Stigter, E. Anouk; Guo, Zhong; Bon, Robin S.; Wu, Yao-Wen; Choidas, Axel; Wolf, Alexander; Menninger, Sascha; Waldmann, Herbert; Blankenfeldt, Wulf; Goody, Roger S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8330-8340</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the Ras superfamily of small GTPases are frequently mutated in cancer.  Therefore, inhibitors have been developed to address the activity of these GTPases by inhibiting their prenylating enzymes FTase, GGTase I, and RabGGTase.  In contrast to FTase and GGTase I, only a handful of RabGGTase inhibitors have been developed.  The most active RabGGTase inhibitor known until recently was an FTase inhibitor which hit RabGGTase as an off-target.  We recently reported our efforts to tune the selectivity of these inhibitors toward RabGGTase.  Here we describe an extended set of selective inhibitors.  The requirements for selective RabGGTase inhibitors are described in detail, guided by multiple crystal structures.  In order to relate in vitro and cellular activity, a high-throughput assay system to detect the attachment of [3H]geranylgeranyl groups to Rab was used.  Selective RabGGTase inhibition allows the establishment of novel drug discovery programs aimed at the development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-15HKuegUrVg90H21EOLACvtfcHk0lgCmndd7qrHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlags73P&md5=022aa7d6b3f6321a379d20ff28f11513</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm300624s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300624s%26sid%3Dliteratum%253Aachs%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26atitle%3DDevelopment%2520of%2520selective%252C%2520potent%2520RabGGTase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8330%26epage%3D8340%26doi%3D10.1021%2Fjm300624s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Structure-guided development of selective RabGGTase inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4957</span><span class="NLM_x">–</span> <span class="NLM_lpage">4961</span><span class="refDoi"> DOI: 10.1002/anie.201101210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2Fanie.201101210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4957-4961&author=R.+S.+Bonauthor=Z.+Guoauthor=E.+A.+Stigterauthor=S.+Wetzelauthor=S.+Menningerauthor=A.+Wolfauthor=A.+Choidasauthor=K.+Alexandrovauthor=W.+Blankenfeldtauthor=R.+S.+Goodyauthor=H.+Waldmann&title=Structure-guided+development+of+selective+RabGGTase+inhibitors&doi=10.1002%2Fanie.201101210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201101210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201101210%26sid%3Dliteratum%253Aachs%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DStructure-guided%2520development%2520of%2520selective%2520RabGGTase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D4957%26epage%3D4961%26doi%3D10.1002%2Fanie.201101210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Deraeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiLucrezia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menninger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choidas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-W.</span><span> </span><span class="NLM_article-title">Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">7384</span><span class="NLM_x">–</span> <span class="NLM_lpage">7391</span><span class="refDoi"> DOI: 10.1021/ja211305j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja211305j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7384-7391&author=C.+Deraeveauthor=Z.+Guoauthor=R.+S.+Bonauthor=W.+Blankenfeldtauthor=R.+DiLucreziaauthor=A.+Wolfauthor=S.+Menningerauthor=E.+A.+Stigterauthor=S.+Wetzelauthor=A.+Choidasauthor=K.+Alexandrovauthor=H.+Waldmannauthor=R.+S.+Goodyauthor=Y.-W.+Wu&title=Psoromic+acid+is+a+selective+and+covalent+Rab-prenylation+inhibitor+targeting+autoinhibited+RabGGTase&doi=10.1021%2Fja211305j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Psoromic Acid is a Selective and Covalent Rab-Prenylation Inhibitor Targeting Autoinhibited RabGGTase</span></div><div class="casAuthors">Deraeve, Celine; Guo, Zhong; Bon, Robin S.; Blankenfeldt, Wulf; DiLucrezia, Raffaella; Wolf, Alexander; Menninger, Sascha; Stigter, E. Anouk; Wetzel, Stefan; Choidas, Axel; Alexandrov, Kirill; Waldmann, Herbert; Goody, Roger S.; Wu, Yao-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7384-7391</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Post-translational attachment of geranylgeranyl isoprenoids to Rab GTPases, the key organizers of intracellular vesicular transport, is essential for their function.  Rab geranylgeranyl transferase (RabGGTase) is responsible for prenylation of Rab proteins.  Recently, RabGGTase inhibitors have been proposed to be potential therapeutics for treatment of cancer and osteoporosis.  However, the development of RabGGTase selective inhibitors is complicated by its structural and functional similarity to other protein prenyltransferases.  Herein we report identification of the natural product psoromic acid (PA) that potently and selectively inhibits RabGGTase with an IC50 of 1.3 μM.  Structure-activity relationship anal. suggested a minimal structure involving the depsidone core with a 3-hydroxyl and 4-aldehyde motif for binding to RabGGTase.  Anal. of the crystal structure of the RabGGTase:PA complex revealed that PA forms largely hydrophobic interactions with the isoprenoid binding site of RabGGTase and that it attaches covalently to the N-terminus of the α subunit.  We found that in contrast to other protein prenyltransferases, RabGGTase is autoinhibited through N-terminal αHis2 coordination with the catalytic zinc ion.  Mutation of αHis dramatically enhances the reaction rate, indicating that the activity of RabGGTase is likely regulated in vivo.  The covalent binding of PA to the N-terminus of the RabGGTase α subunit seems to potentiate its interaction with the active site and explains the selectivity of PA for RabGGTase.  Therefore, psoromic acid provides a new starting point for the development of selective RabGGTase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppe_-HUfnkhbVg90H21EOLACvtfcHk0lgHBu3Z-tuBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFGisr4%253D&md5=5542dd49f315b5feb0d547a96d658f30</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja211305j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja211305j%26sid%3Dliteratum%253Aachs%26aulast%3DDeraeve%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DBon%26aufirst%3DR.%2BS.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DDiLucrezia%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DStigter%26aufirst%3DE.%2BA.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DGoody%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DY.-W.%26atitle%3DPsoromic%2520acid%2520is%2520a%2520selective%2520and%2520covalent%2520Rab-prenylation%2520inhibitor%2520targeting%2520autoinhibited%2520RabGGTase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D7384%26epage%3D7391%26doi%3D10.1021%2Fja211305j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span> </span><span class="NLM_article-title">Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">6861</span><span class="NLM_x">–</span> <span class="NLM_lpage">6868</span><span class="refDoi"> DOI: 10.1074/jbc.M806952200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1074%2Fjbc.M806952200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=19074143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=6861-6868&author=R.+A.+Baronauthor=R.+Tavareauthor=A.+C.+Figueiredoauthor=K.+M.+B%C5%82a%C5%BCewskaauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=F.+H.+Ebetinoauthor=A.+Taylorauthor=M.+J.+Rogersauthor=F.+P.+Coxonauthor=M.+C.+Seabra&title=Phosphonocarboxylates+inhibit+the+second+geranylgeranyl+addition+by+Rab+geranylgeranyl+transferase&doi=10.1074%2Fjbc.M806952200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase</span></div><div class="casAuthors">Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.; Ebetino, Frank H.; Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.; Seabra, Miguel C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6861-6868</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Rab geranylgeranyl transferase (RGGT) catalyzes the post-translational geranylgeranyl (GG) modification of (usually) two C-terminal cysteines in Rab GTPases.  Here we studied the mechanism of the Rab geranylgeranylation reaction by bisphosphonate analogs in which one phosphonate group is replaced by a carboxylate (phosphonocarboxylate, PC).  The phosphonocarboxylates used were 3-PEHPC, which was previously reported, and 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid ((+)-3-IPEHPC), a >25-fold more potent related compd. as measured by both IC50 and Ki.  (+)-3-IPEHPC behaves as a mixed-type inhibitor with respect to GG pyrophosphate (GGPP) and an uncompetitive inhibitor with respect to Rab substrates.  We propose that phosphonocarboxylates prevent only the second GG transfer onto Rabs based on the following evidence.  First, geranylgeranylation of Rab proteins ending with a single cysteine motif such as CAAX, is not affected by the inhibitors, either in vitro or in vivo.  Second, the addn. of an -AAX sequence onto Rab-CC proteins protects the substrate from inhibition by the inhibitors.  Third, we demonstrate directly that in the presence of (+)-3-IPEHPC, Rab-CC and Rab-CXC proteins are modified by only a single GG addn.  The presence of (+)-3-IPEHPC resulted in a preference for the Rab N-terminal cysteine to be modified first, suggesting an order of cysteine geranylgeranylation in RGGT catalysis.  Our results further suggest that the inhibitor binds to a site distinct from the GGPP-binding site on RGGT.  We suggest that phosphonocarboxylate inhibitors bind to a GG-cysteine binding site adjacent to the active site, which is necessary to align the mono-GG-Rab for the second GG addn.  These inhibitors may represent a novel therapeutic approach in Rab-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxdjzU5KNkqLVg90H21EOLACvtfcHk0lgHBu3Z-tuBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislWrurc%253D&md5=3ca6c13644b28cdf5c8f504ad2064833</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806952200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806952200%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DTavare%26aufirst%3DR.%26aulast%3DFigueiredo%26aufirst%3DA.%2BC.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26atitle%3DPhosphonocarboxylates%2520inhibit%2520the%2520second%2520geranylgeranyl%2520addition%2520by%2520Rab%2520geranylgeranyl%2520transferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D6861%26epage%3D6868%26doi%3D10.1074%2Fjbc.M806952200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard-Favier, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundy, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsten, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bala, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marma, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span> </span><span class="NLM_article-title">Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3454</span><span class="NLM_x">–</span> <span class="NLM_lpage">3464</span><span class="refDoi"> DOI: 10.1021/jm900232u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900232u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVahsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3454-3464&author=C.+E.+McKennaauthor=B.+A.+Kashemirovauthor=K.+M.+B%C5%82a%C5%BCewskaauthor=I.+Mallard-Favierauthor=C.+A.+Stewartauthor=J.+Rojasauthor=M.+W.+Lundyauthor=F.+H.+Ebetinoauthor=R.+A.+Baronauthor=J.+E.+Dunfordauthor=M.+L.+Kirstenauthor=M.+C.+Seabraauthor=J.+L.+Balaauthor=M.+S.+Marmaauthor=M.+J.+Rogersauthor=F.+P.+Coxon&title=Synthesis%2C+chiral+high+performance+liquid+chromatographic+resolution+and+enantiospecific+activity+of+a+potent+new+geranylgeranyl+transferase+inhibitor%2C+2-hydroxy-3-imidazo%5B1%2C2-a%5Dpyridin-3-yl-2-phosphonopropionic+acid&doi=10.1021%2Fjm900232u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Chiral High Performance Liquid Chromatographic Resolution and Enantiospecific Activity of a Potent New Geranylgeranyl Transferase Inhibitor, 2-Hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid</span></div><div class="casAuthors">McKenna, Charles E.; Kashemirov, Boris A.; Blazewska, Katarzyna M.; Mallard-Favier, Isabelle; Stewart, Charlotte A.; Rojas, Javier; Lundy, Mark W.; Ebetino, Frank H.; Baron, Rudi A.; Dunford, James E.; Kirsten, Marie L.; Seabra, Miguel C.; Bala, Joy L.; Marma, Mong S.; Rogers, Michael J.; Coxon, Fraser P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3454-3464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(3-Pyridyl)-2-hydroxy-2-phosphonopropanoic acid (3-PEHPC, I) is a phosphonocarboxylate (PC) analog of 2-(3-pyridyl)-1-hydroxyethylidenebis(phosphonic acid) (risedronic acid, II), an osteoporosis drug that decreases bone resorption by inhibiting farnesyl pyrophosphate synthase (FPPS) in osteoclasts, preventing protein prenylation.  I has lower bone affinity than II and weakly inhibits Rab geranylgeranyl transferase (RGGT), selectively preventing prenylation of Rab GTPases.  Herein is reported the synthesis and biol. studies of 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid (3-IPEHPC, III), the PC analog of minodronic acid IV.  Like I, III selectively inhibited Rab11 vs. Rap 1A prenylation in J774 cells, and decreased cell viability, but was 33-60× more active in these assays.  After resolving III by chiral HPLC (>98% ee), it was found that (+)-III-E1 was much more potent than (-)-III-E2 in an isolated RGGT inhibition assay, ∼17× more potent (LED 3 μM) than (-)-III-E2 in inhibiting Rab prenylation in J774 cells and >26× more active in the cell viability assay.  The enantiomers of I exhibited a 4-fold or smaller potency difference in the RGGT and prenylation inhibition assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQ1Lns8200bVg90H21EOLACvtfcHk0lhsIceYScVqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVahsrw%253D&md5=d9b22461df25e9f061aac6c5503790ad</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900232u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900232u%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DMallard-Favier%26aufirst%3DI.%26aulast%3DStewart%26aufirst%3DC.%2BA.%26aulast%3DRojas%26aufirst%3DJ.%26aulast%3DLundy%26aufirst%3DM.%2BW.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DKirsten%26aufirst%3DM.%2BL.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DBala%26aufirst%3DJ.%2BL.%26aulast%3DMarma%26aufirst%3DM.%2BS.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26atitle%3DSynthesis%252C%2520chiral%2520high%2520performance%2520liquid%2520chromatographic%2520resolution%2520and%2520enantiospecific%2520activity%2520of%2520a%2520potent%2520new%2520geranylgeranyl%2520transferase%2520inhibitor%252C%25202-hydroxy-3-imidazo%255B1%252C2-a%255Dpyridin-3-yl-2-phosphonopropionic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3454%26epage%3D3464%26doi%3D10.1021%2Fjm900232u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Błażewska, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haiges, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry and SAR of a series of minodronate analogues as RGGT inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4826</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.04.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2011.04.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4820-4826&author=K.+M.+B%C5%82a%C5%BCewskaauthor=F.+Niauthor=R.+Haigesauthor=B.+A.+Kashemirovauthor=F.+P.+Coxonauthor=C.+A.+Stewartauthor=R.+Baronauthor=M.+J.+Rogersauthor=M.+C.+Seabraauthor=F.+H.+Ebetinoauthor=C.+E.+McKenna&title=Synthesis%2C+stereochemistry+and+SAR+of+a+series+of+minodronate+analogues+as+RGGT+inhibitors&doi=10.1016%2Fj.ejmech.2011.04.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.063%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26aulast%3DNi%26aufirst%3DF.%26aulast%3DHaiges%26aufirst%3DR.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DStewart%26aufirst%3DC.%2BA.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%252C%2520stereochemistry%2520and%2520SAR%2520of%2520a%2520series%2520of%2520minodronate%2520analogues%2520as%2520RGGT%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4820%26epage%3D4826%26doi%3D10.1016%2Fj.ejmech.2011.04.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Coxon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najumudeen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oetken-Lindholm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Way, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abankwa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.06.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2014.06.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=25016230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=77-89&author=F.+P.+Coxonauthor=L.+Joachimiakauthor=A.+K.+Najumudeenauthor=G.+Breenauthor=J.+Gmachauthor=C.+Oetken-Lindholmauthor=R.+Wayauthor=J.+E.+Dunfordauthor=D.+Abankwaauthor=K.+M.+B%C5%82a%C5%BCewska&title=Synthesis+and+characterization+of+novel+phosphonocarboxylate+inhibitors+of+RGGT&doi=10.1016%2Fj.ejmech.2014.06.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT</span></div><div class="casAuthors">Coxon, Fraser P.; Joachimiak, Lukasz; Najumudeen, Arafath Kaja; Breen, George; Gmach, Joanna; Oetken-Lindholm, Christina; Way, Rebecca; Dunford, James E.; Abankwa, Daniel; Blazewska, Katarzyna M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-89</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphonocarboxylate (PC) analogs of the anti-osteoporotic drugs, bisphosphonates, represent the first class of selective inhibitors of Rab geranylgeranyl transferase (RabGGTase, RGGT), an enzyme implicated in several diseases including ovarian, breast and skin cancer.  Here we present the synthesis and biol. characterization of an extended set of this class of compds., including lipophilic derivs. of the known RGGT inhibitors.  From this new panel of PCs, we have identified an inhibitor of RGGT that is of similar potency as the most active published phosphonocarboxylate, but of higher selectivity towards this enzyme compared to prenyl pyrophosphate synthases.  New insights into structural requirements are also presented, showing that only PC analogs of the most potent 3rd generation bisphosphonates inhibit RGGT.  In addn., the first phosphonocarboxylate-derived GGPPS inhibitor is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHuQvk6JcRLVg90H21EOLACvtfcHk0lhsIceYScVqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKktLfK&md5=6e3e4a74d8887fa2619d678bae5e8327</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.06.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.06.062%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DJoachimiak%26aufirst%3DL.%26aulast%3DNajumudeen%26aufirst%3DA.%2BK.%26aulast%3DBreen%26aufirst%3DG.%26aulast%3DGmach%26aufirst%3DJ.%26aulast%3DOetken-Lindholm%26aufirst%3DC.%26aulast%3DWay%26aufirst%3DR.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DAbankwa%26aufirst%3DD.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520novel%2520phosphonocarboxylate%2520inhibitors%2520of%2520RGGT%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D77%26epage%3D89%26doi%3D10.1016%2Fj.ejmech.2014.06.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holstein, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, D. F.</span><span> </span><span class="NLM_article-title">N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.bmcl.2015.04.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2331-2334&author=X.+Zhouauthor=E.+J.+Bornauthor=C.+Allenauthor=S.+A.+Holsteinauthor=D.+F.+Wiemer&title=N-Oxide+derivatives+of+3-%283-pyridyl%29-2-phosphonopropanoic+acids+as+potential+inhibitors+of+Rab+geranylgeranylation&doi=10.1016%2Fj.bmcl.2015.04.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DBorn%26aufirst%3DE.%2BJ.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DHolstein%26aufirst%3DS.%2BA.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DN-Oxide%2520derivatives%2520of%25203-%25283-pyridyl%2529-2-phosphonopropanoic%2520acids%2520as%2520potential%2520inhibitors%2520of%2520Rab%2520geranylgeranylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2331%26epage%3D2334%26doi%3D10.1016%2Fj.bmcl.2015.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues Poveda, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkamala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Pacanowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jm801023u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801023u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=976-988&author=Y.+Songauthor=F.-Y.+Linauthor=F.+Yinauthor=M.+Henslerauthor=C.+A.+Rodrigues+Povedaauthor=D.+Mukkamalaauthor=R.+Caoauthor=H.+Wangauthor=C.+T.+Moritaauthor=D.+Gonzalez+Pacanowskaauthor=V.+Nizetauthor=E.+Oldfield&title=Phosphonosulfonates+are+potent%2C+selective+inhibitors+of+dehydrosqualene+synthase+and+staphyloxanthin+biosynthesis+in+Staphylococcus+aureus&doi=10.1021%2Fjm801023u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801023u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801023u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.-Y.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DRodrigues%2BPoveda%26aufirst%3DC.%2BA.%26aulast%3DMukkamala%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DC.%2BT.%26aulast%3DGonzalez%2BPacanowska%26aufirst%3DD.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DPhosphonosulfonates%2520are%2520potent%252C%2520selective%2520inhibitors%2520of%2520dehydrosqualene%2520synthase%2520and%2520staphyloxanthin%2520biosynthesis%2520in%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjm801023u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">The synthesis of phosphinic acid analogues (<b>1s</b>, <b>2s</b>, <b>1t</b>, <b>2t</b>) involved prior synthesis of phosphinates (<b>6s</b>, <b>6t</b>) from P(III) precursors (for details, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Matviiuk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lherbet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorichko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitenko, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltas, M.</span><span> </span><span class="NLM_article-title">Synthesis of 3-heteroaryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.ejmech.2013.10.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=46-52&author=T.+Matviiukauthor=G.+Moriauthor=C.+Lherbetauthor=F.+Rodriguezauthor=M.+R.+Pascaauthor=M.+Gorichkoauthor=B.+Guidettiauthor=Z.+Voitenkoauthor=M.+Baltas&title=Synthesis+of+3-heteroaryl+substituted+pyrrolidine-2%2C5-diones+via+catalytic+Michael+reaction+and+evaluation+of+their+inhibitory+activity+against+InhA+and+Mycobacterium+tuberculosis&doi=10.1016%2Fj.ejmech.2013.10.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DMatviiuk%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DLherbet%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DF.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DGorichko%26aufirst%3DM.%26aulast%3DGuidetti%26aufirst%3DB.%26aulast%3DVoitenko%26aufirst%3DZ.%26aulast%3DBaltas%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25203-heteroaryl%2520substituted%2520pyrrolidine-2%252C5-diones%2520via%2520catalytic%2520Michael%2520reaction%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520activity%2520against%2520InhA%2520and%2520Mycobacterium%2520tuberculosis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D71%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.ejmech.2013.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2Fj.bmc.2006.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=17049248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=403-412&author=M.+Hayakawaauthor=H.+Kaizawaauthor=K.-i.+Kawaguchiauthor=N.+Ishikawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.-i.+Tsukamotoauthor=F.+I.+Raynaudauthor=M.+D.+Waterfieldauthor=P.+Parkerauthor=P.+Workman&title=Synthesis+and+biological+evaluation+of+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors&doi=10.1016%2Fj.bmc.2006.09.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors</span></div><div class="casAuthors">Hayakawa, Masahiko; Kaizawa, Hiroyuki; Kawaguchi, Ken-ichi; Ishikawa, Noriko; Koizumi, Tomonobu; Ohishi, Takahide; Yamano, Mayumi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi; Raynaud, Florence I.; Waterfield, Michael D.; Parker, Peter; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">403-412</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">3-{1-[(4-Fluorophenyl)sulfonyl]-1H-pyrazol-3-yl}-2-methylimidazo[1,2-a]pyridine, 2a, was discovered in our chem. library as a novel p110α inhibitor with an IC50 of 0.67 μM, through screening in a scintillation proximity assay.  Optimization of the substituents of 2a increased the p110α inhibitory activity by more than 300-fold (2g: IC50 = 0.0018 μM).  Further structural modification of 2g afforded thiazole deriv. 12 (I), which has potent p110α inhibitory activity (IC50 of 0.0028 μM) and is highly selective for p110α over other PI3K isoforms.  Compd. 12 also inhibited serum-induced cell proliferation of A375 and HeLa cells in vitro with IC50 values of 0.14 μM and 0.21 μM, resp., and suppressed tumor growth by 37% in a mouse HeLa xenograft model when dosed i.p. at 25 mg/kg.  These results suggest that selective p110α inhibitors may have potential as cancer therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtD0faWirHM7Vg90H21EOLACvtfcHk0lhEJg9cUlTJNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cmt77L&md5=775c2f4e69fd565d13df597610ec44dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DK.-i.%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D403%26epage%3D412%26doi%3D10.1016%2Fj.bmc.2006.09.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Enguehard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thery, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauvelle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">(Hetero)arylation of 6-halogenoimidazo[1,2-a]pyridines differently substituted at C(2): influence of the 2-substituent on the Suzuki cross-coupling reaction</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">3610</span><span class="NLM_x">–</span> <span class="NLM_lpage">3615</span><span class="refDoi"> DOI: 10.1002/1522-2675(20011219)84:12<3610::AID-HLCA3610>3.0.CO;2-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2001&pages=3610-3615&author=C.+Enguehardauthor=M.+Hervetauthor=I.+Theryauthor=J.-L.+Renouauthor=F.+Fauvelleauthor=A.+Gueiffier&title=%28Hetero%29arylation+of+6-halogenoimidazo%5B1%2C2-a%5Dpyridines+differently+substituted+at+C%282%29%3A+influence+of+the+2-substituent+on+the+Suzuki+cross-coupling+reaction&doi=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1522-2675%252820011219%252984%253A12%253C3610%253A%253AAID-HLCA3610%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard%26aufirst%3DC.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DThery%26aufirst%3DI.%26aulast%3DRenou%26aufirst%3DJ.-L.%26aulast%3DFauvelle%26aufirst%3DF.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3D%2528Hetero%2529arylation%2520of%25206-halogenoimidazo%255B1%252C2-a%255Dpyridines%2520differently%2520substituted%2520at%2520C%25282%2529%253A%2520influence%2520of%2520the%25202-substituent%2520on%2520the%2520Suzuki%2520cross-coupling%2520reaction%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2001%26volume%3D84%26spage%3D3610%26epage%3D3615%26doi%3D10.1002%2F1522-2675%2820011219%2984%3A12%3C3610%3A%3AAID-HLCA3610%3E3.0.CO%3B2-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span><span class="refDoi"> DOI: 10.1021/jm101405t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101405t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1365-1378&author=S.+Sasakiauthor=S.+Kitamuraauthor=N.+Negoroauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=N.+Suzukiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Haradaauthor=Y.+Tanakaauthor=M.+Kobayashiauthor=N.+Tadaauthor=M.+Funamiauthor=T.+Tanakaauthor=Y.+Yamamotoauthor=K.+Fukatsuauthor=T.+Yasumaauthor=Y.+Momose&title=Design%2C+synthesis%2C+and+biological+activity+of+potent+and+orally+available+G+protein-coupled+receptor+40+agonists&doi=10.1021%2Fjm101405t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm101405t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101405t%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520potent%2520and%2520orally%2520available%2520G%2520protein-coupled%2520receptor%252040%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1365%26epage%3D1378%26doi%3D10.1021%2Fjm101405t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Maegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udzu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bora, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sajiki, H.</span><span> </span><span class="NLM_article-title">Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki–Miyaura coupling reactions in aqueous media</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5937</span><span class="NLM_x">–</span> <span class="NLM_lpage">5943</span><span class="refDoi"> DOI: 10.1002/chem.200601795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1002%2Fchem.200601795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=17444548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVShsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5937-5943&author=T.+Maegawaauthor=Y.+Kitamuraauthor=S.+Sakoauthor=T.+Udzuauthor=A.+Sakuraiauthor=A.+Tanakaauthor=Y.+Kobayashiauthor=K.+Endoauthor=U.+Boraauthor=T.+Kuritaauthor=A.+Kozakiauthor=Y.+Monguchiauthor=H.+Sajiki&title=Heterogeneous+Pd%2FC-catalyzed+ligand-free%2C+room-temperature+Suzuki%E2%80%93Miyaura+coupling+reactions+in+aqueous+media&doi=10.1002%2Fchem.200601795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki-Miyaura coupling reactions in aqueous media</span></div><div class="casAuthors">Maegawa, Tomohiro; Kitamura, Yoshiaki; Sako, Satoko; Udzu, Takahiro; Sakurai, Ai; Tanaka, Asami; Kobayashi, Yusuke; Endo, Koichi; Bora, Utpal; Kurita, Takanori; Kozaki, Atsushi; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5937-5943</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A mild and efficient ligand-free Suzuki-Miyaura coupling reaction catalyzed by heterogeneous Pd/C was developed.  Aryl bromides and triflates undergo the cross-coupling with aryl boronic acids in excellent yields without the presence of any additives in aq. media at room temp.  (Arylvinyl)boronic acids are also applicable to this coupling reaction and provide the trans-stilbene derivs. in high yields.  The application of wet-type Pd/C to the coupling reaction was achieved without any loss of activity under aerobic conditions, and the reuse of Pd/C is feasible for a fifth run without significant loss of activity.  Inductively coupled plasma (ICP) mass-spectrometric anal. of the filtrate from the reaction mixt. of 4-bromonitrobenzene with phenylboronic acid demonstrated that the palladium metal hardly leached into the soln. within the limits of the detector (< 1 ppm), thus suggesting that the present Suzuki-Miyaura reaction proceeded by heterogeneous catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_7xlhOb_DnrVg90H21EOLACvtfcHk0liYWh2SgT-6CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVShsbw%253D&md5=94183aadfac6c97edaeeec4fd22571ad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchem.200601795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200601795%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DSako%26aufirst%3DS.%26aulast%3DUdzu%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DBora%26aufirst%3DU.%26aulast%3DKurita%26aufirst%3DT.%26aulast%3DKozaki%26aufirst%3DA.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DHeterogeneous%2520Pd%252FC-catalyzed%2520ligand-free%252C%2520room-temperature%2520Suzuki%25E2%2580%2593Miyaura%2520coupling%2520reactions%2520in%2520aqueous%2520media%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2007%26volume%3D13%26spage%3D5937%26epage%3D5943%26doi%3D10.1002%2Fchem.200601795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Katayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitarai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span> </span><span class="NLM_article-title">Isolation of intermediary anti-aldol adducts of the Horner-Wadsworth-Emmons reaction utilizing direct titanium-aldol addition and Successive Bronsted acid promoted stereoselective elimination leading to (Z)-α,β-unsaturated esters</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">0129</span><span class="NLM_x">–</span> <span class="NLM_lpage">0132</span><span class="refDoi"> DOI: 10.1055/s-2005-922787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1055%2Fs-2005-922787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=0129-0132&author=M.+Katayamaauthor=R.+Nagaseauthor=K.+Mitaraiauthor=T.+Misakiauthor=Y.+Tanabe&title=Isolation+of+intermediary+anti-aldol+adducts+of+the+Horner-Wadsworth-Emmons+reaction+utilizing+direct+titanium-aldol+addition+and+Successive+Bronsted+acid+promoted+stereoselective+elimination+leading+to+%28Z%29-%CE%B1%2C%CE%B2-unsaturated+esters&doi=10.1055%2Fs-2005-922787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-922787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-922787%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DM.%26aulast%3DNagase%26aufirst%3DR.%26aulast%3DMitarai%26aufirst%3DK.%26aulast%3DMisaki%26aufirst%3DT.%26aulast%3DTanabe%26aufirst%3DY.%26atitle%3DIsolation%2520of%2520intermediary%2520anti-aldol%2520adducts%2520of%2520the%2520Horner-Wadsworth-Emmons%2520reaction%2520utilizing%2520direct%2520titanium-aldol%2520addition%2520and%2520Successive%2520Bronsted%2520acid%2520promoted%2520stereoselective%2520elimination%2520leading%2520to%2520%2528Z%2529-%25CE%25B1%252C%25CE%25B2-unsaturated%2520esters%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D0129%26epage%3D0132%26doi%3D10.1055%2Fs-2005-922787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">This strategy also worked for condensation of nicotinaldehyde with triethyl phosphonoacetate, showing applicability of this method also to pyridine analogues. Reduction of thus obtained compound leads to desoxy analogue of the first RGGT inhibitor, compound 3-PEHPC.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Misra, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhaduri, A. P.</span><span> </span><span class="NLM_article-title">In search of imidazo[1,2-a]pyridine derivatives exhibiting resistance for catalytic hydrogenation</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3236</span><span class="refDoi"> DOI: 10.1080/00397919908085948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F00397919908085948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=3227-3236&author=A.+P.+Misraauthor=K.+Rajauthor=A.+P.+Bhaduri&title=In+search+of+imidazo%5B1%2C2-a%5Dpyridine+derivatives+exhibiting+resistance+for+catalytic+hydrogenation&doi=10.1080%2F00397919908085948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In search of imidazo[1,2-a]pyridine derivatives exhibiting resistance for catalytic hydrogenation</span></div><div class="casAuthors">Misra, Anju P.; Raj, K.; Bhaduri, A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3227-3236</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Effect of substituents on the pyridine ring of imidazo[1,2-a]pyridine derivs. have been studied to ascertain the structural requirement for offering resistance towards catalytic hydrogenation of the title compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGramQlhMmesZrVg90H21EOLACvtfcHk0lhqjBp0urlNrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFChs7c%253D&md5=2f9c76d9be307cab4c08d0d728393602</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919908085948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919908085948%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DA.%2BP.%26aulast%3DRaj%26aufirst%3DK.%26aulast%3DBhaduri%26aufirst%3DA.%2BP.%26atitle%3DIn%2520search%2520of%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520exhibiting%2520resistance%2520for%2520catalytic%2520hydrogenation%26jtitle%3DSynth.%2520Commun.%26date%3D1999%26volume%3D29%26spage%3D3227%26epage%3D3236%26doi%3D10.1080%2F00397919908085948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">In two out of twenty cases (<b>9k</b>, <b>9p</b>), yields were ∼35%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lin, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Schutter, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghuis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3201</span><span class="NLM_x">–</span> <span class="NLM_lpage">3215</span><span class="refDoi"> DOI: 10.1021/jm201657x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201657x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Srtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3201-3215&author=Y.-S.+Linauthor=J.+Parkauthor=J.+W.+De+Schutterauthor=X.+F.+Huangauthor=A.+M.+Berghuisauthor=M.+Sebagauthor=Y.+S.+Tsantrizos&title=Design+and+synthesis+of+active+site+inhibitors+of+the+human+farnesyl+pyrophosphate+synthase%3A+apoptosis+and+inhibition+of+ERK+phosphorylation+in+multiple+myeloma+cells&doi=10.1021%2Fjm201657x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells</span></div><div class="casAuthors">Lin, Yih-Shyan; Park, Jaeok; De Schutter, Joris W.; Huang, Xian Fang; Berghuis, Albert M.; Sebag, Michael; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3201-3215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of N-BPs inhibitors I and II (R1, R3 = thienyl, Ph, naphthyl, pyridinyl, substituted Ph, pyrazolyl, etc.; R2 = H, F; X = CH, N; Y = CH2, NH) of human farnesyl pyrophosphate synthase (hFPPS) was designed that interact with a larger portion of the GPP subpocket, as compared to the current therapeutic drugs, and rigidify the 364KRRK367 tail of hFPPS in the closed conformation in the absence of IPP.  The compds. I (Y = CH2) were prepd. by reaction of the corresponding bromo-3-chloromethylpyridines with methylenediphosphonate CH2[PO(OEt)2]2 with subsequent optional fluorination with N-fluoro-N-(phenylsulfonyl)benzenesulfonamide, and Suzuki coupling with boronates R1B(OH)2 or R1Bpin; the aminophosphonates (I, Y = NH, II) were prepd. by reaction of the corresponding bromo-2-pyridinamine or bromoaniline with di-Et phosphonate with subsequent Suzuki coupling.  The resulting diphosphonate tetraesters were hydrolyzed to free acids and tested for inhibition of the hFPPS.  Human farnesyl pyrophosphate synthase (hFPPS) controls intracellular levels of FPP and post-translational prenylation of small GTPase proteins, which are essential for cell signaling and cell proliferation.  Clin. investigations provide evidence that N-BP inhibitors of hFPPS are disease modifying agents that improve survival of multiple myeloma (MM) patients via mechanisms unrelated to their skeletal effects.  An analog of this series was used to demonstrate inhibition of the intended biol. target, resulting in apoptosis and down-regulation of ERK phosphorylation in human MM cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_8acK6CKzzrVg90H21EOLACvtfcHk0lhqjBp0urlNrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Srtro%253D&md5=ff5aafd5c764169176133928e94c3551</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm201657x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201657x%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BF.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520active%2520site%2520inhibitors%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%253A%2520apoptosis%2520and%2520inhibition%2520of%2520ERK%2520phosphorylation%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3201%26epage%3D3215%26doi%3D10.1021%2Fjm201657x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">In four out of thirty three cases (<b>2k</b>, <b>2i</b>, <b>2d</b>, <b>1r</b>), yields were in the range 27–45%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Paolini, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Aromaticity in heterocyclic systems. IV. Substitution reactions of imidazo [1,2-a]pyridine and related methyl derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span><span class="refDoi"> DOI: 10.1021/jo01023a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01023a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=4085-4090&author=J.+P.+Paoliniauthor=R.+K.+Robins&title=Aromaticity+in+heterocyclic+systems.+IV.+Substitution+reactions+of+imidazo+%5B1%2C2-a%5Dpyridine+and+related+methyl+derivatives&doi=10.1021%2Fjo01023a024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo01023a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01023a024%26sid%3Dliteratum%253Aachs%26aulast%3DPaolini%26aufirst%3DJ.%2BP.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DAromaticity%2520in%2520heterocyclic%2520systems.%2520IV.%2520Substitution%2520reactions%2520of%2520imidazo%2520%255B1%252C2-a%255Dpyridine%2520and%2520related%2520methyl%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D4085%26epage%3D4090%26doi%3D10.1021%2Fjo01023a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Enguehard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6575</span><span class="refDoi"> DOI: 10.1021/jo000698z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000698z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlCisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6572-6575&author=C.+Enguehardauthor=J.-L.+Renouauthor=V.+Collotauthor=M.+Hervetauthor=S.+Raultauthor=A.+Gueiffier&title=Reactivity+of+3-iodoimidazo%5B1%2C2-a%5Dpyridines+using+a+Suzuki-type+cross-coupling+reaction&doi=10.1021%2Fjo000698z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reaction</span></div><div class="casAuthors">Enguehard, Cecile; Renou, Jean-Louis; Collot, Valerie; Hervet, Maud; Rault, Sylvain; Gueiffier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6572-6575</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influence of base and solvent in Suzuki cross-coupling reaction of various 2-substituted-3-iodoimidazo[1,2-a]pyridines I (R1 = H, Me; R2 = H, Me, Me3C, EtO2C, Ph, 4-FC6H4) with boronic acids R3B(OH)2 (R3 = Me, Ph, 2-thienyl, 3-thienyl) providing imidazopyridines II was reported.  The reactivity was largely influenced by the nature of the substituents.  Optimized yields and shortened times of reaction were obtained using strong bases in DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjoH37Xzg6LVg90H21EOLACvtfcHk0lhQ_rMb_FewEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlCisbk%253D&md5=a19d17da72256f93571fb7e16fa5a04e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo000698z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000698z%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard%26aufirst%3DC.%26aulast%3DRenou%26aufirst%3DJ.-L.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3DReactivity%2520of%25203-iodoimidazo%255B1%252C2-a%255Dpyridines%2520using%2520a%2520Suzuki-type%2520cross-coupling%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D6572%26epage%3D6575%26doi%3D10.1021%2Fjo000698z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Laemmerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, W.</span><span> </span><span class="NLM_article-title">Quinine and quinidine derivatives as chiral selectors. I. Brush type chiral stationary phases for high-performance liquid chromatography based on cinchonan carbamates and their application as chiral anion exchangers</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">741</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/0021-9673(96)00137-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1016%2F0021-9673%2896%2900137-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=741&publication_year=1996&pages=33-48&author=M.+Laemmerhoferauthor=W.+Lindner&title=Quinine+and+quinidine+derivatives+as+chiral+selectors.+I.+Brush+type+chiral+stationary+phases+for+high-performance+liquid+chromatography+based+on+cinchonan+carbamates+and+their+application+as+chiral+anion+exchangers&doi=10.1016%2F0021-9673%2896%2900137-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0021-9673%2896%2900137-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9673%252896%252900137-9%26sid%3Dliteratum%253Aachs%26aulast%3DLaemmerhofer%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DW.%26atitle%3DQuinine%2520and%2520quinidine%2520derivatives%2520as%2520chiral%2520selectors.%2520I.%2520Brush%2520type%2520chiral%2520stationary%2520phases%2520for%2520high-performance%2520liquid%2520chromatography%2520based%2520on%2520cinchonan%2520carbamates%2520and%2520their%2520application%2520as%2520chiral%2520anion%2520exchangers%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D1996%26volume%3D741%26spage%3D33%26epage%3D48%26doi%3D10.1016%2F0021-9673%2896%2900137-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dudakovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonnahme, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1124/jpet.107.132217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1124%2Fjpet.107.132217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=18083912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=1028-1036&author=A.+Dudakovicauthor=A.+J.+Wiemerauthor=K.+M.+Lambauthor=L.+A.+Vonnahmeauthor=S.+E.+Dietzauthor=R.+J.+Hohl&title=Inhibition+of+geranylgeranyl+diphosphate+synthase+induces+apoptosis+through+multiple+mechanisms+and+displays+synergy+with+inhibition+of+other+isoprenoid+biosynthetic+enzymes&doi=10.1124%2Fjpet.107.132217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes</span></div><div class="casAuthors">Dudakovic, Amel; Wiemer, Andrew J.; Lamb, Kimberly M.; Vonnahme, Laura A.; Dietz, Sara E.; Hohl, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1028-1036</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitors of isoprenoid synthesis are widely used for treatment of human diseases, including hypercholesterolemia and osteoporosis, and they have the potential to be useful for treatment of cancer.  Statin drugs inhibit the enzyme HMG-CoA reductase, whereas nitrogenous bisphosphonates have more recently been shown to inhibit farnesyl disphosphate synthase.  In addn., our lab. has recently developed several potent and specific bisphosphonate inhibitors of geranylgeranyl diphosphate synthase, including digeranyl bisphosphonate.  Because all three enzymes fall in the same biosynthetic pathway and many of the biol. effects are due to depletion of downstream products, we hypothesized that simultaneous inhibition of these enzymes would result in synergistic growth inhibition.  In this study, we show that inhibition of geranylgeranyl diphosphate synthase induces apoptosis in K562 leukemia cells.  This induction of apoptosis is in part dependent upon both geranylgeranyl diphosphate depletion and accumulation of farnesyl diphosphate.  Combinations of either lovastatin or zoledronate with digeranyl bisphosphonate synergistically inhibited growth and induced apoptosis.  These combinations also potently inhibited cellular geranylgeranylation.  These results support the potential for combinations of multiple inhibitors of isoprene biosynthesis to inhibit cancer cell growth or metastasis at clin. achievable concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNp7BB_fJ-srVg90H21EOLACvtfcHk0lhQ_rMb_FewEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajs7c%253D&md5=a74030eb704b2bf2fb5fe44cd668eee8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.132217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.132217%26sid%3Dliteratum%253Aachs%26aulast%3DDudakovic%26aufirst%3DA.%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26aulast%3DLamb%26aufirst%3DK.%2BM.%26aulast%3DVonnahme%26aufirst%3DL.%2BA.%26aulast%3DDietz%26aufirst%3DS.%2BE.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520geranylgeranyl%2520diphosphate%2520synthase%2520induces%2520apoptosis%2520through%2520multiple%2520mechanisms%2520and%2520displays%2520synergy%2520with%2520inhibition%2520of%2520other%2520isoprenoid%2520biosynthetic%2520enzymes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D1028%26epage%3D1036%26doi%3D10.1124%2Fjpet.107.132217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Wiemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, D. F.</span><span> </span><span class="NLM_article-title">The intermediate enzymes of isoprenoid metabolism as anticancer targets</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.2174/187152009788451860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.2174%2F187152009788451860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=526-542&author=A.+J.+Wiemerauthor=R.+J.+Hohlauthor=D.+F.+Wiemer&title=The+intermediate+enzymes+of+isoprenoid+metabolism+as+anticancer+targets&doi=10.2174%2F187152009788451860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F187152009788451860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152009788451860%26sid%3Dliteratum%253Aachs%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DThe%2520intermediate%2520enzymes%2520of%2520isoprenoid%2520metabolism%2520as%2520anticancer%2520targets%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D526%26epage%3D542%26doi%3D10.2174%2F187152009788451860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ehrick, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puleo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachas, L. G.</span><span> </span><span class="NLM_article-title">Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1021/bc700196q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700196q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=315-321&author=R.+S.+Ehrickauthor=M.+Capaccioauthor=D.+A.+Puleoauthor=L.+G.+Bachas&title=Ligand-modified+aminobisphosphonate+for+linking+proteins+to+hydroxyapatite+and+bone+surface&doi=10.1021%2Fbc700196q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Modified Aminobisphosphonate for Linking Proteins to Hydroxyapatite and Bone Surface</span></div><div class="casAuthors">Ehrick, Robin S.; Capaccio, Marcello; Puleo, David A.; Bachas, Leonidas G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An increase in bone resorption is one of the main symptoms of osteoporosis, a disease that affects more and more individuals every day.  Bisphosphonates are known to inhibit bone resorption and thus are being used as a treatment for osteoporosis.  Aminobisphosphonates present a functionality that can be easily used for conjugation to other mols., such as peptides, proteins, and ligands for protein recognition.  In this study, an aminobisphosphonate conjugated with biotin was used as a model linker for protein attachment to bone.  With this system, the interaction of biotinylated aminobisphosphonate with hydroxyapatite, a major mineral component of bone, was investigated.  Quantification of the binding of aminobisphosphonate to hydroxyapatite was performed using a fluorescently labeled antibody for biotin.  Addnl., the interaction of the biotinylated aminobisphosphonate with multiple treatments of cortical bone from the mid-shaft of a cow femur was studied.  It was demonstrated that modified aminobisphosphonate reagents can bind hydroxyapatite and bone at high levels, while the biotin functionality is free to be recognized by the fluorescently labeled antibiotin antibody, suggesting that modified aminobisphosphonates could be used to link other peptides or proteins to the bone surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX4nV2KZRrTLVg90H21EOLACvtfcHk0lj_4ziJhe2Qrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjE&md5=b342469f717686b32b5d5be6b0f9dfd0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbc700196q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700196q%26sid%3Dliteratum%253Aachs%26aulast%3DEhrick%26aufirst%3DR.%2BS.%26aulast%3DCapaccio%26aufirst%3DM.%26aulast%3DPuleo%26aufirst%3DD.%2BA.%26aulast%3DBachas%26aufirst%3DL.%2BG.%26atitle%3DLigand-modified%2520aminobisphosphonate%2520for%2520linking%2520proteins%2520to%2520hydroxyapatite%2520and%2520bone%2520surface%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D315%26epage%3D321%26doi%3D10.1021%2Fbc700196q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Marma, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebetino, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triffitt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of α-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5967</span><span class="NLM_x">–</span> <span class="NLM_lpage">5975</span><span class="refDoi"> DOI: 10.1021/jm0702884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0702884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5967-5975&author=M.+S.+Marmaauthor=Z.+Xiaauthor=C.+Stewartauthor=F.+Coxonauthor=J.+E.+Dunfordauthor=R.+Baronauthor=B.+A.+Kashemirovauthor=F.+H.+Ebetinoauthor=J.+T.+Triffittauthor=R.+G.+G.+Russellauthor=C.+E.+McKenna&title=Synthesis+and+biological+evaluation+of+%CE%B1-halogenated+bisphosphonate+and+phosphonocarboxylate+analogues+of+risedronate&doi=10.1021%2Fjm0702884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0702884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0702884%26sid%3Dliteratum%253Aachs%26aulast%3DMarma%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DStewart%26aufirst%3DC.%26aulast%3DCoxon%26aufirst%3DF.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%25CE%25B1-halogenated%2520bisphosphonate%2520and%2520phosphonocarboxylate%2520analogues%2520of%2520risedronate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5967%26epage%3D5975%26doi%3D10.1021%2Fjm0702884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Palsuledesai, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochocki, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowski, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M. D.</span><span> </span><span class="NLM_article-title">A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1039/C3MB70593E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1039%2FC3MB70593E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=24577581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1094-1103&author=C.+C.+Palsuledesaiauthor=J.+D.+Ochockiauthor=T.+W.+Markowskiauthor=M.+D.+Distefano&title=A+combination+of+metabolic+labeling+and+2D-DIGE+analysis+in+response+to+a+farnesyltransferase+inhibitor+facilitates+the+discovery+of+new+prenylated+proteins&doi=10.1039%2FC3MB70593E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins</span></div><div class="casAuthors">Palsuledesai, Charuta C.; Ochocki, Joshua D.; Markowski, Todd W.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein prenylation is a post-translational modification required for proper cellular localization and activity of many important eukaryotic proteins.  Farnesyltransferase inhibitors (FTIs) have been explored extensively for their antitumor activity.  To assist in identifying potentially new and more useful markers for therapeutic applications, we developed a strategy that uses a combination of metabolic labeling and 2D DIGE (differential gel electrophoresis) to discover new prenylated proteins whose cellular levels are influenced by FTIs.  In this approach, metabolic labeling of prenylated proteins was first carried out with an alkyne-modified isoprenoid analog, C15Alk, in the presence or absence of the FTI L-744,832.  The resulting alkyne-tagged proteins were then labeled with Cy3-N3 and Cy5-N3 and subjected to 2D-DIGE.  Multiple spots having altered levels of labeling in presence of the FTI were obsd.  Mass spectrometric anal. of some of the differentially labeled spots identified several known prenylated proteins, along with HisRS, PACN-3, GNAI-1 and GNAI-2, which are not known to be prenylated.  In vitro farnesylation of a C-terminal peptide sequence derived from GNAI-1 and GNAI-2 produced a farnesylated product, suggesting GNAI-1 and GNAI-2 are potential novel farnesylated proteins.  These results suggest that this new strategy could be useful for the identification of prenylated proteins whose level of post-translational modification has been modulated by the presence of an FTI.  Addnl., this approach, which decreases sample complexity and thereby facilitates anal., should be applicable to studies of other post-translational modifications as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHeFeK67Hx7Vg90H21EOLACvtfcHk0lj_4ziJhe2Qrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlyksLw%253D&md5=cc624951893bdad5204484e1337869bb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC3MB70593E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MB70593E%26sid%3Dliteratum%253Aachs%26aulast%3DPalsuledesai%26aufirst%3DC.%2BC.%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DMarkowski%26aufirst%3DT.%2BW.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DA%2520combination%2520of%2520metabolic%2520labeling%2520and%25202D-DIGE%2520analysis%2520in%2520response%2520to%2520a%2520farnesyltransferase%2520inhibitor%2520facilitates%2520the%2520discovery%2520of%2520new%2520prenylated%2520proteins%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D1094%26epage%3D1103%26doi%3D10.1039%2FC3MB70593E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0ljN8EazfVTmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerutti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0ljN8EazfVTmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gmach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huben, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Błażewska, K. M.</span><span> </span><span class="NLM_article-title">α-Fluoro phosphonocarboxylates: the NMR analysis of the heteronuclear ABMX spin system</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span><span class="refDoi"> DOI: 10.1080/10426507.2014.909427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=10.1080%2F10426507.2014.909427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&pages=1216-1225&author=J.+Gmachauthor=K.+Hubenauthor=K.+M.+B%C5%82a%C5%BCewska&title=%CE%B1-Fluoro+phosphonocarboxylates%3A+the+NMR+analysis+of+the+heteronuclear+ABMX+spin+system&doi=10.1080%2F10426507.2014.909427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">α-Fluoro Phosphonocarboxylates: the NMR Analysis of the Heteronuclear ABMX Spin System</span></div><div class="casAuthors">Gmach, Joanna; Huben, Krzysztof; Blazewska, Katarzyna M.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1216-1225</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1563-5325</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The α-fluoro phosphonocarboxylate analogs of bisphosphonates have recently received attention due to their activity against Rab geranylgeranyl transferase, an enzyme implicated in a no. of disease conditions.  Most of the NMR data reported in the literature describing dialkyl α-fluorophosphonates are defined as first-order spectra.  Here, we report a second-order pattern obsd. in 19F NMR spectrum, being a part of heteronuclear ABMX spin system.  Such a spin system, CH2C(F)P, was subjected to NMR anal. supported by iteration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XA7B26U-f7Vg90H21EOLACvtfcHk0ljN8EazfVTmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWju7zN&md5=f31cd0752fe43659a09e60fd3665036f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F10426507.2014.909427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426507.2014.909427%26sid%3Dliteratum%253Aachs%26aulast%3DGmach%26aufirst%3DJ.%26aulast%3DHuben%26aufirst%3DK.%26aulast%3DB%25C5%2582a%25C5%25BCewska%26aufirst%3DK.%2BM.%26atitle%3D%25CE%25B1-Fluoro%2520phosphonocarboxylates%253A%2520the%2520NMR%2520analysis%2520of%2520the%2520heteronuclear%2520ABMX%2520spin%2520system%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem.%26date%3D2014%26volume%3D189%26spage%3D1216%26epage%3D1225%26doi%3D10.1080%2F10426507.2014.909427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GTS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GTS','PDB','4GTS'); return false;">PDB: 4GTS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i135"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00811">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82444"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00811">10.1021/acs.jmedchem.7b00811</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full experimental details, including spectra (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>31</sup>P NMR) of all compounds, data on separation of enantiomers (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Protein structures; cytotoxic efficacy on HeLa cell line of the studied compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_002.zip">ZIP</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_001.pdf">jm7b00811_si_001.pdf (25.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_002.zip">jm7b00811_si_002.zip (943.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00811/suppl_file/jm7b00811_si_003.csv">jm7b00811_si_003.csv (2.38 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00811&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00811" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00811" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c60cadc53c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
